"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtAU_IN","meanArtPer_AU_IN_FIRST","meanArtPer_AU_IN_LAST","meanArtPer_AU_IN_CORR","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q4_nSJR","Q3_nSJR","Q1_percSJR","Q2_percSJR","Q4_percSJR","Q3_percSJR","meanTCperArt","mean_NTC","InternCoauthorship","AffCoauthorship","meanCitationTrend","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","total_docs","nDoc_wALTM","percDoc_wALTM","medianAltmetricScore","cited_by_accounts_count_mean_top25AltmScore","cited_by_accounts_count_min_top25AltmScore","cited_by_accounts_count_max_top25AltmScore","cited_by_fbwalls_count_mean_top25AltmScore","cited_by_fbwalls_count_min_top25AltmScore","cited_by_fbwalls_count_max_top25AltmScore","cited_by_feeds_count_mean_top25AltmScore","cited_by_feeds_count_min_top25AltmScore","cited_by_feeds_count_max_top25AltmScore","cited_by_gplus_count_mean_top25AltmScore","cited_by_gplus_count_min_top25AltmScore","cited_by_gplus_count_max_top25AltmScore","cited_by_msm_count_mean_top25AltmScore","cited_by_msm_count_min_top25AltmScore","cited_by_msm_count_max_top25AltmScore","cited_by_patents_count_mean_top25AltmScore","cited_by_patents_count_min_top25AltmScore","cited_by_patents_count_max_top25AltmScore","cited_by_peer_review_sites_count_mean_top25AltmScore","cited_by_peer_review_sites_count_min_top25AltmScore","cited_by_peer_review_sites_count_max_top25AltmScore","cited_by_policies_count_mean_top25AltmScore","cited_by_policies_count_min_top25AltmScore","cited_by_policies_count_max_top25AltmScore","cited_by_posts_count_mean_top25AltmScore","cited_by_posts_count_min_top25AltmScore","cited_by_posts_count_max_top25AltmScore","cited_by_rdts_count_mean_top25AltmScore","cited_by_rdts_count_min_top25AltmScore","cited_by_rdts_count_max_top25AltmScore","cited_by_rh_count_mean_top25AltmScore","cited_by_rh_count_min_top25AltmScore","cited_by_rh_count_max_top25AltmScore","cited_by_tweeters_count_mean_top25AltmScore","cited_by_tweeters_count_min_top25AltmScore","cited_by_tweeters_count_max_top25AltmScore","cited_by_videos_count_mean_top25AltmScore","cited_by_videos_count_min_top25AltmScore","cited_by_videos_count_max_top25AltmScore","cited_by_wikipedia_count_mean_top25AltmScore","cited_by_wikipedia_count_min_top25AltmScore","cited_by_wikipedia_count_max_top25AltmScore","cohorts.com_mean_top25AltmScore","cohorts.com_min_top25AltmScore","cohorts.com_max_top25AltmScore","cohorts.doc_mean_top25AltmScore","cohorts.doc_min_top25AltmScore","cohorts.doc_max_top25AltmScore","cohorts.pub_mean_top25AltmScore","cohorts.pub_min_top25AltmScore","cohorts.pub_max_top25AltmScore","cohorts.sci_mean_top25AltmScore","cohorts.sci_min_top25AltmScore","cohorts.sci_max_top25AltmScore","readers.citeulike_mean_top25AltmScore","readers.citeulike_min_top25AltmScore","readers.citeulike_max_top25AltmScore","readers.connotea_mean_top25AltmScore","readers.connotea_min_top25AltmScore","readers.connotea_max_top25AltmScore","readers.mendeley_mean_top25AltmScore","readers.mendeley_min_top25AltmScore","readers.mendeley_max_top25AltmScore","readers_count_mean_top25AltmScore","readers_count_min_top25AltmScore","readers_count_max_top25AltmScore"
"IRCCS_RIZZOLI",2000,159,7,4.09433962264151,0.244239631336406,0.654088050314465,0.584905660377358,0.377358490566038,0.132075471698113,7,52,37,24,22,0.33,0.23,0.15,0.14,52.95,1.16806846694559,0.232704402515723,0.647798742138365,NA,0.534853132136521,0.435195178989027,0.445821185617104,0.44017094017094,"ALDO TONI;PIERO PICCI;SUSANNA STEA;G. CIAPETTI;DONATELLA GRANCHI;L. SAVARINO;MILENA FINI;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;A. PIZZOFERRATO;LUCIANO MERLINI;SANDRO GIANNINI;CRISTIANA FORNI;KATIA SCOTLANDI;MAURILIO MARCACCI;PATRIZIA BACCHINI;GAETANO BACCI;GIANLUCA GIAVARESI;MASSIMO SERRA","16;16;15;14;13;13;12;12;11;11;11;10;10;8;8;8;8;8;7;7","ALDO TONI;SUSANNA STEA;DONATELLA GRANCHI;SANDRO GIANNINI;MARCO VICECONTI;MASSIMILIANO BALEANI;LUCA CRISTOFOLINI;G. CIAPETTI;PIERO PICCI;MILENA FINI;A. PIZZOFERRATO;L. SAVARINO;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;WILLIAM L. BLALOCK;MAURILIO MARCACCI;E. CENNI;BATTISTA BORGHI;A. CASATI","3.61;2.94;2.63;2.46;2.2;2.2;2.12;2.04;1.99;1.77;1.75;1.75;1.71;1.6;1.49;1.23;1.21;1.21;1.14;1.14","ALDO TONI;PIERO PICCI;SUSANNA STEA;G. CIAPETTI;DONATELLA GRANCHI;L. SAVARINO;MILENA FINI;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;A. PIZZOFERRATO;LUCIANO MERLINI;SANDRO GIANNINI;CRISTIANA FORNI;KATIA SCOTLANDI;MAURILIO MARCACCI;PATRIZIA BACCHINI;GAETANO BACCI;GIANLUCA GIAVARESI;MASSIMO SERRA","16;16;15;14;13;13;12;12;11;11;11;10;10;8;8;8;8;8;7;7","ALDO TONI;SUSANNA STEA;DONATELLA GRANCHI;SANDRO GIANNINI;MARCO VICECONTI;MASSIMILIANO BALEANI;LUCA CRISTOFOLINI;G. CIAPETTI;PIERO PICCI;MILENA FINI;A. PIZZOFERRATO;L. SAVARINO;ROBERTO GIARDINO;ALESSANDRA LONGHI;M. ROCCA;WILLIAM L. BLALOCK;MAURILIO MARCACCI;E. CENNI;BATTISTA BORGHI;A. CASATI","3.61;2.94;2.63;2.46;2.2;2.2;2.12;2.04;1.99;1.77;1.75;1.75;1.71;1.6;1.49;1.23;1.21;1.21;1.14;1.14","PIERO PICCI;ROBERTO GIARDINO;GAETANO BACCI;ALDO TONI;MARCO VICECONTI;PATRIZIA BACCHINI;LUCA CRISTOFOLINI;FRANCO BERTONI;MAURILIO MARCACCI;ALESSANDRA LONGHI;STEFANO FERRARI;CRISTIANA FORNI;M. ROCCA;ANGELO CAPPELLO;ELIZAVETA KON;RANIERI CANCEDDA;RODOLFO QUARTO;A. BOYDE;ALESSANDRO CORSI;ANITA MURAGLIA","1567;1123;1085;1057;1047;1040;1035;1028;1011;971;958;948;871;844;754;754;754;751;751;751","PIERO PICCI;ROBERTO GIARDINO;GAETANO BACCI;ALDO TONI;FRANCO BERTONI;MAURILIO MARCACCI;ALESSANDRA LONGHI;STEFANO FERRARI;CRISTIANA FORNI;MARCO VICECONTI;M. ROCCA;ELIZAVETA KON;PATRIZIA BACCHINI;LUCIANO MERLINI;DAVIDE MAR√çA DONATI;G. CIAPETTI;MARCO MANFRINI;ALBERTO LEARDINI;PIETRO RUGGIERI;MICHELA VERSARI","1567;1123;1085;1050;1028;1011;971;958;948;947;871;754;697;693;657;617;579;577;549;522","PIERO PICCI;ALDO TONI;SUSANNA STEA;L. SAVARINO;G. CIAPETTI;ROBERTO GIARDINO;MILENA FINI;DONATELLA GRANCHI;M. ROCCA;ALESSANDRA LONGHI;A. PIZZOFERRATO;LUCIANO MERLINI;SANDRO GIANNINI;STEFANO FERRARI;MAURILIO MARCACCI;CRISTIANA FORNI;GAETANO BACCI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;MASSIMO SERRA","16;15;14;13;13;12;12;12;11;11;9;9;9;9;8;8;8;8;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;POLITICAL SCIENCE;PHILOSOPHY;PSYCHOLOGY;ART;GEOLOGY;BUSINESS;ECONOMICS;HISTORY;SOCIOLOGY","129;62;34;26;22;16;16;8;5;4;3;2;2;1;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;ANATOMY;CELL BIOLOGY;COMPOSITE MATERIAL;IMMUNOLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;BIOMEDICAL ENGINEERING;METALLURGY;OPTICS;ENVIRONMENTAL HEALTH;RADIOLOGY;ENDOCRINOLOGY;ORTHODONTICS;ANESTHESIA;DENTISTRY;PHYSICAL MEDICINE AND REHABILITATION;STRUCTURAL ENGINEERING","66;55;48;40;33;23;22;21;21;21;20;15;13;12;11;11;10;9;8;8;8;8","GENE;IN VITRO;CHEMOTHERAPY;OSTEOSARCOMA;IMPLANT;CANCER;SARCOMA;POPULATION;PROSTHESIS;ALTERNATIVE MEDICINE;APOPTOSIS;RECEPTOR;ARTHROPLASTY;BIOPSY;CELL CULTURE;CYTOKINE;DNA;IMMUNOHISTOCHEMISTRY;CARTILAGE;CEMENT;DISEASE;INCIDENCE (GEOMETRY);KINEMATICS;LESION;MUSCULAR DYSTROPHY;OSTEOPOROSIS;RADIATION THERAPY;RADIOGRAPHY;TUMOR NECROSIS FACTOR ALPHA","28;17;14;14;13;12;12;11;11;10;10;10;9;8;8;8;7;7;6;6;6;6;6;6;6;6;6;6;6","FIXATION (POPULATION GENETICS);ALLELE;BREAST CANCER;CHROMOSOME;GENE EXPRESSION;BONE CEMENT;PROGRAMMED CELL DEATH;TRANSCRIPTION FACTOR;CYTOTOXICITY;EWING'S SARCOMA;MUSCLE BIOPSY;MYOGENESIS;OSSEOINTEGRATION;OSTEOARTHRITIS;PERIPHERAL BLOOD MONONUCLEAR CELL;POLYMERASE CHAIN REACTION;AMENORRHEA;BIOREMEDIATION;CELL CYCLE;CHEMOKINE;CISPLATIN;CYTOTOXIC T CELL;ETOPOSIDE;FEMORAL CONDYLE;GAIT ANALYSIS;GIANT CELL TUMORS;GROUND REACTION FORCE;METASTASIS;MUTATION;RECEPTOR TYROSINE KINASE;RHABDOMYOSARCOMA;VASCULITIS","9;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ADJUVANT CHEMOTHERAPY;IFOSFAMIDE;NUCLEAR PROTEIN;BIOSTIMULATION;GIANT CELL ARTERITIS;PROPIDIUM IODIDE;ARTICULAR CARTILAGE;C2C12;CHEMOKINE RECEPTOR;DNA FRAGMENTATION;EMBRYONAL RHABDOMYOSARCOMA;FLUORESCENCE IN SITU HYBRIDIZATION;GENE MAPPING;IN SITU HYBRIDIZATION;INTERFACE (MATTER);LOSS OF HETEROZYGOSITY;MISSENSE MUTATION;MYOGENIN;NEUTRAL RED;ONCOGENE;PRIMARY TUMOR;XQ28","5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;BONE NEOPLASMS;FEMALE;MALE;;ADULT;OSTEOSARCOMA;MIDDLE AGED;ADOLESCENT;AGED;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ANIMALS;KNEE JOINT;MUSCLE, SKELETAL;SARCOMA, EWING;BIOCOMPATIBLE MATERIALS;CHILD;DOXORUBICIN;TIBIA;FEMUR","96;59;58;57;44;44;40;33;26;25;24;23;20;18;18;16;15;15;15;14","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;LOW-LEVEL LASER THERAPY IN BIOMEDICAL APPLICATIONS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;DESIGN AND CONTROL OF SOFT ROBOTIC SYSTEMS;EFFECTS OF BLOOD TRANSFUSION IN CLINICAL PRACTICE;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF RAS SIGNALING PATHWAYS;PATHOPHYSIOLOGY OF MYOCARDIAL REPERFUSION INJURY;ROLE OF CHEMOKINE RECEPTORS IN CANCER METASTASIS","27;21;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","TOTAL HIP REPLACEMENT;EWING'S SARCOMA;OSTEOSARCOMA;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;ADJUVANT CHEMOTHERAPY;BONE CEMENT;PROSTHETIC JOINT INFECTIONS;BIOCOMPATIBILITY;BIOMATERIAL;BIOMECHANICS;BONE REGENERATION;BONE RESORPTION;FEMORAL FRACTURES;HIP FRACTURE;KNEE BIOMECHANICS;REGIMEN;BIOSTIMULATION;CHEMOKINE RECEPTORS;CHONDROSARCOMA","15;9;9;7;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3","NEOADJUVANT CHEMOTHERAPY;TOTAL HIP;HIP PROSTHESES;PATIENTS TREATED;BONE CEMENT;BONE CEMENTS;GIANT CELL;GROWTH FACTOR;HIP ARTHROPLASTY;ISTITUTO ORTOPEDICO;MUSCULAR DYSTROPHY;RISK FACTORS;STROMAL CELLS;BONE MARROW;EWINGS SARCOMA;EXPERIMENTAL STUDY;FEMALE PATIENTS;GENETIC MAPPING;HIGH-GRADE OSTEOSARCOMA;HUMAN OSTEOSARCOMA;LOCALIZED OSTEOSARCOMA;MARROW STROMAL;ORTOPEDICO RIZZOLI;POLYMYALGIA RHEUMATICA;REFINED GENETIC;REPRODUCTIVE FUNCTIONS;SISTER CHROMATID;THALASSEMIC PATIENTS;AC GENE;ACCELERATE BONE","8;7;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","ALLOGENIC BLOOD;CELL LINES;GIANT CELL;RHABDOMYOSARCOMA CELL;AUTOLOGOUS BLOOD;BLOOD TRANSFUSION;II ALPHA;ANTI-TOPO II;ODDS RATIO;RATIO CI;LASER BIOSTIMULATION;AUTOTRANSFUSION REGIMEN;CELL TUMOR;DAYS -TH;DAYS NA;ENDURANCE LIMIT;GROWTH FACTOR;HAEMOGLOBIN CONCENTRATION;HERERBB RECEPTORS;HIP REVISION;HUMAN RHABDOMYOSARCOMA;INTEGRATED AUTOTRANSFUSION;KNEE ARTHROPLASTY;LEFT UNTREATED;PATIENTS UNDERGOING;SURFACE EXPRESSION;AGE RANGE;CELL RICH;CELL TUMORS;CERAMIC FEMORAL","12;10;10;10;8;8;8;7;6;6;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3",159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2001,191,6.17277486910995,3.47643979057592,0.287650602409639,0.738219895287958,0.544502617801047,0.120418848167539,0.141361256544503,3,55,36,59,18,0.29,0.19,0.31,0.09,36.74,0.804032980552058,0.172774869109948,0.591623036649215,NA,0.502477119082117,0.420041691483026,0.45973822305326,0.25124716553288,"MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;PIERO PICCI;ALDO TONI;PAOLA TORRICELLI;LUCIANO MERLINI;ALESSANDRA LONGHI;DONATELLA GRANCHI;MARCO VICECONTI;BATTISTA BORGHI;G. BACCI;RAFFAELE PASCARELLA;DOMENICO TIGANI;LUCA CRISTOFOLINI;G. CIAPETTI;E. CENNI;CARLA RENATA ARCIOLA;ARMANDO GIUNTI;CRISTIANA FORNI","25;21;18;16;12;12;9;9;9;9;9;8;8;8;8;8;8;7;7;7","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCA CRISTOFOLINI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;ALBERTO LEARDINI;BATTISTA BORGHI;RAFFAELE PASCARELLA;SAVERIO AFFATATO;GIOVANNI LUIGI DI GENNARO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;MARIO MERCURI;MASSIMILIANO BALEANI;DOMENICO TIGANI;DONATELLA GRANCHI;L CAMPANACCI","4.36;3.9;3.26;2.72;2.23;2.21;2.15;2.02;1.75;1.72;1.72;1.65;1.65;1.6;1.6;1.56;1.5;1.46;1.39;1.32","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;PIERO PICCI;ALDO TONI;PAOLA TORRICELLI;LUCIANO MERLINI;ALESSANDRA LONGHI;DONATELLA GRANCHI;MARCO VICECONTI;BATTISTA BORGHI;G. BACCI;RAFFAELE PASCARELLA;DOMENICO TIGANI;LUCA CRISTOFOLINI;G. CIAPETTI;E. CENNI;CARLA RENATA ARCIOLA;ARMANDO GIUNTI;CRISTIANA FORNI","25;21;18;16;12;12;9;9;9;9;9;8;8;8;8;8;8;7;7;7","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCA CRISTOFOLINI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;ALBERTO LEARDINI;BATTISTA BORGHI;RAFFAELE PASCARELLA;SAVERIO AFFATATO;GIOVANNI LUIGI DI GENNARO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;MARIO MERCURI;MASSIMILIANO BALEANI;DOMENICO TIGANI;DONATELLA GRANCHI;L CAMPANACCI","4.36;3.9;3.26;2.72;2.23;2.21;2.15;2.02;1.75;1.72;1.72;1.65;1.65;1.6;1.6;1.56;1.5;1.46;1.39;1.32","MILENA FINI;PIERO PICCI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;STEFANO FERRARI;LUCIANO MERLINI;ALESSANDRA LONGHI;G. BACCI;ANDREA FACCHINI;M. MERCURI;L CAMPANACCI;ENRICO BERTINI;PATRIZIA SABATELLI;CRISTIANA FORNI;R. BIAGINI;FRANCO BERTONI;DAVIDE MAR√çA DONATI;GUGLIELMINA PEPE;FRANCESCO BERTONI;BRUNELLA GRIGOLO","1108;1091;894;835;723;704;703;696;615;600;532;501;494;482;427;426;416;408;372;362","MILENA FINI;PIERO PICCI;GIANLUCA GIAVARESI;ROBERTO GIARDINO;LUCIANO MERLINI;STEFANO FERRARI;ALESSANDRA LONGHI;G. BACCI;ANDREA FACCHINI;L CAMPANACCI;M. MERCURI;DAVIDE MAR√çA DONATI;CRISTIANA FORNI;PATRIZIA SABATELLI;BRUNELLA GRIGOLO;LIVIA ROSETI;FRANCO BERTONI;STEFANO BANDIERA;A BRICCOLI;N. NICOLI ALDINI","1090;906;817;733;704;643;623;597;569;532;514;416;402;367;362;360;322;320;317;315","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;PIERO PICCI;PAOLA TORRICELLI;ALDO TONI;DONATELLA GRANCHI;LUCIANO MERLINI;MARCO VICECONTI;STEFANO FERRARI;G. CIAPETTI;BATTISTA BORGHI;E. CENNI;L CAMPANACCI;G. BACCI;L. SAVARINO;LUCA CRISTOFOLINI;CARLA RENATA ARCIOLA;ALESSANDRA LONGHI;LUCIO MONTANARO","24;18;17;13;12;11;9;9;9;9;8;8;8;7;7;7;7;7;7;6","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;ENGINEERING;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;GEOLOGY;ECONOMICS;ART;SOCIOLOGY","164;55;40;35;22;18;18;17;6;4;3;2;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;GENETICS;BIOCHEMISTRY;COMPOSITE MATERIAL;BIOMEDICAL ENGINEERING;ENDOCRINOLOGY;DENTISTRY;RADIOLOGY;IMMUNOLOGY;ORTHODONTICS;ANESTHESIA;MOLECULAR BIOLOGY;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;GEOMETRY;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;STRUCTURAL ENGINEERING","97;53;42;35;30;29;25;21;17;15;15;14;14;13;13;12;11;8;8;8;8;8","GENE;FEMUR;IN VITRO;IMPLANT;OSTEOSARCOMA;PROSTHESIS;ORTHOPEDIC SURGERY;ALTERNATIVE MEDICINE;CANCER;CHEMOTHERAPY;OSTEOPOROSIS;LESION;ENZYME;RECEPTOR;BACTERIA;POPULATION;CARTILAGE;CEMENT;LUMBAR;METHOTREXATE;OSTEOTOMY;RADIOGRAPHY;SARCOMA;TIBIA","23;19;18;17;15;13;12;11;11;11;11;10;9;9;8;8;7;7;7;7;7;7;7;7","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);STAPHYLOCOCCUS AUREUS;BONE MINERAL;MUTATION;OSSEOINTEGRATION;ALKALINE PHOSPHATASE;BONE CEMENT;CHONDROCYTE;CISPLATIN;GROWTH FACTOR;METASTASIS;STRESS SHIELDING;UMBILICAL VEIN;BREAST CANCER;DOXORUBICIN;OSTEOBLAST;OVARIECTOMIZED RAT;BRACHIAL PLEXUS BLOCK;EXON;FEMORAL CONDYLE;GENE DUPLICATION;PROGRAMMED CELL DEATH","9;8;7;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3","IFOSFAMIDE;STAPHYLOCOCCUS EPIDERMIDIS;NEOADJUVANT THERAPY;OSTEOCALCIN;OSTEOPENIA;ARTICULAR CARTILAGE;COMPARATIVE GENOMIC HYBRIDIZATION;HIGH TIBIAL OSTEOTOMY;KARYOTYPE;LIMB-GIRDLE MUSCULAR DYSTROPHY;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICROCOCCACEAE;NUCLEAR PROTEIN;PERIPHERAL MYELIN PROTEIN 22;PRIMARY TUMOR;STAPHYLOCOCCUS;ANEUPLOIDY;ANTIRHEUMATIC DRUGS;ARTHROPATHY;BASIC FIBROBLAST GROWTH FACTOR;BIOSTIMULATION;BONE HISTOMORPHOMETRY;CARDIAC INDEX;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CASPASE;CEFAMANDOLE;CHEMOKINE RECEPTOR;COENZYME Q ‚Äì CYTOCHROME C REDUCTASE;COMPOUND HETEROZYGOSITY;CYSTATIN;CYTOGENETICS;DEHYDROEPIANDROSTERONE SULFATE;DISTORTION (MUSIC);DNA METHYLATION;ENTEROCOCCUS FAECALIS;ETHYLENE OXIDE;FAS LIGAND;FIBRONECTINS;FLUORESCENCE IN SITU HYBRIDIZATION;GENE EXPRESSION PROFILING;GENU VARUM;IMIPENEM;INSULIN-LIKE GROWTH FACTOR;INTERFACE (MATTER);JURKAT CELLS;KNEE PAIN;LACHMAN TEST;LEIGH DISEASE;LOW LEVEL LASER THERAPY;MAMMOGRAPHY;METAPHASE;MHC CLASS I;MISSENSE MUTATION;MMP2;MMP9;OPERON;OSTEOPOROTIC FRACTURE;POINT MUTATION;RETINOBLASTOMA PROTEIN;RIBONUCLEOPROTEIN;SOLITARY FIBROUS TUMOR;STAPHYLOCOCCAL INFECTIONS;STERILIZATION (ECONOMICS);STROKE VOLUME;THROMBOMODULIN;TOBRAMYCIN;TRYPSINIZATION;TUMOR SUPPRESSOR GENE;VANCOMYCIN;VINCRISTINE;VITRONECTIN;VON KOSSA STAIN","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;BONE NEOPLASMS;OSTEOSARCOMA;ADULT;MIDDLE AGED;ADOLESCENT;CHILD;;AGED;ANIMALS;FEMUR;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;KNEE JOINT;ORTHOPEDIC PROCEDURES;TIME FACTORS;BIOMECHANICAL PHENOMENA;FRACTURES, BONE;PROSTHESIS DESIGN","141;79;74;67;54;47;43;41;31;28;27;27;24;20;19;18;18;16;16;16","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;OSTEOPOROSIS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;LOW-LEVEL LASER THERAPY IN BIOMEDICAL APPLICATIONS;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BONE TISSUE ENGINEERING AND BIOMATERIALS;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US","30;17;8;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","OSTEOSARCOMA;TOTAL HIP REPLACEMENT;INTERNAL FIXATION;BIOMECHANICS;HIP ARTHROPLASTY;TOTAL KNEE REPLACEMENT;BONE CEMENT;HIP JOINT MECHANICS;HIP MORPHOLOGY;POSTOPERATIVE PAIN;STRESS SHIELDING;ANATOMICAL RECONSTRUCTION;BONE REGENERATION;CHONDROCYTE;FEMORAL NERVE;FRACTURE CLASSIFICATION;LOW-LEVEL LASER THERAPY;REHABILITATION;SKELETAL MUSCLE ATROPHY;ANIMAL MODEL","13;12;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3","MUSCULAR DYSTROPHY;NEOADJUVANT CHEMOTHERAPY;ACRYLIC BONE;ENDOTHELIAL CELLS;BONE CEMENT;BONE CEMENTS;GROWTH FACTOR;HIP ARTHROPLASTY;EXPERIMENTAL STUDY;HUMAN ENDOTHELIAL;RAT BONE;STAPHYLOCOCCUS AUREUS;TOTAL HIP;ANKLE COMPLEX;BONE MARROW;BONE TUMOUR;BREAST LESIONS;CELLS INCUBATED;COMPOSITE FEMURS;DAY SURGERY;DIODE LASER;EWINGS SARCOMA;HIP STEM;HUMAN OSTEOSARCOMA;HYDROXYAPATITE-COATED TAPERED;INTERCELLULAR ADHESION;INTERLEUKIN- EXPRESSION;LOWER LIMB;MARROW STROMAL;MODULAR PROSTHETIC","6;6;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;MUSCLE FIBERS;MHC CLASS;DE JONGHE;INTERMEDIATE CMT;NEUROL -CROSSREF;X-LINKED VACUOLATED;PUBMED GOOGLE;VACUOLATED MYOPATHY;MEMBRANE ATTACK;ATTACK COMPLEX;TUMOR NECROSIS;CHARCOT-MARIE-TOOTH DISEASE;AUTOSOMAL DOMINANT;VAN BROECKHOVEN;AL DE;CHARCOT-MARIE-TOOTH NEUROPATHY;LOUBOUTIN JP;SURFACE MEMBRANE;COMPLEMENT MEMBRANE;DOMINANT INTERMEDIATE;FIBERSANN NEUROL;FMS FARDEAU;INFLAMMATORY MYOPATHIES;INJURED MUSCLE;JP CHATEAU;MARTIN J-J;MUSCLE FIBERSANN;MYOPATHY COMPLEMENT","56;46;22;21;20;19;18;18;17;17;14;12;12;11;10;10;9;9;9;9;8;8;8;8;8;8;8;8;8;8",191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2002,182,6.58791208791209,3.58791208791209,0.278713629402757,0.714285714285714,0.554945054945055,0.230769230769231,0.181318681318681,5,65,39,44,13,0.36,0.21,0.24,0.07,48.18,0.873345021665432,0.236263736263736,0.648351648351648,NA,0.542682181743324,0.466231283848359,0.481442006269592,0.451484542393633,"MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCIANO MERLINI;DONATELLA GRANCHI;ANGELO CAPPELLO;SAULO MARTELLI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;DAVIDE MAR√çA DONATI;N. NICOLI ALDINI;MASSIMO SERRA;MAURILIO MARCACCI;E. CENNI;ARMANDO GIUNTI;KATIA SCOTLANDI;NICOLA BALDINI;SUSANNA STEA","20;19;18;16;15;11;10;10;10;9;9;9;9;8;8;8;7;7;7;7","ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SAULO MARTELLI;GIANLUCA GIAVARESI;DONATELLA GRANCHI;MARCO VICECONTI;ANGELO CAPPELLO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;ALBERTO LEARDINI;SANDRO GIANNINI;DAVIDE CAMPOCCIA;BATTISTA BORGHI;LUCIANO MERLINI;SUSANNA STEA;PAOLA TORRICELLI;E. CENNI;BERIL TALIM;S PADERNI","3.34;3.21;3.15;2.93;2.91;2.78;2.68;2.19;1.89;1.89;1.79;1.78;1.75;1.53;1.53;1.51;1.5;1.47;1.43;1.34","MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;ALDO TONI;LUCIANO MERLINI;DONATELLA GRANCHI;ANGELO CAPPELLO;SAULO MARTELLI;MARCO VICECONTI;PAOLA TORRICELLI;PIERO PICCI;DAVIDE MAR√çA DONATI;N. NICOLI ALDINI;MASSIMO SERRA;MAURILIO MARCACCI;E. CENNI;ARMANDO GIUNTI;KATIA SCOTLANDI;NICOLA BALDINI;SUSANNA STEA","20;19;18;16;15;11;10;10;10;9;9;9;9;8;8;8;7;7;7;7","ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SAULO MARTELLI;GIANLUCA GIAVARESI;DONATELLA GRANCHI;MARCO VICECONTI;ANGELO CAPPELLO;CARLA RENATA ARCIOLA;LUCIO MONTANARO;ALBERTO LEARDINI;SANDRO GIANNINI;DAVIDE CAMPOCCIA;BATTISTA BORGHI;LUCIANO MERLINI;SUSANNA STEA;PAOLA TORRICELLI;E. CENNI;BERIL TALIM;S PADERNI","3.34;3.21;3.15;2.93;2.91;2.78;2.68;2.19;1.89;1.89;1.79;1.78;1.75;1.53;1.53;1.51;1.5;1.47;1.43;1.34","LUCIANO MERLINI;MILENA FINI;GIANLUCA GIAVARESI;ROBERTO GIARDINO;PIERO PICCI;DAVIDE MAR√çA DONATI;ALICE STEINBRECHER;ANA-ELINA LEHESJOKI;BERT VAN DER ZWAAG;BRU CORMAND;CHRISTOPHER A. WALSH;DANIEL BELTR√ÅN-VALERO DE BERNAB√â;DAVID CHITAYAT;ELLEN VAN BEUSEKOM;HAN G. BRUNNER;HANS VAN BOKHOVEN;H√úLYA KAYSERILI;JACOPO CELLI;JES√öS CRUCES;SOPHIE CURRIER","2323;984;971;877;698;685;680;680;680;680;680;680;680;680;680;680;680;680;680;680","LUCIANO MERLINI;MILENA FINI;GIANLUCA GIAVARESI;ROBERTO GIARDINO;PIERO PICCI;ANDREA FACCHINI;STEFANO FERRARI;A. PIACENTINI;N. NICOLI ALDINI;MASSIMO SERRA;GINA LISIGNOLI;G. BACCI;NICOLA BALDINI;PAOLA TORRICELLI;DAVIDE MAR√çA DONATI;BERIL TALIM;KATIA SCOTLANDI;ALDO TONI;DAVIDE CAMPOCCIA;M. MERCURI","2161;971;929;752;698;584;548;527;523;506;491;482;477;457;454;448;448;441;436;429","MILENA FINI;GIANLUCA GIAVARESI;ALDO TONI;LUCIANO MERLINI;ROBERTO GIARDINO;SAULO MARTELLI;MARCO VICECONTI;DONATELLA GRANCHI;PIERO PICCI;PAOLA TORRICELLI;N. NICOLI ALDINI;E. CENNI;M. MERCURI;MASSIMO SERRA;MAURILIO MARCACCI;G. CIAPETTI;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;L. SAVARINO;NICOLA BALDINI","19;17;15;14;14;10;10;10;9;9;9;8;8;8;8;7;7;7;7;6","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PHYSICS;ECONOMICS;PHILOSOPHY;GEOLOGY;POLITICAL SCIENCE;GEOGRAPHY;PSYCHOLOGY;ART;BUSINESS;SOCIOLOGY","148;68;38;31;30;21;18;18;6;4;3;3;2;2;1;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;BIOCHEMISTRY;GENETICS;MOLECULAR BIOLOGY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;RADIOLOGY;CELL BIOLOGY;ORTHODONTICS;ARTIFICIAL INTELLIGENCE;IMMUNOLOGY;ENVIRONMENTAL HEALTH;DENTISTRY;CANCER RESEARCH;ENDOCRINOLOGY;METALLURGY;PHYSICAL THERAPY;STRUCTURAL ENGINEERING","87;47;39;37;34;34;26;25;25;21;20;20;17;17;16;14;11;11;11;10;10","GENE;IMPLANT;IN VITRO;POPULATION;FEMUR;OSTEOSARCOMA;CELL CULTURE;ORTHOPEDIC SURGERY;ALTERNATIVE MEDICINE;CHEMOTHERAPY;ENZYME;OSTEOPOROSIS;IN VIVO;RECEPTOR;TIBIA;CANCER;PROSTHESIS;BIOMECHANICS;CARTILAGE;DISEASE;MUSCULAR DYSTROPHY;SARCOMA;TITANIUM","31;20;17;16;13;13;12;12;10;10;10;10;9;9;9;8;8;7;7;7;7;7;7","OSSEOINTEGRATION;FIXATION (POPULATION GENETICS);OSTEOBLAST;ALKALINE PHOSPHATASE;MUTATION;OSTEOARTHRITIS;CHEMOKINE;EXTERNAL FIXATION;POLYMERASE CHAIN REACTION;BONE CEMENT;EXON;GENE EXPRESSION;MAXIMUM BUBBLE PRESSURE METHOD;METASTASIS;OVARIECTOMIZED RAT;PHENOTYPE;PROGRAMMED CELL DEATH;TRANSFECTION;ALLELE;BONE MINERAL;BREAST CANCER;CELL CYCLE;CHONDROCYTE;CISPLATIN;COLLAGEN VI;CONGENITAL MUSCULAR DYSTROPHY;CUBIC ZIRCONIA;DEMENTIA;EWING'S SARCOMA;FEMORAL NECK;FIBROBLAST;GROWTH FACTOR;TRANSCRIPTION FACTOR;ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE","12;10;9;8;8;7;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","INTERFACE (MATTER);CHEMOKINE RECEPTOR;MISSENSE MUTATION;COMPOUND HETEROZYGOSITY;DBM;DIACYLGLYCEROL KINASE;DNA FRAGMENTATION;HAPLOTYPE;IL-2 RECEPTOR;MOLECULAR MEDICINE;NEOADJUVANT THERAPY;NUCLEAR PROTEIN;ONCOGENE;OSTEOCALCIN;POINT MUTATION;PROPIDIUM IODIDE;STAPHYLOCOCCUS EPIDERMIDIS;ACHILLES TENDON RUPTURE;ALLELE FREQUENCY;ALPHA (FINANCE);ALTERNATIVE SPLICING;ALVEOLAR RHABDOMYOSARCOMA;AMPLICON;ANTISENSE RNA;ARTICULAR CARTILAGE;AUTOPHOSPHORYLATION;BASIC FIBROBLAST GROWTH FACTOR;BONE HISTOMORPHOMETRY;BRADYCARDIA;CARBOPLATIN;CAVEOLIN 3;CEFAMANDOLE;CXCL10;CYCLIN-DEPENDENT KINASE 2;CYSTATIN;DEHYDROEPIANDROSTERONE SULFATE;DEPHOSPHORYLATION;DIFFERENTIAL DISPLAY;DISMUTASE;ETHYLENE OXIDE;EXOME SEQUENCING;FEBRILE NEUTROPENIA;FRAMESHIFT MUTATION;FUNCTIONAL RESIDUAL CAPACITY;GENE EXPRESSION PROFILING;GLYCINE RECEPTOR;HEMATOPOIETIC GROWTH FACTOR;HETEROZYGOTE ADVANTAGE;HIGH TIBIAL OSTEOTOMY;IFOSFAMIDE;IMIPENEM;IMMUNOTOXIN;KNEE SURGERY;LEUCINE ZIPPER;LMNA;MASTECTOMY;METHACRYLATE;OSTEOPENIA;OSTEOPROTEGERIN;PEAK INSPIRATORY PRESSURE;PENETRANCE;PILON FRACTURE;PKC ALPHA;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PRIMARY TUMOR;PROTEIN PHOSPHORYLATION;PROXIMAL MUSCLE WEAKNESS;RANKL;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;RESTRICTION SITE;REVERSE TRANSCRIPTASE;RNA SPLICING;SERIAL MANIPULATOR;SMN1;TELERADIOLOGY;TELEROBOTICS;THROMBOMODULIN;TOBRAMYCIN;TROCHANTER;TROGLITAZONE;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VANCOMYCIN;VASCULAR DEMENTIA;VON KOSSA STAIN","4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;BONE NEOPLASMS;MALE;OSTEOSARCOMA;ADULT;MIDDLE AGED;AGED;OSTEOBLASTS;;RNA, MESSENGER;ADOLESCENT;FOLLOW-UP STUDIES;SARCOMA, EWING;ANIMALS;ARTHROPLASTY, REPLACEMENT, HIP;FEMUR;OSTEOPOROSIS;MUSCULAR DYSTROPHIES;TUMOR CELLS, CULTURED","122;72;67;63;53;45;43;38;38;35;34;29;24;24;23;23;23;21;20;20","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TISSUE ENGINEERING AND BIOMATERIALS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;DESIGN AND CONTROL OF SOFT ROBOTIC SYSTEMS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;OPERATIVE MANAGEMENT OF PELVIC FRACTURES;ROLE OF CHEMOKINE RECEPTORS IN CANCER METASTASIS;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;DUAL-ENERGY COMPUTED TOMOGRAPHY;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;OSTEOARTHRITIS AND CARTILAGE REPAIR;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPIDEMIOLOGY AND TREATMENT OF CLAVICLE AND ACROMIOCLAVICULAR INJURIES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MICROSURGICAL RECONSTRUCTION TECHNIQUES","24;13;10;8;7;6;5;4;4;4;4;4;3;3;3;3;2;2;2;2","TOTAL HIP REPLACEMENT;OSTEOSARCOMA;OSTEOBLAST ADHESION;TOTAL KNEE REPLACEMENT;BIOMECHANICS;INTERNAL FIXATION;CANCELLOUS BONE;EWING'S SARCOMA;HIP ARTHROPLASTY;BONE REGENERATION;HIP JOINT MECHANICS;IMPLANT STABILITY;KNEE BIOMECHANICS;SURGICAL PLANNING;BONE CEMENT;FRACTURE CLASSIFICATION;HIP FRACTURE;INTERFACE (MATTER);K-EDGE IMAGING;SKELETAL MUSCLE ATROPHY","14;10;9;9;7;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4","MUSCULAR DYSTROPHY;ACRYLIC BONE;BONE CEMENT;EXTERNAL FIXATION;OSTEOBLAST-LIKE CELLS;BONE CEMENTS;ENMC INTERNATIONAL;INTERNATIONAL WORKSHOP;TOTAL HIP;BONE TUMORS;CEMENT EXTRACTS;CONGENITAL MUSCULAR;FEMORAL NECK;FINITE ELEMENT;HIP ARTHROPLASTY;HIP JOINT;HIP PROSTHESES;HIP PROSTHESIS;HIP REPLACEMENT;KNEE REPLACEMENT;MG OSTEOBLAST-LIKE;NEOADJUVANT CHEMOTHERAPY;OSTEOSARCOMA CELLS;TITANIUM IMPLANTS;TOTAL KNEE;ACETABULAR CUPS;ALKALINE PHOSPHATASE;ANIMAL STUDY;ANKLE REPLACEMENT;ARTICULAR SURFACES","8;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;CELL LINES;LAMIN AC;PUBMED GOOGLE;CELL LINE;EWINGS SARCOMA;AUTOSOMAL RECESSIVE;MUSCULOSKELETAL CELLS;RBCC EXPRESSION;MUSCULAR DYSTROPHY;OSTEOSARCOMA CELL;PARTIAL LIPODYSTROPHY;AUTOSOMAL DOMINANT;DI BARLETTA;GROWTH FACTOR;LMNA GENE;RAFFAELE DI;CCN EXPRESSION;HUMAN OSTEOSARCOMA;NEPHROBLASTOMA OVEREXPRESSED;FAMILIAL PARTIAL;GENE NOV;GENET -CROSSREF;RB EXPRESSION;CCN FAMILY;COLLAGEN VI;CONGENITAL MUSCULAR;CONNECTIVE TISSUE;ES CELLS","59;53;30;25;23;21;20;14;14;14;13;13;13;11;11;11;11;11;10;10;10;9;9;9;9;8;8;8;8;8",182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2003,195,7,4.02564102564103,0.248407643312102,0.692307692307692,0.656410256410256,0.312820512820513,0.133333333333333,6,68,55,44,17,0.35,0.28,0.23,0.09,54.93,1.03779298536119,0.235897435897436,0.692307692307692,NA,0.501695785846356,0.438290493676051,0.467901234567901,0.480458729440169,"MILENA FINI;ROBERTO GIARDINO;ALDO TONI;MARCO VICECONTI;GIANLUCA GIAVARESI;LUCIANO MERLINI;PIERO PICCI;SANDRO GIANNINI;STEFANO FERRARI;GAETANO BACCI;ARMANDO GIUNTI;ALESSANDRA LONGHI;PAOLA TORRICELLI;DAVIDE MAR√çA DONATI;L. SAVARINO;FRANCO BERTONI;CRISTIANA FORNI;MARIO MERCURI;N. NICOLI ALDINI;MAURILIO MARCACCI","23;22;17;16;14;13;13;12;12;12;11;11;11;11;10;10;9;9;9;8","MARCO VICECONTI;ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SANDRO GIANNINI;SAVERIO AFFATATO;LUCIANO MERLINI;L. SAVARINO;GIANLUCA GIAVARESI;PAOLA TORRICELLI;MASSIMILIANO BALEANI;ARMANDO GIUNTI;ANGELO CAPPELLO;GAETANO BACCI;FRANCO BERTONI;LUCA CRISTOFOLINI;SANDRA MARTELLI;ALESSANDRA LONGHI;MARIA GRAZIA BENEDETTI;PATRIZIA BACCHINI","3.79;3.61;3.43;3.31;2.57;2.31;2.1;2.06;1.98;1.74;1.67;1.56;1.53;1.53;1.51;1.4;1.39;1.39;1.32;1.32","MILENA FINI;ROBERTO GIARDINO;ALDO TONI;MARCO VICECONTI;GIANLUCA GIAVARESI;LUCIANO MERLINI;PIERO PICCI;SANDRO GIANNINI;STEFANO FERRARI;GAETANO BACCI;ARMANDO GIUNTI;ALESSANDRA LONGHI;PAOLA TORRICELLI;DAVIDE MAR√çA DONATI;L. SAVARINO;FRANCO BERTONI;CRISTIANA FORNI;MARIO MERCURI;N. NICOLI ALDINI;MAURILIO MARCACCI","23;22;17;16;14;13;13;12;12;12;11;11;11;11;10;10;9;9;9;8","MARCO VICECONTI;ALDO TONI;MILENA FINI;ROBERTO GIARDINO;SANDRO GIANNINI;SAVERIO AFFATATO;LUCIANO MERLINI;L. SAVARINO;GIANLUCA GIAVARESI;PAOLA TORRICELLI;MASSIMILIANO BALEANI;ARMANDO GIUNTI;ANGELO CAPPELLO;GAETANO BACCI;FRANCO BERTONI;LUCA CRISTOFOLINI;SANDRA MARTELLI;ALESSANDRA LONGHI;MARIA GRAZIA BENEDETTI;PATRIZIA BACCHINI","3.79;3.61;3.43;3.31;2.57;2.31;2.1;2.06;1.98;1.74;1.67;1.56;1.53;1.53;1.51;1.4;1.39;1.39;1.32;1.32","ROBERTO GIARDINO;STEFANO FERRARI;DAVIDE MAR√çA DONATI;LUCIANO MERLINI;MILENA FINI;PIERO PICCI;FRANCO BERTONI;ALESSANDRA LONGHI;PAOLA TORRICELLI;GAETANO BACCI;MARIO MERCURI;CRISTIANA FORNI;PATRIZIA SABATELLI;A BRICCOLI;GIANLUCA GIAVARESI;MARCO VICECONTI;LIA RIMONDINI;MARTA COLUMBARO;MARCO MANFRINI;PATRIZIA BACCHINI","1639;1318;1285;1269;1251;1205;1065;1050;1043;972;968;905;854;842;775;744;734;730;729;700","ROBERTO GIARDINO;LUCIANO MERLINI;MILENA FINI;PIERO PICCI;STEFANO FERRARI;DAVIDE MAR√çA DONATI;PAOLA TORRICELLI;FRANCO BERTONI;GAETANO BACCI;MARIO MERCURI;ALESSANDRA LONGHI;GIANLUCA GIAVARESI;MARTA COLUMBARO;MARCO VICECONTI;CRISTIANA FORNI;A BRICCOLI;SANDRO GIANNINI;ALDO TONI;L. SAVARINO;ARMANDO GIUNTI","1430;1268;1220;1200;1081;1043;1043;1009;972;907;813;775;730;726;668;661;652;620;576;544","MILENA FINI;ROBERTO GIARDINO;ALDO TONI;MARCO VICECONTI;GIANLUCA GIAVARESI;LUCIANO MERLINI;PIERO PICCI;SANDRO GIANNINI;STEFANO FERRARI;GAETANO BACCI;PAOLA TORRICELLI;ARMANDO GIUNTI;L. SAVARINO;ALESSANDRA LONGHI;FRANCO BERTONI;N. NICOLI ALDINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;CRISTIANA FORNI;KATIA SCOTLANDI","22;17;16;15;14;12;12;12;12;12;11;10;10;9;9;9;8;8;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHYSICS;GEOLOGY;PSYCHOLOGY;PHILOSOPHY;ECONOMICS;ART;POLITICAL SCIENCE;SOCIOLOGY","163;60;47;42;31;29;25;19;8;6;4;3;1;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;CELL BIOLOGY;GENETICS;ORTHODONTICS;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;GEOMETRY;IMMUNOLOGY;METALLURGY;RADIOLOGY;DENTISTRY;CANCER RESEARCH;PHYSICAL THERAPY;ONCOLOGY","92;60;46;41;38;34;34;22;22;21;19;16;15;15;15;15;14;13;13;12","GENE;FEMUR;CHEMOTHERAPY;IN VITRO;OSTEOSARCOMA;IMPLANT;RADIOGRAPHY;RECEPTOR;ALTERNATIVE MEDICINE;BIOMECHANICS;ENZYME;POPULATION;SARCOMA;CANCER;IN VIVO;OSTEOPOROSIS;DISEASE;RADIATION THERAPY;TITANIUM;ORIENTATION (VECTOR SPACE);ORTHOPEDIC SURGERY;OSTEOLYSIS","22;21;19;18;18;15;13;13;11;11;11;11;11;10;10;10;9;9;9;8;8;8","FIXATION (POPULATION GENETICS);OSTEOBLAST;OSSEOINTEGRATION;CISPLATIN;ALKALINE PHOSPHATASE;BONE MINERAL;FEMORAL NECK;METASTASIS;OSTEOARTHRITIS;BREAST CANCER;CHEMOKINE;DOXORUBICIN;EWING'S SARCOMA;GAIT ANALYSIS;GROWTH FACTOR;KYPHOSIS;OSTEOCLAST;PROTEIN KINASE B;SUBLUXATION;ALLELE;AUTOCRINE SIGNALLING;BONE CEMENT;CELL CYCLE;DEMENTIA;GENE EXPRESSION;GENOTYPE;GIANT-CELL TUMOR OF BONE;MUTATION;PI3K/AKT/MTOR PATHWAY;PROGRAMMED CELL DEATH;TRANSCRIPTION FACTOR;VIABILITY ASSAY","8;8;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","IFOSFAMIDE;CHEMOKINE RECEPTOR;CXCL10;ONCOGENE;OSTEOCALCIN;ARTICULAR CARTILAGE;GIANT CELL ARTERITIS;INTERFACE (MATTER);NEOADJUVANT THERAPY;NUCLEAR PROTEIN;OSTEOPENIA;PRIMARY TUMOR;RANKL;RNA SPLICING;TRANSLATION (BIOLOGY);ACTIN CYTOSKELETON;ACTINOMYCES NAESLUNDII;ADENOMATOUS POLYPOSIS COLI;AKT1;AMP DEAMINASE;ANTERIOR TALOFIBULAR LIGAMENT;ANTIFOLATE;AZOOSPERMIA;BACTERIAL ADHESIN;BETA-CATENIN;BONE METASTASIS;C2C12;CAPROLACTONE;CASPASE;CASPASE 3;CATHEPSIN K;CAVEOLIN;CAVEOLIN 3;COGNITIVE DECLINE;COMPARATIVE GENOMIC HYBRIDIZATION;CTGF;DIFFUSING CAPACITY;DISTORTION (MUSIC);DNA MICROARRAY;FAMILIAL ADENOMATOUS POLYPOSIS;FLUORESCENCE IN SITU HYBRIDIZATION;GENE EXPRESSION PROFILING;GENETICALLY MODIFIED MOUSE;GENOTYPING;HAPLOTYPE;HUMAN GENOME;INSULIN-LIKE GROWTH FACTOR;LIMB-GIRDLE MUSCULAR DYSTROPHY;LMNA;LOSS OF HETEROZYGOSITY;LY294002;MAMMARY GLAND;MAMMARY TUMOR;MASTECTOMY;MEAN ARTERIAL PRESSURE;MEK INHIBITOR;METALORGANIC VAPOUR PHASE EPITAXY;MITOCHONDRIAL FUSION;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;MMP2;MMP9;MOLECULAR MEDICINE;NERVE BIOPSY;NUCLEOPLASM;OLIGOMYCIN;OSTEOPOROTIC FRACTURE;OSTEOPROTEGERIN;P-GLYCOPROTEIN;PATELLAR LIGAMENT;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PROTO-ONCOGENE PROTEINS C-AKT;PTEN;SECONDARY HYPERPARATHYROIDISM;STAPHYLOCOCCUS EPIDERMIDIS;TAMOXIFEN;THIN PLATE SPLINE;TIMP1;TRANSACTIVATION;TROPISETRON;VASCULAR DEMENTIA;VINCRISTINE;WARBURG EFFECT;WORTMANNIN","7;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;FEMALE;MALE;OSTEOSARCOMA;ADULT;FEMUR;SARCOMA, EWING;MIDDLE AGED;OSTEOBLASTS;ADOLESCENT;NEOPLASM RECURRENCE, LOCAL;AGED;;ANIMALS;CHILD;GIANT CELL TUMOR OF BONE;MATERIALS TESTING;MUSCLE, SKELETAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","145;101;86;73;68;55;51;47;44;40;38;35;30;28;28;28;26;25;25;22","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DENTAL RESTORATIVE MATERIALS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MULTIPOTENT MESENCHYMAL STEM CELLS;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;APPLICATION OF 3D PRINTING IN MEDICAL ANATOMY EDUCATION;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY","32;18;10;7;5;5;4;3;3;3;3;3;3;3;3;3;2;2;2;2","TOTAL HIP REPLACEMENT;EWING'S SARCOMA;BIOMECHANICS;OSTEOSARCOMA;HIP ARTHROPLASTY;OSTEOBLAST ADHESION;KNEE BIOMECHANICS;OSTEOLYSIS;TOTAL KNEE REPLACEMENT;INTERNAL FIXATION;SOFT TISSUE SARCOMA;BIOCOMPATIBILITY;GIANT CELL TUMOR;HIP FRACTURE;TREATMENT;FRACTURE CLASSIFICATION;HIP ARTHROSCOPY;HIP JOINT MECHANICS;IMPLANT STABILITY;KYPHOSIS","20;13;11;10;9;9;8;8;8;6;6;5;5;5;5;4;4;4;4;4","EWINGS SARCOMA;TOTAL HIP;NEOADJUVANT CHEMOTHERAPY;PATIENTS TREATED;FINITE ELEMENT;GIANT CELL;HIP REPLACEMENT;TOTAL KNEE;CELL TUMOR;CEMENTED HIP;HIP ARTHROPLASTY;HUMAN OSTEOBLASTS;MICRO-DIFFRACTION ANALYSIS;MUSCLE STANDARDIZED;OSTEOSARCOMA CELLS;PROSTHETIC SURFACE;RECONSTRUCTED BONE;RHEUMATOID ARTHRITIS;SOFT TISSUE;SPATIAL RESOLUTION;STAINLESS STEEL;STANDARDIZED FEMUR;STEM CELLS;TISSUE ENGINEERING;X-RAY MICRO-DIFFRACTION;ZR PROSTHETIC;AMBULANT CHILDREN;BACTERIAL COLONIZATION;BONE REPAIR;BOTULINUM TOXIN","7;7;6;6;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","GIANT CELL;CELL TUMORS;U- OS;PLASMA THCY;BRACHIAL PLEXUS;COMPLETE SURGERY;EWINGS SARCOMA;INTERSCALENE BRACHIAL;KNEE REPLACEMENT;LIMB SALVAGE;MOTOR FUNCTION;TOTAL KNEE;ATRIAL FIBRILLATIONFLUTTER;INTERSCALENE ANALGESIA;LOCAL ANESTHETIC;LUNG METASTASES;NEOADJUVANT CHEMOTHERAPY;ONSET TIME;PATHOLOGIC FRACTURE;POSTOPERATIVE ANALGESIA;ROPIVACAINE POSTOPERATIVE;SIGNIFICANT INCREASE;SKELETAL MUSCLE;SURGICAL BLOCK;THCY CONCENTRATIONS;ACHIEVED REMISSION;ATRIAL STANDSTILL;BONERESORBING ACTIVITY;CELL LINE;CELL TUMOR","11;8;8;7;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3",195,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2004,181,6.59116022099448,3.65745856353591,0.273413897280967,0.646408839779006,0.607734806629834,0.259668508287293,0.209944751381215,6,71,34,46,20,0.39,0.19,0.25,0.11,37.28,0.792325297386241,0.287292817679558,0.679558011049724,NA,0.495153156839578,0.457704674746475,0.45279593318809,0.459220779220779,"MARCO VICECONTI;MILENA FINI;NICOLA BALDINI;PATRIZIA BACCHINI;ALBERTO LEARDINI;FRANCO BERTONI;ARMANDO GIUNTI;GIANLUCA GIAVARESI;PIERO PICCI;FRANCESCO BERTONI;G. CIAPETTI;KATIA SCOTLANDI;ALDO TONI;STEFANIA PAGANI;ROBERTO GIARDINO;PAOLA TORRICELLI;MASSIMO SERRA;FRANCESCO TRAINA;DONATELLA GRANCHI;SANDRO GIANNINI","17;15;15;15;13;13;12;12;12;9;9;8;8;8;8;8;7;7;7;7","MARCO VICECONTI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;PATRIZIA BACCHINI;FRANCO BERTONI;NICOLA BALDINI;MARCO MANFRINI;ARMANDO GIUNTI;MILENA FINI;ALDO TONI;PIERO PICCI;SANDRO GIANNINI;FRANCESCO TRAINA;FRANCESCO BERTONI;AGNESE ANDOLLINA;G. CIAPETTI;FABIO CATANI;BATTISTA BORGHI;ANDREA CASATI;L. SAVARINO","3.8;3.2;2.95;2.8;2.37;2.13;1.93;1.81;1.79;1.69;1.64;1.51;1.39;1.35;1.32;1.28;1.21;1.17;1.17;1.16","MARCO VICECONTI;MILENA FINI;NICOLA BALDINI;PATRIZIA BACCHINI;ALBERTO LEARDINI;FRANCO BERTONI;ARMANDO GIUNTI;GIANLUCA GIAVARESI;PIERO PICCI;FRANCESCO BERTONI;G. CIAPETTI;KATIA SCOTLANDI;ALDO TONI;STEFANIA PAGANI;ROBERTO GIARDINO;PAOLA TORRICELLI;MASSIMO SERRA;FRANCESCO TRAINA;DONATELLA GRANCHI;SANDRO GIANNINI","17;15;15;15;13;13;12;12;12;9;9;8;8;8;8;8;7;7;7;7","MARCO VICECONTI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;PATRIZIA BACCHINI;FRANCO BERTONI;NICOLA BALDINI;MARCO MANFRINI;ARMANDO GIUNTI;MILENA FINI;ALDO TONI;PIERO PICCI;SANDRO GIANNINI;FRANCESCO TRAINA;FRANCESCO BERTONI;AGNESE ANDOLLINA;G. CIAPETTI;FABIO CATANI;BATTISTA BORGHI;ANDREA CASATI;L. SAVARINO","3.8;3.2;2.95;2.8;2.37;2.13;1.93;1.81;1.79;1.69;1.64;1.51;1.39;1.35;1.32;1.28;1.21;1.17;1.17;1.16","MILENA FINI;PAOLA TORRICELLI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;LUCIANO MERLINI;PATRIZIA BACCHINI;PIERO PICCI;ANTONELLA MOTTA;CLAUDIO MIGLIARESI;MARCO VICECONTI;MATILDE TSCHON;ALBERTO LEARDINI;N. NICOLI ALDINI;SANDRO GIANNINI;FRANCO BERTONI;ANDREW H. CROSBY;CHRISTIAN WINDPASSINGER;CHRISTINE VERELLEN;CHRISTOS PROUKAKIS;ERWIN PETEK","966;787;732;638;476;464;447;431;431;429;398;396;387;377;362;361;361;361;361;361","MILENA FINI;PAOLA TORRICELLI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;LUCIANO MERLINI;PATRIZIA BACCHINI;MARCO VICECONTI;ALBERTO LEARDINI;PIERO PICCI;N. NICOLI ALDINI;MATILDE TSCHON;FRANCO BERTONI;STEFANO FERRARI;CARLA RENATA ARCIOLA;LUCIO MONTANARO;GAETANO BACCI;MASSIMO SERRA;NICOLA BALDINI;GIORDANO NICOLETTI;LORENA LANDUZZI","966;787;732;638;476;441;429;396;393;387;386;362;340;336;336;311;291;290;284;284","MARCO VICECONTI;NICOLA BALDINI;MILENA FINI;FRANCO BERTONI;PATRIZIA BACCHINI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;PIERO PICCI;G. CIAPETTI;KATIA SCOTLANDI;PAOLA TORRICELLI;STEFANIA PAGANI;ROBERTO GIARDINO;ALDO TONI;DONATELLA GRANCHI;L. SAVARINO;MASSIMO SERRA;R. GIARDINO;FRANCESCO BERTONI;FRANCESCO TRAINA","17;15;15;13;13;13;12;10;9;8;8;8;8;7;7;7;7;7;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;ECONOMICS;GEOLOGY;PSYCHOLOGY;BUSINESS;HISTORY","141;72;35;30;25;19;17;14;6;4;4;3;2;2","SURGERY;PATHOLOGY;INTERNAL MEDICINE;BIOCHEMISTRY;GENETICS;ANATOMY;COMPOSITE MATERIAL;BIOMEDICAL ENGINEERING;CANCER RESEARCH;CELL BIOLOGY;ORTHODONTICS;IMMUNOLOGY;MOLECULAR BIOLOGY;RADIOLOGY;METALLURGY;PROGRAMMING LANGUAGE;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;ONCOLOGY;DENTISTRY;MICROBIOLOGY","75;49;46;33;32;31;26;25;25;21;20;17;15;15;12;12;11;10;10;9;9","GENE;OSTEOSARCOMA;CANCER;IN VITRO;RECEPTOR;IMPLANT;ORTHOPEDIC SURGERY;CHEMOTHERAPY;TIBIA;ALTERNATIVE MEDICINE;OSTEOPOROSIS;SARCOMA;SOFTWARE;ANKLE;ENZYME;FEMUR;IMMUNOHISTOCHEMISTRY;BIOCOMPATIBILITY;CELL;APOPTOSIS;BACTERIA;CELL CULTURE;CYTOKINE;IN VIVO;KINEMATICS","24;19;18;16;14;13;12;11;11;10;10;10;10;9;9;9;9;8;8;7;7;7;7;7;7","OSTEOBLAST;METASTASIS;ALKALINE PHOSPHATASE;BONE CEMENT;BONE MINERAL;FIXATION (POPULATION GENETICS);GENE EXPRESSION;OSTEOARTHRITIS;ACTIVATOR (GENETICS);CYCLOPHOSPHAMIDE;EWING'S SARCOMA;FEMORAL NECK;FIBULA;MULTIPLE DRUG RESISTANCE;OSTEOCLAST;STAPHYLOCOCCUS AUREUS;BIOFILM;BREAST CANCER;CELL CYCLE;CHONDROCYTE;DOXORUBICIN;FIBROBLAST;HIP FRACTURE;MUTATION;OSSEOINTEGRATION;PROGRAMMED CELL DEATH;PROTOCOL (SCIENCE);SOFTWARE DEVELOPMENT;VIRULENCE","10;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","COMPARATIVE GENOMIC HYBRIDIZATION;ONCOGENE;OSTEOPROTEGERIN;RANKL;ACTIN CYTOSKELETON;ALVEOLAR RHABDOMYOSARCOMA;CHEMOKINE RECEPTOR;COMPONENT-BASED SOFTWARE ENGINEERING;ECORI;ENTEROCOCCUS FAECALIS;LACTIDE;METALORGANIC VAPOUR PHASE EPITAXY;PROSTATE DISEASE;PROSTATE-SPECIFIC ANTIGEN;RIBOTYPING;STAPHYLOCOCCUS EPIDERMIDIS;ADENOCARCINOMA OF THE LUNG;ADJUVANT CHEMOTHERAPY;AMPLICON;ANAPLASTIC LYMPHOMA KINASE;ANOIKIS;ANTERIOR TALOFIBULAR LIGAMENT;ANTHRACYCLINE;ARTHROPATHY;BACTERIAL ADHESIN;BONE METASTASIS;BRAIN-DERIVED NEUROTROPHIC FACTOR;BREFELDIN A;CASPASE;CATHEPSIN K;CD99;CONNEXIN;CTGF;CTL*;CYSTECTOMY;DNA METHYLATION;DNA MICROARRAY;EMBRYONAL RHABDOMYOSARCOMA;EPIRUBICIN;FAS LIGAND;FAS RECEPTOR;FIBROBLAST GROWTH FACTOR RECEPTOR 1;GENE DOSAGE;GENE MUTATION;GENETICALLY MODIFIED MOUSE;HEMOLYSIN;HER2/NEU;INTERLEUKIN 21;KNEE SURGERY;LOW LEVEL LASER THERAPY;METHACRYLATE;METHYL METHACRYLATE;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MISSENSE MUTATION;MMP2;OSTEOCALCIN;OSTEOPOROTIC FRACTURE;P-GLYCOPROTEIN;PLACENTA;POINT MUTATION;PRIMARY TUMOR;PROPIDIUM IODIDE;PTEN;PUSTULOSIS;RIBOSOME;SECONDARY HYPERPARATHYROIDISM;SOFTWARE CONSTRUCTION;SOFTWARE RENDERING;STAPHYLOCOCCUS;SYNOVIAL FLUID;TARTRATE-RESISTANT ACID PHOSPHATASE;THORACIC VERTEBRAE;TIMP1;TRANSPOSABLE ELEMENT;TROPOMYOSIN RECEPTOR KINASE B;TUMOR SUPPRESSOR GENE;TUOHY NEEDLE;VINCRISTINE;VIRULENCE FACTOR;VON KOSSA STAIN","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;MALE;FEMALE;OSTEOSARCOMA;ADULT;MIDDLE AGED;;AGED;OSTEOBLASTS;ADOLESCENT;FEMUR;BIOCOMPATIBLE MATERIALS;AGED, 80 AND OVER;ANIMALS;MEMBRANE GLYCOPROTEINS;ARTHROPLASTY, REPLACEMENT, HIP;BONE AND BONES;TIBIA;CHILD","125;81;61;60;60;46;41;36;36;31;24;24;23;20;20;20;19;19;19;18","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;OSTEOPOROSIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIODEGRADABLE POLYMERS AS BIOMATERIALS AND PACKAGING;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;OSTEOARTHRITIS AND CARTILAGE REPAIR;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOMEDICAL APPLICATIONS OF SILK BIOMATERIALS;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CANCER OF UNKNOWN PRIMARY SITE;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES","19;19;9;8;8;5;5;5;4;3;3;3;3;3;2;2;2;2;2;2","OSTEOSARCOMA;EWING'S SARCOMA;TOTAL KNEE REPLACEMENT;BIOCOMPATIBILITY;KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;FRACTURE CLASSIFICATION;HIP ARTHROPLASTY;OSTEOBLAST ADHESION;BIOMECHANICS;BONE CEMENT;HIP FRACTURE;INTERNAL FIXATION;IDENTIFICATION (BIOLOGY);MANDIBULAR RECONSTRUCTION;MICROSURGICAL RECONSTRUCTION;REGIMEN;BIOMATERIAL;BONE MINERAL DENSITY;BONE REGENERATION","10;9;9;8;8;8;6;6;6;5;5;5;5;4;4;4;4;3;3;3","EWINGS SARCOMA;APPLICATION FRAMEWORK;MULTIMOD APPLICATION;TOTAL HIP;BONE TUMORS;CELL LINE;EPIDURAL NEEDLE;HIP REPLACEMENT;IIN VITROI;KNEE ARTHROPLASTY;MULTIDRUG RESISTANT;NEEDLE ROTATION;OSTEOSARCOMA CELLS;PRE-OPERATIVE PLANNING;ANKLE CENTER;AXIS IDENTIFICATION;BENIGN LESION;BIOCOMPATIBILITY EVALUATION;BONE CEMENT;CANCER MHRPC;CENTER LOCATION;CHEMICAL VAPOUR;CORTICAL BONE;DEGENERATIVE ATYPIA;DELIVERY SYSTEMS;DIAGNOSTIC TECHNIQUES;DISTAL RADIAL;DRUG DELIVERY;FEMORAL NECK;FIBROUS DYSPLASIA","5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AMINO ACID;CENTRAL LOW-GRADE;LOW-GRADE OSTEOSARCOMA;PRIMARY TUMOR;CELL LINES;CELL VACCINE;EPIDURAL CATHETER;LUNG METASTASES;NEUT-ŒúMT MICE;TUMOR ONSET;BDNF SECRETION;IL--ENGINEERED CELL;LOCAL ANESTHETIC;MESOTHELIAL CELLS;MM CELLS;NONMALIGNANT MESOTHELIAL;PLASMA AMINO;POSITIVE STAINING;PTHR GENE;PULMONARY METASTASES;RHABDOMYOSARCOMA CELLS;AMINO ACIDS;BALB-NEUT MICE;BOLOGNA ITALY;BONE-CEMENT INTERFACE;CELL LINE;CELL PROLIFERATION;CELL TYPES;CELLS EXPRESSING;CONTROL SUBJECTS","7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3",181,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2005,191,7,3.79581151832461,0.263448275862069,0.643979057591623,0.649214659685864,0.246073298429319,0.198952879581152,2,74,42,40,23,0.39,0.22,0.21,0.12,54.95,1.03784990961959,0.267015706806283,0.738219895287958,NA,0.462974037926571,0.377517891429569,0.428190723134543,0.373181530676787,"PIERO PICCI;MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;MAURILIO MARCACCI;ALBERTO LEARDINI;NICOLA BALDINI;ALDO TONI;MARCO VICECONTI;ARMANDO GIUNTI;GAETANO BACCI;SANDRO GIANNINI;MARIO MERCURI;ANDREA FACCHINI;BRUNELLA GRIGOLO;ANGELO CAPPELLO;ALESSANDRA LONGHI;STEFANO BORIANI;FRANCO BERTONI;A. FACCHINI","16;14;14;12;12;11;11;11;11;10;10;9;9;9;8;8;8;8;8;8","MARCO VICECONTI;ALBERTO LEARDINI;ALDO TONI;MAURILIO MARCACCI;MILENA FINI;ROBERTO GIARDINO;PIERO PICCI;FABIO CATANI;ANGELO CAPPELLO;ARMANDO GIUNTI;NICOLA BALDINI;SANDRO GIANNINI;GIANLUCA GIAVARESI;GAETANO BACCI;M. FRAVISINI;STEFANO BORIANI;ANDREA FACCHINI;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;BRUNELLA GRIGOLO","2.44;2.43;2.28;2;1.88;1.88;1.82;1.73;1.73;1.7;1.66;1.61;1.51;1.43;1.38;1.36;1.34;1.25;1.23;1.22","PIERO PICCI;MILENA FINI;ROBERTO GIARDINO;GIANLUCA GIAVARESI;MAURILIO MARCACCI;ALBERTO LEARDINI;NICOLA BALDINI;ALDO TONI;MARCO VICECONTI;ARMANDO GIUNTI;GAETANO BACCI;SANDRO GIANNINI;MARIO MERCURI;ANDREA FACCHINI;BRUNELLA GRIGOLO;ALESSANDRA LONGHI;STEFANO BORIANI;FRANCO BERTONI;A. FACCHINI;MICHELA VERSARI","16;14;14;12;12;11;11;11;11;10;10;9;9;9;8;8;8;8;8;7","MARCO VICECONTI;ALBERTO LEARDINI;ALDO TONI;MAURILIO MARCACCI;MILENA FINI;ROBERTO GIARDINO;PIERO PICCI;FABIO CATANI;ARMANDO GIUNTI;NICOLA BALDINI;SANDRO GIANNINI;GIANLUCA GIAVARESI;GAETANO BACCI;M. FRAVISINI;STEFANO BORIANI;ANDREA FACCHINI;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;BRUNELLA GRIGOLO;CARLA RENATA ARCIOLA","2.44;2.43;2.28;2;1.88;1.88;1.82;1.73;1.7;1.66;1.61;1.51;1.43;1.38;1.36;1.34;1.25;1.23;1.22;1.18","PIERO PICCI;ALBERTO LEARDINI;GAETANO BACCI;CARLA RENATA ARCIOLA;DAVIDE CAMPOCCIA;LUCIO MONTANARO;MILENA FINI;ROBERTO GIARDINO;NICOLA BALDINI;DAVIDE MAR√çA DONATI;ENRICO LUCARELLI;KATIA SCOTLANDI;MARIA CRISTINA MANARA;STEFANIA BENINI;GIANLUCA GIAVARESI;MARIO MERCURI;ALESSANDRA LONGHI;BRUNELLA GRIGOLO;MASSIMO SERRA;MARTA COLUMBARO","1185;961;872;775;775;775;681;681;677;632;629;627;627;627;621;611;573;563;557;546","ALBERTO LEARDINI;GAETANO BACCI;PIERO PICCI;CARLA RENATA ARCIOLA;DAVIDE CAMPOCCIA;LUCIO MONTANARO;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;GIANLUCA GIAVARESI;KATIA SCOTLANDI;ALESSANDRA LONGHI;MARIO MERCURI;ROBERTO GIARDINO;MARTA COLUMBARO;ANDREA FACCHINI;STEFANO FERRARI;FRANCO BERTONI;MICHELA VERSARI;MARIA BENEDETTA DONATI","961;872;837;775;775;775;641;632;622;621;593;573;558;549;546;544;542;531;520;505","PIERO PICCI;MILENA FINI;MAURILIO MARCACCI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;ALDO TONI;MARCO VICECONTI;ROBERTO GIARDINO;ANDREA FACCHINI;GAETANO BACCI;NICOLA BALDINI;SANDRO GIANNINI;A. FACCHINI;ARMANDO GIUNTI;FRANCO BERTONI;ALESSANDRA LONGHI;BRUNELLA GRIGOLO;MARIO MERCURI;STEFANO FERRARI;CARLA RENATA ARCIOLA","13;13;12;12;11;11;11;11;10;10;10;9;8;8;8;8;7;7;7;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PSYCHOLOGY;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;ART;BUSINESS;GEOLOGY;HISTORY","162;60;32;31;25;20;19;15;6;4;3;3;3;1;1;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;BIOCHEMISTRY;BIOMEDICAL ENGINEERING;GENETICS;CELL BIOLOGY;RADIOLOGY;COMPOSITE MATERIAL;IMMUNOLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;ORTHODONTICS;DENTISTRY;ENDOCRINOLOGY;ARTIFICIAL INTELLIGENCE;CLASSICAL MECHANICS;COMPUTER VISION;METALLURGY;ONCOLOGY","95;69;62;37;33;25;25;20;20;19;18;17;16;16;16;13;12;10;10;9;9;9","GENE;ALTERNATIVE MEDICINE;OSTEOSARCOMA;CHEMOTHERAPY;IN VITRO;CANCER;POPULATION;CARTILAGE;FEMUR;ORTHOPEDIC SURGERY;RADIOGRAPHY;SARCOMA;IMPLANT;KINEMATICS;PROSTHESIS;DISEASE;TIBIA;ARTHROPLASTY;BACTERIA;LESION;PROSPECTIVE COHORT STUDY;RECEPTOR","21;19;17;16;16;15;15;13;13;13;12;12;11;10;10;9;9;8;8;8;8;8","OSTEOARTHRITIS;BREAST CANCER;CHONDROCYTE;FIXATION (POPULATION GENETICS);MUTATION;STAPHYLOCOCCUS AUREUS;METASTASIS;PHENOTYPE;EWING'S SARCOMA;FIBULA;GROWTH FACTOR;LAMIN;MOTION CAPTURE;OSSEOINTEGRATION;OSTEOBLAST;PLATELET-RICH PLASMA;TRANSCRIPTION FACTOR;ALKALINE PHOSPHATASE;BONE MINERAL;CD44;CHEMOKINE;CISPLATIN;CYTOTOXICITY;DEMENTIA;DOXORUBICIN;DYNAMIC HIP SCREW;FIBROBLAST;GAIT ANALYSIS;RNA;SOFT TISSUE SARCOMA;T CELL;TITANIUM ALLOY;TRANSFECTION;TYPE II COLLAGEN","16;9;7;7;7;7;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;STAPHYLOCOCCUS EPIDERMIDIS;ADJUVANT CHEMOTHERAPY;NEOADJUVANT THERAPY;LMNA;NUCLEAR PROTEIN;STAPHYLOCOCCUS;CAPROLACTONE;CHEMOKINE RECEPTOR;GIANT CELL ARTERITIS;HETEROCHROMATIN;IFOSFAMIDE;INTERFACE (MATTER);LIMB-GIRDLE MUSCULAR DYSTROPHY;OSTEOCALCIN;STERILIZATION (ECONOMICS);VANCOMYCIN;VASCULAR DEMENTIA;AMES TEST;ANTIFOLATE;ANTIRETROVIRAL THERAPY;BACTERIAL ADHESIN;BASIC FIBROBLAST GROWTH FACTOR;CASPASE 3;CD28;CD3;CD40;CD86;CD99;CHONDROITIN SULFATE PROTEOGLYCAN;CHONDROMATOSIS;CTLA-4;CXCL10;CXCR4;CYTOSTASIS;DNA MISMATCH REPAIR;EMBRYONAL RHABDOMYOSARCOMA;FOLINIC ACID;GENETICALLY MODIFIED MOUSE;GLYCOPROTEIN 130;HIGH TIBIAL OSTEOTOMY;HISTONE DEACETYLASE;IL-2 RECEPTOR;IMMUNOTOXIN;INSULIN-LIKE GROWTH FACTOR;INTESTINAL CANCER;KERATAN SULFATE;KNEE SURGERY;LYMPHOPOIESIS;MAMMARY GLAND;MAMMARY TUMOR;MEDIAL MENISCUS;METASTASECTOMY;MICROARRAY ANALYSIS TECHNIQUES;MICROSATELLITE;MISSENSE MUTATION;MOLECULAR MEDICINE;MULTICENTER TRIAL;MULTIPLEX POLYMERASE CHAIN REACTION;ONCOGENE;P-GLYCOPROTEIN;PEROXIREDOXIN;PEROXYNITRITE;PLASMA CELL GRANULOMA;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POLY ADP RIBOSE POLYMERASE;PRENATAL DIAGNOSIS;PRIMARY TUMOR;RADIAL HEAD FRACTURE;RIBOSOME;RNA INTERFERENCE;RNA SPLICING;SISTER CHROMATIDS;STEROL REGULATORY ELEMENT-BINDING PROTEIN;TELEROBOTICS;THORACIC VERTEBRAE;TLR2;TOBRAMYCIN;TRASTUZUMAB;VINCRISTINE;VIRULENCE FACTOR","11;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;BONE NEOPLASMS;ADULT;OSTEOSARCOMA;MIDDLE AGED;;AGED;CHONDROCYTES;ADOLESCENT;CARTILAGE, ARTICULAR;KNEE JOINT;TREATMENT OUTCOME;AGED, 80 AND OVER;OSTEOBLASTS;SARCOMA, EWING;ANIMALS;ARTHROPLASTY, REPLACEMENT, HIP;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","135;75;69;64;56;49;45;42;41;32;30;29;27;25;23;22;22;21;21;17","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BONE TISSUE ENGINEERING AND BIOMATERIALS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT OF SPINAL METASTATIC TUMORS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DUAL-ENERGY COMPUTED TOMOGRAPHY;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS","24;19;14;8;7;6;6;5;4;3;3;3;3;3;3;2;2;2;2;2","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;OSTEOSARCOMA;EWING'S SARCOMA;OSTEOBLAST ADHESION;DISTAL RADIUS FRACTURES;INTERNAL FIXATION;OSTEOLYSIS;AGGRECAN;CHONDROCYTE;HIP JOINT MECHANICS;SOFT TISSUE SARCOMA;ADJUVANT CHEMOTHERAPY;ANTERIOR CRUCIATE LIGAMENT;BONE MINERAL DENSITY;HIP ARTHROPLASTY;HIP FRACTURE;MOTION CAPTURE;NEOADJUVANT THERAPY","15;11;11;10;9;8;6;6;6;5;5;5;5;4;4;4;4;4;4;4","TOTAL HIP;HIP ARTHROPLASTY;SOFT TISSUE;NEOADJUVANT CHEMOTHERAPY;ANTERIOR CRUCIATE;CLINICAL ISOLATES;CRUCIATE LIGAMENT;EWINGS SARCOMA;SURGICAL TREATMENT;CEMENTLESS HIP;COGNITIVE IMPAIRMENT;EXTERNAL FIXATION;FINITE ELEMENT;GROWTH FACTOR;IIN VITROI;IIN VIVOI;LIGAMENT RECONSTRUCTION;MILD COGNITIVE;ORTHOPEDIC INFECTIONS;OSTEOID OSTEOMA;PERTROCHANTERIC FRACTURES;PROSPECTIVE RANDOMIZED;RANDOMIZED STUDY;STEM CELLS;TOTAL KNEE;ADULT PATIENTS;ANTIBIOTIC RESISTANCE;ARTHROPLASTY RESULTS;AUTOLOGOUS CELL;AUTOLOGOUS CHONDROCYTE","8;7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","LAMIN AC;GROWTH FACTOR;MUSCULAR DYSTROPHY;POSTERIOR SLOPE;TIBIAL COMPONENT;ASEPTIC LOOSENING;BONE SARCOMA;GENE EXPRESSION;HYLAMER POLYETHYLENE;AC PHOSPHORYLATION;BONE LOSS;CDCDNULL T-CELLS;CELL LINES;CLINICAL ISOLATES;EWINGS SARCOMA;GIRDLE MUSCULAR;GROWTH FACTORS;LIMB GIRDLE;MG MG;OSTEOCHONDRAL LESIONS;PATIENTS UNDERGOING;PMR PATIENTS;REGRESSION LINE;SERUM LEVELS;STAPHYLOCOCCUS EPIDERMIDIS;TIBIAL PLATEAU;ANGIOGENIC FACTORS;ANGULAR DIFFERENCE;CD CD;COX REGRESSION","11;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3",191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2006,191,7.25130890052356,3.7696335078534,0.265277777777778,0.581151832460733,0.643979057591623,0.209424083769634,0.225130890052356,0,78,41,36,28,0.41,0.21,0.19,0.15,50.94,0.997341355326309,0.361256544502618,0.769633507853403,NA,0.509522075780586,0.422697998259356,0.44979769685652,0.415396341463415,"MILENA FINI;MARCO VICECONTI;PIERO PICCI;SANDRO GIANNINI;ALESSANDRA LONGHI;FRANCO BERTONI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;MAURILIO MARCACCI;NICOLA BALDINI;ALDO TONI;CARLA RENATA ARCIOLA;ROBERTO GIARDINO;LUCA CRISTOFOLINI;MARIA GRAZIA BENEDETTI;GAETANO BACCI;ELIZAVETA KON;PATRIZIA BACCHINI;LUCIO MONTANARO;FRANCESCO TRAINA","20;19;18;15;14;13;12;12;12;12;12;11;11;10;10;10;9;9;9;9","MARCO VICECONTI;MILENA FINI;SANDRO GIANNINI;FRANCO BERTONI;PIERO PICCI;ALDO TONI;ALBERTO LEARDINI;CARLA RENATA ARCIOLA;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;MAURILIO MARCACCI;MARIA GRAZIA BENEDETTI;ROBERTO GIARDINO;SAVERIO AFFATATO;NICOLA BALDINI;FRANCESCO TRAINA;GIANLUCA GIAVARESI;LUCIO MONTANARO;PATRIZIA BACCHINI;STEFANO ZAFFAGNINI","3.45;2.98;2.73;2.3;2.27;2.16;2.15;2.07;2;1.96;1.96;1.82;1.69;1.63;1.61;1.55;1.49;1.48;1.43;1.4","MILENA FINI;MARCO VICECONTI;PIERO PICCI;SANDRO GIANNINI;ALESSANDRA LONGHI;FRANCO BERTONI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;MAURILIO MARCACCI;NICOLA BALDINI;ALDO TONI;CARLA RENATA ARCIOLA;ROBERTO GIARDINO;LUCA CRISTOFOLINI;MARIA GRAZIA BENEDETTI;GAETANO BACCI;ELIZAVETA KON;PATRIZIA BACCHINI;LUCIO MONTANARO;FRANCESCO TRAINA","20;19;18;15;14;13;12;12;12;12;12;11;11;10;10;10;9;9;9;9","MARCO VICECONTI;MILENA FINI;SANDRO GIANNINI;FRANCO BERTONI;PIERO PICCI;ALDO TONI;ALBERTO LEARDINI;CARLA RENATA ARCIOLA;ALESSANDRA LONGHI;LUCA CRISTOFOLINI;MAURILIO MARCACCI;MARIA GRAZIA BENEDETTI;ROBERTO GIARDINO;SAVERIO AFFATATO;NICOLA BALDINI;FRANCESCO TRAINA;GIANLUCA GIAVARESI;LUCIO MONTANARO;PATRIZIA BACCHINI;STEFANO ZAFFAGNINI","3.45;2.98;2.73;2.3;2.27;2.16;2.15;2.07;2;1.96;1.96;1.82;1.69;1.63;1.61;1.55;1.49;1.48;1.43;1.4","PIERO PICCI;SANDRO GIANNINI;ALBERTO LEARDINI;GAETANO BACCI;ALESSANDRA LONGHI;MILENA FINI;MICHELA VERSARI;MAURILIO MARCACCI;FRANCO BERTONI;PATRIZIA BACCHINI;MARIO MERCURI;MARCO VICECONTI;A BRICCOLI;ELIZAVETA KON;MARIA GRAZIA BENEDETTI;GIANLUCA GIAVARESI;LISA BERTI;CARLA RENATA ARCIOLA;ROBERTO GIARDINO;D. BETTINELLI","1668;1141;1084;1069;1059;989;916;898;845;833;799;790;789;753;711;679;664;651;645;622","PIERO PICCI;MILENA FINI;ALESSANDRA LONGHI;GAETANO BACCI;MICHELA VERSARI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;MARCO VICECONTI;PATRIZIA BACCHINI;FRANCO BERTONI;ELIZAVETA KON;A BRICCOLI;MARIA GRAZIA BENEDETTI;MARIO MERCURI;GIANLUCA GIAVARESI;LISA BERTI;ROBERTO GIARDINO;D. BETTINELLI;R. NATIVO","1629;985;967;924;901;898;882;870;790;779;777;753;712;711;708;675;664;645;622;622","MILENA FINI;MARCO VICECONTI;PIERO PICCI;SANDRO GIANNINI;NICOLA BALDINI;MAURILIO MARCACCI;GIANLUCA GIAVARESI;ALBERTO LEARDINI;FRANCO BERTONI;ROBERTO GIARDINO;ALDO TONI;ALESSANDRA LONGHI;MARIA GRAZIA BENEDETTI;LUCA CRISTOFOLINI;FRANCESCO TRAINA;CARLA RENATA ARCIOLA;ELIZAVETA KON;STEFANO ZAFFAGNINI;LUCIO MONTANARO;PAOLA TORRICELLI","19;19;17;12;12;12;11;11;11;11;11;11;10;10;9;9;9;8;8;8","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;MATHEMATICS;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;ART;HISTORY;PSYCHOLOGY;SOCIOLOGY","147;66;55;47;36;26;25;9;8;4;4;1;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;BIOCHEMISTRY;COMPOSITE MATERIAL;ANATOMY;BIOMEDICAL ENGINEERING;GENETICS;CANCER RESEARCH;CELL BIOLOGY;ORTHODONTICS;ARTIFICIAL INTELLIGENCE;METALLURGY;RADIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENDOCRINOLOGY;ONCOLOGY;MOLECULAR BIOLOGY;OPTICS;ORGANIC CHEMISTRY","81;57;52;37;37;36;33;30;26;21;21;17;17;15;13;12;12;11;11;10","CANCER;CHEMOTHERAPY;GENE;OSTEOSARCOMA;ALTERNATIVE MEDICINE;SARCOMA;CARTILAGE;IN VITRO;RECEPTOR;IMPLANT;RADIOGRAPHY;CELL CULTURE;ENZYME;BACTERIA;FEMUR;TENDON;GAIT;ARTHROPLASTY;DISEASE;IMMUNOHISTOCHEMISTRY;KINEMATICS;POLYETHYLENE;SOFTWARE","22;22;20;20;19;16;15;15;14;13;11;10;10;9;9;9;8;7;7;7;7;7;7","OSTEOARTHRITIS;METASTASIS;ACTIVATOR (GENETICS);ALKALINE PHOSPHATASE;BREAST CANCER;CELL CYCLE;OSTEOBLAST;OSTEOCLAST;STAPHYLOCOCCUS AUREUS;BIOFILM;GAIT ANALYSIS;CHONDROCYTE;ETOPOSIDE;EWING'S SARCOMA;OSSEOINTEGRATION;CANCER CELL;CHONDROGENESIS;CISPLATIN;CYCLOPHOSPHAMIDE;MAXIMUM BUBBLE PRESSURE METHOD;MENISCUS;ROTATOR CUFF INJURY;TRANSFECTION","15;9;7;7;7;6;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;RANKL;OSTEOCALCIN;OSTEOPROTEGERIN;IFOSFAMIDE;INTERFACE (MATTER);NEOADJUVANT THERAPY;PRIMARY TUMOR;STAPHYLOCOCCUS;ADJUVANT CHEMOTHERAPY;BONE METASTASIS;CD99;CYCLIN;ENTEROCOCCUS FAECALIS;GIANT CELL ARTERITIS;MEDIAL MENISCUS;ONCOGENE;RESONANCE FREQUENCY ANALYSIS;VANCOMYCIN;VINCRISTINE;VIRULENCE FACTOR","8;7;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;BONE NEOPLASMS;OSTEOSARCOMA;FEMALE;MALE;;ADULT;MIDDLE AGED;ANIMALS;ADOLESCENT;AGED;KNEE JOINT;OSTEOBLASTS;BIOMECHANICAL PHENOMENA;NEOPLASM RECURRENCE, LOCAL;TREATMENT OUTCOME;SARCOMA, EWING;FEMUR;BIOCOMPATIBLE MATERIALS;BIOMARKERS, TUMOR","111;105;73;58;58;48;48;30;27;25;24;24;24;23;21;21;20;19;18;18","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TISSUE ENGINEERING AND BIOMATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIOMECHANICS OF RUNNING-RELATED INJURIES;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ANALYSIS OF THREE-DIMENSIONAL SHAPE STRUCTURES;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;CORROSION INHIBITORS AND PROTECTION MECHANISMS;DENTAL RESTORATIVE MATERIALS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES","29;25;10;10;9;7;5;5;4;4;3;3;2;2;2;2;2;2;2;2","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;OSTEOSARCOMA;EWING'S SARCOMA;TOTAL KNEE REPLACEMENT;SOFT TISSUE SARCOMA;BIOMECHANICS;SURFACE MODIFICATION;BIOCOMPATIBILITY;BIOMATERIAL;BONE REMODELING;GAIT ANALYSIS;IMAGING;METAL-ON-METAL BEARINGS;OSTEOBLAST ADHESION;ROTATOR CUFF TEARS;BIOMECHANICAL ANALYSIS;BONE REGENERATION;BONE RESORPTION;CHONDROGENESIS","16;14;14;12;9;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3","NEOADJUVANT CHEMOTHERAPY;EWINGS SARCOMA;TOTAL HIP;GAIT ANALYSIS;JOINT SIMULATOR;OSTEOSARCOMA PATIENTS;ROTATOR CUFF;SERUM LEVELS;SINGLE INSTITUTION;STROMAL CELLS;TOTAL KNEE;ACETABULAR CUPS;ACL RECONSTRUCTION;BONE CEMENT;CEMENTLESS HIP;HIP ARTHROPLASTY;HIP JOINT;HIP REPLACEMENT;KNEE ARTHROPLASTY;MARROW STROMAL;MUSCULAR DYSTROPHY;OSTEOBLAST-LIKE CELLS;PATIENTS TREATED;RECEPTOR ACTIVATOR;ACID SCAFFOLD;ACRYLIC BONE;ALLOGRAFT TRANSPLANTATION;ANKLE ARTHROSIS;ANKLE JOINT;BIOPHYSICAL STIMULATION","8;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","OSTEOSARCOMA PATIENTS;NUCLEAR IRS-;ORTHOPAEDIC RESEARCH;PATIENTS TREATED;PG SYNTHESIS;BONE LOSS;CELL LINES;LOCAL RECURRENCE;NEOADJUVANT CHEMOTHERAPY;SURGICAL MARGINS;ALKALINE PHOSPHATASE;BREAST CANCER;COLLAGEN FIBRILS;COLON CANCER;HISTOLOGIC RESPONSE;INTERSCALENE ANALGESIA;LUNG METASTASES;MM CELLS;ORTHOP RES;PATIENT-CONTROLLED INTERSCALENE;RESEARCH SOCIETY;TUMOUR CELLS;BENIGN TUMOURS;BONE METASTASES;BONE RESORPTION;CELL CYCLE;CHEMOTHERAPY PROTOCOLS;CLINICAL SAMPLES;COLLAGEN TYPE;DUCTAL CANCER","7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3",191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2007,187,6.88235294117647,3.9144385026738,0.255464480874317,0.631016042780749,0.6524064171123,0.224598930481283,0.245989304812834,2,71,58,21,21,0.38,0.31,0.11,0.11,49.42,0.936457260447404,0.310160427807487,0.711229946524064,NA,0.477502988187747,0.426995798319328,0.466737313081361,0.338672768878719,"MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;STEFANO FERRARI;ROBERTO GIARDINO;STEFANO ZAFFAGNINI;MILENA FINI;NICOLA BALDINI;GIANLUCA GIAVARESI;BARBARA BORDINI;PIER‚ÄêLUIGI LOLLINI;ALESSANDRA LONGHI;FULVIA TADDEI;MARIO MERCURI;FRANCO BERTONI;PATRIZIA NANNI;KATIA SCOTLANDI;LORENA LANDUZZI","27;15;15;14;12;12;11;10;10;10;9;8;8;8;8;8;8;7;7;7","MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;BARBARA BORDINI;FULVIA TADDEI;STEFANO ZAFFAGNINI;NICOLA BALDINI;ROBERTO GIARDINO;STEFANO FERRARI;ALDO TONI;SANDRO GIANNINI;ANDREA FACCHINI;MARIO MERCURI;FRANCO BERTONI;MILENA FINI;PAOLO ERANI;MASSIMILIANO BALEANI;FABIO BARUFFALDI","5.21;3.84;2.4;2.2;1.85;1.61;1.59;1.54;1.51;1.45;1.45;1.38;1.3;1.29;1.28;1.26;1.22;1.16;1.15;1.14","MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;STEFANO FERRARI;ROBERTO GIARDINO;STEFANO ZAFFAGNINI;MILENA FINI;NICOLA BALDINI;GIANLUCA GIAVARESI;BARBARA BORDINI;PIER‚ÄêLUIGI LOLLINI;ALESSANDRA LONGHI;FULVIA TADDEI;MARIO MERCURI;FRANCO BERTONI;PATRIZIA NANNI;KATIA SCOTLANDI;LORENA LANDUZZI","27;15;15;14;12;12;11;10;10;10;9;8;8;8;8;8;8;7;7;7","MARCO VICECONTI;LUCA CRISTOFOLINI;PIERO PICCI;MAURILIO MARCACCI;PATRIZIA BACCHINI;BARBARA BORDINI;FULVIA TADDEI;STEFANO ZAFFAGNINI;NICOLA BALDINI;ROBERTO GIARDINO;STEFANO FERRARI;ALDO TONI;SANDRO GIANNINI;ANDREA FACCHINI;MARIO MERCURI;FRANCO BERTONI;MILENA FINI;PAOLO ERANI;MASSIMILIANO BALEANI;FABIO BARUFFALDI","5.21;3.84;2.4;2.2;1.85;1.61;1.59;1.54;1.51;1.45;1.45;1.38;1.3;1.29;1.28;1.26;1.22;1.16;1.15;1.14","MARCO VICECONTI;LUCA CRISTOFOLINI;MAURILIO MARCACCI;FULVIA TADDEI;ELIZAVETA KON;ENRICO SCHILEO;PIERO PICCI;STEFANO FERRARI;ROBERTO GIARDINO;ALBERTO LEARDINI;ANDREI LAVROUKOV;MADDALENA MASTROGIACOMO;RANIERI CANCEDDA;RODOLFO QUARTO;VLADIMIR MOUKHACHEV;–°. –ú. –ö–£–¢–ï–ü–û–í;FRANCO BERTONI;PATRIZIA BACCHINI;STEFANO ZAFFAGNINI;MARIO MERCURI","1724;1147;1141;1052;880;775;670;670;614;566;566;566;566;566;566;566;550;538;527;516","MARCO VICECONTI;MAURILIO MARCACCI;FULVIA TADDEI;LUCA CRISTOFOLINI;ELIZAVETA KON;ENRICO SCHILEO;PIERO PICCI;STEFANO FERRARI;ROBERTO GIARDINO;ALBERTO LEARDINI;FRANCO BERTONI;STEFANO ZAFFAGNINI;MARIO MERCURI;PATRIZIA BACCHINI;MARIA GRAZIA BENEDETTI;FABIO BARUFFALDI;KATIA SCOTLANDI;GABRIELE PAOLINI;R. NATIVO;S. INGROSSO","1660;1141;1052;1010;880;775;670;656;614;566;550;527;516;506;444;436;417;389;389;389","MARCO VICECONTI;PIERO PICCI;MAURILIO MARCACCI;STEFANO FERRARI;LUCA CRISTOFOLINI;PATRIZIA BACCHINI;ROBERTO GIARDINO;NICOLA BALDINI;MILENA FINI;GIANLUCA GIAVARESI;STEFANO ZAFFAGNINI;FRANCO BERTONI;FULVIA TADDEI;MARIO MERCURI;DONATELLA GRANCHI;ALESSANDRA LONGHI;BARBARA BORDINI;FABIO BARUFFALDI;KATIA SCOTLANDI;PAOLA TORRICELLI","24;15;14;14;14;11;11;10;10;9;9;8;8;8;7;7;7;7;7;7","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;GEOLOGY;HISTORY;ECONOMICS;PSYCHOLOGY;SOCIOLOGY;GEOGRAPHY","149;74;37;37;20;19;18;17;6;5;4;2;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;GENETICS;CELL BIOLOGY;COMPOSITE MATERIAL;BIOMEDICAL ENGINEERING;ORTHODONTICS;CANCER RESEARCH;ENDOCRINOLOGY;RADIOLOGY;DENTISTRY;MOLECULAR BIOLOGY;IMMUNOLOGY;STRUCTURAL ENGINEERING;STATISTICS;ARTIFICIAL INTELLIGENCE;ONCOLOGY","85;57;54;39;35;34;30;26;23;23;19;18;15;14;14;13;12;11;10;9","GENE;ALTERNATIVE MEDICINE;CHEMOTHERAPY;ORTHOPEDIC SURGERY;IMPLANT;SARCOMA;IN VITRO;RECEPTOR;CANCER;CARTILAGE;OSTEOSARCOMA;OSTEOPOROSIS;RADIOGRAPHY;FEMUR;ARTHROPLASTY;ENZYME;CHONDROSARCOMA;POPULATION;PROSTHESIS;TIBIA","31;19;17;17;16;16;15;14;13;13;13;12;12;11;10;10;8;8;8;8","OSTEOARTHRITIS;OSTEOBLAST;GENE EXPRESSION;OSSEOINTEGRATION;ALKALINE PHOSPHATASE;CELL CYCLE;FIXATION (POPULATION GENETICS);STAPHYLOCOCCUS AUREUS;ACTIVATOR (GENETICS);ANTIBIOTIC RESISTANCE;BONE DENSITY;CD34;CELLULAR DIFFERENTIATION;CHONDROCYTE;CHROMATIN;CISPLATIN;GROWTH FACTOR;LAMIN;METASTASIS;OSTEOCLAST","14;8;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;IFOSFAMIDE;OSTEOCALCIN;HETEROCHROMATIN;RANKL;VANCOMYCIN;BASIC FIBROBLAST GROWTH FACTOR;CAPROLACTONE;ENDOSSEOUS IMPLANTS;ENTEROCOCCUS FAECALIS;IMATINIB MESYLATE;INSULIN RECEPTOR;NUCLEAR PROTEIN;ONCOGENE;OSTEOPROTEGERIN;RIBOTYPING;ACHILLES TENDON RUPTURE;ACTIVE IMMUNOTHERAPY;ADJUVANT CHEMOTHERAPY;ALTERNATIVE SPLICING;ANTHRACYCLINE;BUSULFAN;C2C12;CANCER VACCINE;CD146;CD90;CD99;CHEMOKINE RECEPTOR;CHONDROMATOSIS;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;CRACK GROWTH RESISTANCE CURVE;CTGF;CYCLIN D1;DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;DNA METHYLATION;DNA MISMATCH REPAIR;DNA-BINDING PROTEIN;DOUBLE BLIND;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;EMBRYONAL RHABDOMYOSARCOMA;EZRIN;FLUORESCENCE IN SITU HYBRIDIZATION;FUSION PROTEIN;GENTAMICIN SULFATE;GENU VARUM;GIANT CELL ARTERITIS;HEMOLYSIN;HIGH TIBIAL OSTEOTOMY;INSULIN-LIKE GROWTH FACTOR;INTERFACE (MATTER);INTRAVASATION;IŒöB KINASE;JURKAT CELLS;KERATAN SULFATE;KRAS;LAMINOTOMY;LMNA;MAMMARY TUMOR;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICROSATELLITE;MISSENSE MUTATION;MOLECULAR EPIDEMIOLOGY;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MULTIPLEX POLYMERASE CHAIN REACTION;MYOEPITHELIOMA;OLIGOMYCIN;OPIOID PEPTIDE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PATELLAR LIGAMENT;PDGFRA;PHOSPHOINOSITIDE 3-KINASE;PROMOTER;PSEUDOMONAS INFECTION;PTEN;RETINOBLASTOMA PROTEIN;RNA SPLICING;STAPHYLOCOCCUS EPIDERMIDIS;STERILIZATION (ECONOMICS);SYNOVIAL FLUID;TARTRATE-RESISTANT ACID PHOSPHATASE;TRABECTEDIN;TRAMP;TRANSLATION (BIOLOGY);VARUS DEFORMITY;VINCRISTINE","7;6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;FEMALE;MALE;ADULT;MIDDLE AGED;;SARCOMA, EWING;AGED;ANIMALS;FEMUR;OSTEOSARCOMA;ADOLESCENT;OSTEOBLASTS;CHONDROCYTES;CHONDROSARCOMA;BIOMECHANICAL PHENOMENA;KNEE JOINT;ARTHROPLASTY, REPLACEMENT, KNEE;BIOCOMPATIBLE MATERIALS","125;81;62;59;52;43;42;35;30;27;27;24;23;22;20;19;18;18;17;17","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;OSTEOPOROSIS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;IMMUNOBIOLOGY OF DENDRITIC CELLS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING;ROLE OF CCN PROTEINS IN SIGNALING PATHWAYS;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS","30;17;13;11;9;9;6;5;5;4;3;3;3;3;3;2;2;2;2;2","TOTAL HIP REPLACEMENT;EWING'S SARCOMA;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;CHONDROSARCOMA;INTERNAL FIXATION;OSTEOSARCOMA;IMPLANT STABILITY;MESENCHYMAL CHONDROSARCOMA;REPEATABILITY;BIOMECHANICS;FRACTURE CLASSIFICATION;OSTEOBLAST ADHESION;OSTEOCLAST DIFFERENTIATION;POLYMERIC SCAFFOLDS;BONE REGENERATION;CHONDROCYTE;OSSEOINTEGRATION;REGULATION OF BONE HOMEOSTASIS","14;12;12;11;9;7;7;7;6;6;6;5;5;5;5;5;4;4;4;4","TOTAL KNEE;EWINGS SARCOMA;HIP ARTHROPLASTY;MUSCULAR DYSTROPHY;BONE CEMENTS;BONE MARROW;CANCELLOUS BONE;CEMENTED HIP;EWING SARCOMA;FAMILY TUMORS;FINITE ELEMENT;GENE EXPRESSION;HIP STEMS;IIN VITROI;KNEE ARTHROPLASTY;NAVIGATION SYSTEM;OSTEOARTHRITIC CHONDROCYTES;SARCOMA FAMILY;TRABECULAR BONE;ARTICULAR CARTILAGE;BIOFUNCTIONALIZED POLY-Œï-CAPROLACTONE;CANCER CELLS;CARTILAGE DEFECTS;CARTILAGE LESIONS;CELL CARCINOMA;CEMENT MANTLE;CHONDROSARCOMAS ARISING;CONGENITAL MUSCULAR;DEDIFFERENTIATED CHONDROSARCOMAS;ELEMENT MODELS","6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","DNA METHYLATION;CCN PROTEINS;FOLD INCREASES;FOLD NA;NGML ŒúM;CELL GROWTH;GLUCOSAMINE CONCENTRATIONS;MAMMARY CANCER;MUSCULAR DYSTROPHY;SYNOVIAL FLUID;TOTAL HIP;TRANSCRIPTION FACTOR;CANCER CELLS;CARTILAGE DEFECTS;COLLAGEN TYPE;CONGENITAL MUSCULAR;EWINGS SARCOMA;GENE EXPRESSION;HUMAN CHONDROCYTES;IL-Œí EXPRESSION;INFLAMMATORY CYTOKINES;MORQUIO SYNDROME;NEOADJUVANT CHEMOTHERAPY;NONMETASTATIC OSTEOSARCOMA;TOTAL KNEE;TRANSGENIC MICE;TRUNCATED CCN;ULLRICH CONGENITAL;VV ROTATION;ADVERSE EVENTS","12;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3",187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2008,241,6.92116182572614,3.81327800829875,0.262241566920566,0.614107883817427,0.609958506224066,0.157676348547718,0.228215767634855,2,95,70,27,18,0.39,0.29,0.11,0.07,41.86,0.762924063177741,0.286307053941909,0.688796680497925,NA,0.51394420933195,0.464235764235764,0.466162640604831,0.436879432624114,"MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;ROBERTO GIARDINO;LUCA CRISTOFOLINI;ALBERTO LEARDINI;STEFANO ZAFFAGNINI;FULVIA TADDEI;MARIA GRAZIA BENEDETTI;GIANLUCA GIAVARESI;DOMENICO TIGANI;FRANCESCO TRAINA;ARMANDO GIUNTI;ALDO TONI;DONATELLA GRANCHI;MANUELE LAMPASI;SAVERIO AFFATATO;PAOLA TORRICELLI","33;20;18;18;17;17;16;15;14;14;12;10;10;10;9;9;9;8;8;8","MARCO VICECONTI;SANDRO GIANNINI;LUCA CRISTOFOLINI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;ALBERTO LEARDINI;FRANCESCO TRAINA;FULVIA TADDEI;NICOLA BALDINI;STEFANO ZAFFAGNINI;MARIA GRAZIA BENEDETTI;MANUELE LAMPASI;DOMENICO TIGANI;ALDO TONI;MASSIMILIANO BALEANI;O DONZELLI;GIANLUCA GIAVARESI;DAVIDE MAR√çA DONATI;CLAUDIA DI BELLA","6.85;3.43;2.99;2.89;2.82;2.68;2.62;2.61;2.51;2.23;2.18;2.15;1.82;1.77;1.61;1.55;1.48;1.4;1.37;1.34","MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;ROBERTO GIARDINO;LUCA CRISTOFOLINI;ALBERTO LEARDINI;STEFANO ZAFFAGNINI;FULVIA TADDEI;MARIA GRAZIA BENEDETTI;GIANLUCA GIAVARESI;DOMENICO TIGANI;FRANCESCO TRAINA;ARMANDO GIUNTI;ALDO TONI;DONATELLA GRANCHI;MANUELE LAMPASI;SAVERIO AFFATATO;PAOLA TORRICELLI","33;20;18;18;17;17;16;15;14;14;12;10;10;10;9;9;9;8;8;8","MARCO VICECONTI;SANDRO GIANNINI;LUCA CRISTOFOLINI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;ALBERTO LEARDINI;FRANCESCO TRAINA;FULVIA TADDEI;NICOLA BALDINI;STEFANO ZAFFAGNINI;MARIA GRAZIA BENEDETTI;MANUELE LAMPASI;DOMENICO TIGANI;ALDO TONI;MASSIMILIANO BALEANI;O DONZELLI;GIANLUCA GIAVARESI;DAVIDE MAR√çA DONATI;CLAUDIA DI BELLA","6.85;3.43;2.99;2.89;2.82;2.68;2.62;2.61;2.51;2.23;2.18;2.15;1.82;1.77;1.61;1.55;1.48;1.4;1.37;1.34","MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;ADRIANA BIGI;STEFANO ZAFFAGNINI;PAOLA TORRICELLI;ALBERTO MARTEGANI;BJ√òRN SKJOLDBYE;CARLO F√åLICE;CHRISTIAN NOLS√òE;CHRISTOPH F. DIETRICH;D LINDSELL;DAVID H. EVANS;DAVID O. COSGROVE;EDWARD LEEN;F. TRANQUART;FABIO PISCAGLIA;FABRIZIO CALLIADA;G SEIDEL","1126;1071;996;848;786;760;759;755;755;755;755;755;755;755;755;755;755;755;755;755","MARCO VICECONTI;MILENA FINI;MAURILIO MARCACCI;ROBERTO GIARDINO;STEFANO ZAFFAGNINI;FULVIA TADDEI;PAOLA TORRICELLI;MASSIMILIANO BALEANI;NICOLA BALDINI;SPARTACO SANTI;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;MARCO DELCOGLIANO;ENRICO DALL‚ÄôARA;LUCA CRISTOFOLINI;MARIO MERCURI;G. CIAPETTI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO","1093;1071;983;848;747;742;719;662;646;548;510;504;497;497;448;434;419;414;397;379","MARCO VICECONTI;MILENA FINI;SANDRO GIANNINI;MAURILIO MARCACCI;ROBERTO GIARDINO;NICOLA BALDINI;ALBERTO LEARDINI;FULVIA TADDEI;LUCA CRISTOFOLINI;STEFANO ZAFFAGNINI;MARIA GRAZIA BENEDETTI;FRANCESCO TRAINA;GIANLUCA GIAVARESI;DOMENICO TIGANI;DONATELLA GRANCHI;ALDO TONI;G. CIAPETTI;SAVERIO AFFATATO;ARMANDO GIUNTI;DAVIDE MAR√çA DONATI","32;20;18;17;17;16;15;14;14;13;12;10;10;10;9;9;8;8;8;7","MEDICINE;BIOLOGY;MATERIALS SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;ECONOMICS;GEOLOGY;POLITICAL SCIENCE;BUSINESS;ART;GEOGRAPHY","190;78;54;51;39;31;30;25;7;5;4;4;4;3;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;COMPOSITE MATERIAL;GENETICS;CELL BIOLOGY;ORTHODONTICS;BIOMEDICAL ENGINEERING;RADIOLOGY;CANCER RESEARCH;PHYSICAL THERAPY;ENVIRONMENTAL HEALTH;DENTISTRY;ORGANIC CHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION;METALLURGY;GEOMETRY;ARTIFICIAL INTELLIGENCE;CLASSICAL MECHANICS;IMMUNOLOGY;MOLECULAR BIOLOGY;STRUCTURAL ENGINEERING","109;65;62;45;42;38;32;31;30;29;24;22;21;16;15;15;15;14;12;11;11;11;11;11","GENE;IN VITRO;ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;IMPLANT;ARTHROPLASTY;POPULATION;OSTEOSARCOMA;PROSTHESIS;ANKLE;CANCER;CHEMOTHERAPY;FEMUR;RADIOGRAPHY;KINEMATICS;RECEPTOR;CELL CULTURE;BACTERIA;BIOMECHANICS;FINITE ELEMENT METHOD","26;24;22;21;19;18;16;15;15;14;14;12;12;12;11;11;10;9;9;9","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);OSTEOBLAST;STAPHYLOCOCCUS AUREUS;GENE EXPRESSION;ALKALINE PHOSPHATASE;ANTIBIOTIC RESISTANCE;METASTASIS;OSSEOINTEGRATION;OSTEOCLAST;CELLULAR DIFFERENTIATION;GAIT ANALYSIS;ACTIVATOR (GENETICS);BONE CEMENT;CELL CYCLE;KNEE REPLACEMENT;POLYLACTIC ACID;TRABECULAR BONE;TRANSCRIPTION FACTOR;COPOLYMER;DOXORUBICIN;FIBULA;GENOTYPE;MYOGENESIS;PERIPHERAL BLOOD MONONUCLEAR CELL;PROGRAMMED CELL DEATH;PROSTATE CANCER;PROSTHESIS DESIGN;PROTOCOL (SCIENCE)","17;12;12;9;7;6;6;6;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;OSTEOCALCIN;VANCOMYCIN;ARTHROPATHY;C2C12;MEROPENEM;STAPHYLOCOCCUS EPIDERMIDIS;BRAIN-DERIVED NEUROTROPHIC FACTOR;CHEMOKINE RECEPTOR;CYCLIN;GSTP1;MEDIAL MENISCUS;OSTEOPROTEGERIN;PSYCHOLOGICAL REPRESSION;QUANTITATIVE COMPUTED TOMOGRAPHY;RIBOTYPING;STAPHYLOCOCCAL INFECTIONS;ADENOSINE RECEPTOR;ANTHRACYCLINE;ANTIFOLATE;ANTIRETROVIRAL THERAPY;BONE METASTASIS;CASPASE;CAVEOLIN 3;CD99;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;CXCL10;DEFENSIVE MEDICINE;DEGENERATIVE ARTHRITIS;DKK1;DNA METHYLATION;DNA MISMATCH REPAIR;E2F;ENDOCYTIC CYCLE;ENOS;EPH RECEPTOR A2;ERYTHROPOIETIN-PRODUCING HEPATOCELLULAR (EPH) RECEPTOR;FLOXURIDINE;GENE DOSAGE;GENE EXPRESSION PROFILING;GENOTYPING;GERIATRIC DEPRESSION SCALE;GIANT CELL ARTERITIS;HEPATIC ARTERIAL INFUSION;HISTONE DEACETYLASE;IFOSFAMIDE;IMATINIB MESYLATE;IMMATURE TERATOMA;INHIBITOR OF APOPTOSIS;INTERLEUKIN 1Œí;INTERLEUKIN-4 RECEPTOR;INTRA ARTICULAR;IŒöB KINASE;LACHMAN TEST;LACTIDE;LINCOSAMIDES;LMNA;LOCALIZED DISEASE;METASTATIC BREAST CANCER;METASTATIC LESION;MICROSATELLITE;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;MOBILE GENETIC ELEMENTS;MULTILOCUS SEQUENCE TYPING;NEOADJUVANT THERAPY;NUCLEAR PROTEIN;OLIGOMER RESTRICTION;ONCOGENE;PIOGLITAZONE;PIVOT-SHIFT TEST;POROSIMETRY;PRIMARY TUMOR;RANKL;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;SINGULAR BOUNDARY METHOD;STAPHYLOCOCCUS;THORACIC VERTEBRAE;TRANSLATION (BIOLOGY);TRASTUZUMAB;TROPOMYOSIN RECEPTOR KINASE B;VCAM-1;VINORELBINE;WOMAC","4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;BONE NEOPLASMS;ADULT;MIDDLE AGED;AGED;OSTEOSARCOMA;TREATMENT OUTCOME;ANIMALS;OSTEOBLASTS;FEMUR;ARTHROPLASTY, REPLACEMENT, HIP;FOLLOW-UP STUDIES;KNEE JOINT;JOINT INSTABILITY;TISSUE ENGINEERING;ADOLESCENT;AGED, 80 AND OVER","142;78;70;66;61;59;54;47;45;32;31;31;26;24;24;22;21;21;20;20","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;SARCOMA RESEARCH AND TREATMENT;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;OSTEOPOROSIS;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;MANAGEMENT OF SPINAL METASTATIC TUMORS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY","29;13;12;10;8;7;7;6;5;4;4;4;3;3;3;3;3;3;3;3","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;BIOMECHANICS;HIP JOINT MECHANICS;IMPLANT STABILITY;SCAFFOLDS;BONE MINERAL DENSITY;HIP ARTHROSCOPY;INTERNAL FIXATION;LIMB RECONSTRUCTION;OSTEOBLAST ADHESION;OSTEOSARCOMA;POLYMERIC SCAFFOLDS;BIOMATERIAL;BONE CEMENT;CADAVERIC SPASM;CURETTAGE;FRACTURE CLASSIFICATION","21;15;13;10;9;8;6;6;5;5;5;5;5;5;5;4;4;4;4;4","TOTAL HIP;HIP ARTHROPLASTY;BONE MARROW;TOTAL KNEE;GAIT ANALYSIS;KNEE REPLACEMENT;STROMAL CELLS;MARROW STROMAL;SURGICAL TREATMENT;TISSUE ENGINEERING;ACL RECONSTRUCTION;ANTERIOR CRUCIATE;BONE CEMENT;CELL TUMOURS;CRUCIATE LIGAMENT;ELECTROMAGNETIC FIELDS;FINITE ELEMENT;FOLLOW-UP STUDY;GIANT CELL;HUMAN OSTEOSARCOMA;MESENCHYMAL STEM;NAVIGATION SYSTEM;OSTEOSARCOMA CELL;STEM CELLS;ACETABULAR NON-UNION;ACRYLIC BONE;ACRYLIC CEMENT;ADOLESCENT IDIOPATHIC;ANIMAL PET;ANKLE REPLACEMENT","8;7;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","LARSEN SYNDROME;PUBMED SCOPUS;CROSSREF PUBMED;HUMERO-SPINAL DYSOSTOSIS;JOINT DISLOCATIONS;CELL LINES;RECESSIVE LARSEN;CHST DEFICIENCY;STROMAL CELLS;SULFATE TRANSPORTER;GROWTH FACTOR;MED GENET;PEDIATR -ABSTRACT;SPONDYLOEPIPHYSEAL DYSPLASIA;CONGENITAL DISLOCATIONS;CONGENITAL JOINT;DIASTROPHIC DYSPLASIA;DYSPLASIA OMANI;GENE EXPRESSION;GENET -CROSSREF;OMANI TYPE;PROGRESSIVE SPINAL;PUBMED GOOGLE;ARTICULAR CARTILAGE;CHONDROITIN SULFATE;DOMINANT LARSEN;FLEXED POSTURE;LARSENS SYNDROME;TRABECULAR BONE;ACL RECONSTRUCTION","38;36;25;12;12;11;11;10;9;9;8;8;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;5",241,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2009,234,7.53418803418803,3.8034188034188,0.262921348314607,0.534188034188034,0.572649572649573,0.158119658119658,0.243589743589744,2,97,76,14,31,0.41,0.32,0.06,0.13,47.33,1.02317124884171,0.320512820512821,0.760683760683761,NA,0.50102190960852,0.456360900369929,0.480384865668867,0.380177514792899,"MARCO ALBERGHINI;MARCO VICECONTI;PIERO PICCI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;D. VANEL;ELIZAVETA KON;ERIC L. STAALS;MILENA FINI;SAVERIO AFFATATO;STEFANO BORIANI;ARMANDO GIUNTI;M. SPINELLI;MASSIMO SERRA;ALDO TONI","22;22;21;18;15;14;13;12;12;11;11;10;10;10;10;10;9;9;8;8","MARCO VICECONTI;MARCO ALBERGHINI;ALBERTO LEARDINI;MAURILIO MARCACCI;SANDRO GIANNINI;STEFANO BORIANI;PIERO PICCI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;M. SPINELLI;NICOLA BALDINI;STEFANO ZAFFAGNINI;D. VANEL;ALDO TONI;MASSIMILIANO BALEANI;GIUSEPPE FILARDO;LUCIANO MERLINI;SUSANNA STEA;ERIC L. STAALS;ARMANDO GIUNTI","5.01;2.91;2.57;2.47;2.44;2.34;2.2;2.18;2;1.98;1.79;1.71;1.69;1.57;1.52;1.51;1.45;1.44;1.4;1.33","MARCO ALBERGHINI;MARCO VICECONTI;PIERO PICCI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;D. VANEL;ELIZAVETA KON;ERIC L. STAALS;MILENA FINI;SAVERIO AFFATATO;STEFANO BORIANI;ARMANDO GIUNTI;M. SPINELLI;MASSIMO SERRA;ALDO TONI","22;22;21;18;15;14;13;12;12;11;11;10;10;10;10;10;9;9;8;8","MARCO VICECONTI;MARCO ALBERGHINI;ALBERTO LEARDINI;MAURILIO MARCACCI;SANDRO GIANNINI;STEFANO BORIANI;PIERO PICCI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;M. SPINELLI;NICOLA BALDINI;STEFANO ZAFFAGNINI;D. VANEL;ALDO TONI;MASSIMILIANO BALEANI;GIUSEPPE FILARDO;LUCIANO MERLINI;SUSANNA STEA;ERIC L. STAALS;ARMANDO GIUNTI","5.01;2.91;2.57;2.47;2.44;2.34;2.2;2.18;2;1.98;1.79;1.71;1.69;1.57;1.52;1.51;1.45;1.44;1.4;1.33","MAURILIO MARCACCI;GIUSEPPE FILARDO;ELIZAVETA KON;PIERO PICCI;SANDRO GIANNINI;MARCO ALBERGHINI;PIER MARIA FORNASARI;MARCO DELCOGLIANO;ROBERTO BUDA;ALESSANDRO DI MARTINO;ANNARITA CENACCHI;ALESSANDRO RUSSO;MILENA FINI;BRUNELLA GRIGOLO;STEFANO ZAFFAGNINI;ROBERTO GIARDINO;STEFANO FERRARI;MARIO MERCURI;ANTONIO TIMONCINI;ALBERTO LEARDINI","2816;1939;1906;1460;1301;1299;1199;1035;962;863;860;766;695;641;633;577;555;552;548;546","MAURILIO MARCACCI;GIUSEPPE FILARDO;ELIZAVETA KON;SANDRO GIANNINI;PIER MARIA FORNASARI;MARCO ALBERGHINI;PIERO PICCI;ROBERTO BUDA;MARCO DELCOGLIANO;ALESSANDRO DI MARTINO;ANNARITA CENACCHI;ALESSANDRO RUSSO;MILENA FINI;BRUNELLA GRIGOLO;STEFANO ZAFFAGNINI;ROBERTO GIARDINO;MARIO MERCURI;ANTONIO TIMONCINI;ALBERTO LEARDINI;ERIC L. STAALS","2816;1939;1906;1291;1199;998;994;962;870;863;860;766;695;641;633;577;552;548;546;516","MARCO VICECONTI;MARCO ALBERGHINI;PIERO PICCI;MAURILIO MARCACCI;SANDRO GIANNINI;ALBERTO LEARDINI;NICOLA BALDINI;GIUSEPPE FILARDO;STEFANO FERRARI;STEFANO ZAFFAGNINI;D. VANEL;MARIA GRAZIA BENEDETTI;SAVERIO AFFATATO;ELIZAVETA KON;MILENA FINI;ERIC L. STAALS;MASSIMO SERRA;STEFANO BORIANI;ALDO TONI;ROBERTO GIARDINO","22;20;18;18;14;13;12;12;12;11;11;11;10;10;10;10;8;8;8;8","MEDICINE;BIOLOGY;MATERIALS SCIENCE;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;ECONOMICS;GEOLOGY;SOCIOLOGY;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;ENVIRONMENTAL SCIENCE;HISTORY","192;86;40;35;32;30;26;18;4;3;3;3;2;2;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;GENETICS;CANCER RESEARCH;BIOCHEMISTRY;CELL BIOLOGY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;RADIOLOGY;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ORTHODONTICS;IMMUNOLOGY;QUANTUM MECHANICS;ENVIRONMENTAL HEALTH;PHYSICAL THERAPY;CLASSICAL MECHANICS;ORGANIC CHEMISTRY;STATISTICS;STRUCTURAL ENGINEERING","103;81;67;56;41;39;36;36;28;27;23;18;18;17;15;14;13;12;10;10;10;10","GENE;ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;PROSTHESIS;CANCER;SARCOMA;CARTILAGE;CHEMOTHERAPY;OSTEOSARCOMA;ARTHROPLASTY;IN VITRO;POPULATION;BONE MARROW;IMPLANT;APOPTOSIS;GAIT;KINEMATICS;KNEE JOINT;REGENERATION (BIOLOGY);TRANSPLANTATION","39;30;21;21;20;19;18;18;16;15;14;14;13;13;12;10;10;10;10;10","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);GENE EXPRESSION;GAIT ANALYSIS;OSTEOBLAST;CYCLOPHOSPHAMIDE;EWING'S SARCOMA;METASTASIS;CHONDROCYTE;MYOGENESIS;PLATELET-RICH PLASMA;BONE MINERAL;CELL CYCLE;CELLULAR DIFFERENTIATION;FIBULA;LUMBAR VERTEBRAE;NEUROBLASTOMA;PERIPROSTHETIC;PROGRAMMED CELL DEATH;RELIABILITY (SEMICONDUCTOR);RHABDOMYOSARCOMA;STAPHYLOCOCCUS AUREUS","26;9;9;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;C2C12;COMPARATIVE GENOMIC HYBRIDIZATION;SYNOVIAL FLUID;IFOSFAMIDE;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;DNA METHYLATION;EZRIN;GENE EXPRESSION PROFILING;HIGH TIBIAL OSTEOTOMY;INSULIN-LIKE GROWTH FACTOR;MISSENSE MUTATION;MMP2;MYOGENIN;NUCLEAR PROTEIN;OSTEOPROTEGERIN;PDGFRA;RETINOID;UNICOMPARTMENTAL KNEE ARTHROPLASTY;ACHILLES TENDON RUPTURE;ADAMANTINOMA;ALVEOLAR RHABDOMYOSARCOMA;AMPLICON;ANEUPLOIDY;AURORA INHIBITOR;AURORA KINASE;BACTERIAL ADHESIN;BONE DENSITY CONSERVATION AGENTS;BONE MORPHOGENETIC PROTEIN 7;BUSULFAN;CAPROLACTONE;CD99;CELL CYCLE CHECKPOINT;CHEMOKINE RECEPTOR;CHROMOSOME INSTABILITY;COMPOUND HETEROZYGOSITY;CONSENSUS SEQUENCE;COPY-NUMBER VARIATION;CYANOACRYLATE;CYCLIN D1;CYP1A2;CYP2C9;CYP2E1;CYP3A4;CYTOGENETICS;DIACYLGLYCEROL KINASE;DIIMIDE;DNA FRAGMENTATION;DNA MICROARRAY;DNA VACCINATION;DOUBLE BLIND;DUAL ENERGY;ENDOGLIN;ENTEROCOCCUS FAECALIS;FLI1;FLUORESCENCE IN SITU HYBRIDIZATION;GANGLIONEUROMA;GENOME INSTABILITY;GENOTYPING;HSP70;IN SITU HYBRIDIZATION;IN UTERO;INSULIN RECEPTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INSULIN-LIKE GROWTH FACTOR 2;INTERFACE (MATTER);LACHMAN TEST;LMNA;LOCALIZED DISEASE;MCL1;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MITOCHONDRIAL FUSION;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MYOD;ONCOGENE;OSTEOCALCIN;OXFORD KNEE SCORE;PANEL REACTIVE ANTIBODY;PERIAQUEDUCTAL GRAY;PIVOT-SHIFT TEST;QUALITY MANAGEMENT SYSTEM;RANKL;RESPIRATORY RATE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBOTYPING;RNA INTERFERENCE;SELECTED REACTION MONITORING;SINGLE-NUCLEOTIDE POLYMORPHISM;SPINDLE APPARATUS;STAPHYLOCOCCUS EPIDERMIDIS;SYSTEMIC THERAPY;TAMOXIFEN;TENDINOSIS;TERIPARATIDE;THORACIC VERTEBRAE;TRANSCRIPTIONAL REGULATION;TRANSCRIPTOME;TROLOX;VANCOMYCIN;VARUS DEFORMITY;VIROTHERAPY","14;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;BONE NEOPLASMS;MIDDLE AGED;;ADULT;AGED;ADOLESCENT;OSTEOSARCOMA;ANIMALS;SARCOMA, EWING;TIBIA;YOUNG ADULT;KNEE JOINT;TREATMENT OUTCOME;OSTEOBLASTS;FEMUR;RNA, MESSENGER;OSTEOARTHRITIS, KNEE","148;82;81;65;65;61;56;48;36;33;32;28;27;27;26;26;24;23;23;22","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BONE TISSUE ENGINEERING AND BIOMATERIALS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;NEUROBLASTOMA RESEARCH AND TREATMENT;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;MANAGEMENT OF SPINAL METASTATIC TUMORS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES","25;25;12;11;10;7;7;7;6;5;4;4;4;4;3;3;3;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;OSTEOSARCOMA;SOFT TISSUE SARCOMA;HIP ARTHROPLASTY;AUTOLOGOUS CHONDROCYTE IMPLANTATION;BIOMECHANICS;HIP JOINT MECHANICS;METASTATIC SPINE TUMORS;PLATELET-RICH PLASMA;PROXIMAL HUMERUS FRACTURES;REPEATABILITY;SKELETAL MUSCLE ATROPHY;BONE REGENERATION;C2C12;CHONDROSARCOMA;COMPARATIVE GENOMIC HYBRIDIZATION;HYALINE CARTILAGE","20;20;18;15;11;11;7;6;6;5;5;5;5;5;5;4;4;4;4;4","BONE MARROW;GAIT ANALYSIS;MARROW STROMAL;OSTEOCHONDRAL LESIONS;TISSUE ENGINEERING;TOTAL HIP;CHONDROCYTE IMPLANTATION;EWINGS SARCOMA;HIP ARTHROPLASTY;IIN VITROI;KNEE ARTHROPLASTY;MESENCHYMAL STEM;PLATELET-RICH PLASMA;SARCOMA FAMILY;STEM CELLS;STROMAL CELLS;SYNOVIAL FLUID;TOTAL KNEE;AUTOLOGOUS CHONDROCYTE;CELL TRANSPLANTATION;EWING SARCOMA;FAMILY TUMORS;FINITE ELEMENT;HIGH-GRADE OSTEOSARCOMA;HIP JOINT;HUMAN BONE;KIDSCANCERKINOME VALIDATION;KNEE PROSTHESIS;MINIMALLY INVASIVE;MUSCLE APOPTOSIS","5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","CELL LINES;EN BLOC;LOCAL RECURRENCE;MONTH WOMAC;PATIENTS TREATED;KING IV;LOWER LIMB;BLOC RESECTION;FEMORAL HEAD;FUNCTIONAL ABILITY;GENE EXPRESSION;LEVEL TDR;LOCAL TREATMENT;LOCALIZED DISEASE;WOMAC FUNCTIONAL;WOMAC STIFFNESS;BONE MARROW;CLINICAL OUTCOME;ENDOTHELIAL CELLS;GAIT ANALYSIS;KNEE ARTHROPLASTY;LUMBAR CURVE;MINIMALLY INVASIVE;PRP INJECTIONS;SKELETAL MUSCLE;STATISTICAL ANALYSIS;ABILITY MONTH;BASAL WOMAC;BONE MARROW-DERIVED;CARTILAGE REPAIR","12;10;9;8;8;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4",234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2010,217,7.57142857142857,3.5668202764977,0.280361757105943,0.56221198156682,0.599078341013825,0.179723502304147,0.368663594470046,1,92,59,19,18,0.42,0.27,0.09,0.08,46,1.0178089734422,0.36405529953917,0.788018433179724,NA,0.44355167018687,0.430086753663337,0.46379080873718,0.36046511627907,"MARCO VICECONTI;MAURILIO MARCACCI;MARCO ALBERGHINI;SANDRO GIANNINI;PIERO PICCI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ELIZAVETA KON;STEFANO BORIANI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;D. VANEL;PIER‚ÄêLUIGI LOLLINI;DOMENICO TIGANI;GIORDANO NICOLETTI;EUGENIO RIMONDI;COSTANTINO ERRANI;MICHELA BATTISTELLI","19;16;14;14;14;12;12;12;10;9;9;8;8;7;7;7;7;7;7;7","MARCO VICECONTI;STEFANO BORIANI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ALBERTO LEARDINI;MASSIMILIANO BALEANI;MARCO ALBERGHINI;PIERO PICCI;PIETRO RUGGIERI;ELIZAVETA KON;DOMENICO TIGANI;MARIA GRAZIA BENEDETTI;STEFANO ZAFFAGNINI;PETER K√ñHL;LUCA CRISTOFOLINI;ALESSANDRO GASBARRINI;EUGENIO RIMONDI","4.62;2.59;2.41;2.2;2.01;1.85;1.75;1.71;1.65;1.63;1.57;1.52;1.45;1.35;1.3;1.07;1.05;1.03;1.03;1.01","MARCO VICECONTI;MAURILIO MARCACCI;MARCO ALBERGHINI;SANDRO GIANNINI;PIERO PICCI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ELIZAVETA KON;STEFANO BORIANI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;D. VANEL;PIER‚ÄêLUIGI LOLLINI;DOMENICO TIGANI;GIORDANO NICOLETTI;EUGENIO RIMONDI;COSTANTINO ERRANI;MICHELA BATTISTELLI","19;16;14;14;14;12;12;12;10;9;9;8;8;7;7;7;7;7;7;7","MARCO VICECONTI;STEFANO BORIANI;MAURILIO MARCACCI;SANDRO GIANNINI;NICOLA BALDINI;GIUSEPPE FILARDO;MARIO MERCURI;ALBERTO LEARDINI;MASSIMILIANO BALEANI;MARCO ALBERGHINI;PIERO PICCI;PIETRO RUGGIERI;ELIZAVETA KON;DOMENICO TIGANI;MARIA GRAZIA BENEDETTI;STEFANO ZAFFAGNINI;LUCA CRISTOFOLINI;ALESSANDRO GASBARRINI;EUGENIO RIMONDI;COSTANTINO ERRANI","4.62;2.59;2.41;2.2;2.01;1.85;1.75;1.71;1.65;1.63;1.57;1.52;1.45;1.35;1.3;1.07;1.03;1.03;1.01;0.97","GIUSEPPE FILARDO;SANDRO GIANNINI;ELIZAVETA KON;MAURILIO MARCACCI;ROBERTO BUDA;ANNARITA CENACCHI;MARIO MERCURI;PIERO PICCI;LUCIANO MERLINI;MARCO ALBERGHINI;ELISABETTA FALCIERI;MICHELA BATTISTELLI;PATRIZIA SABATELLI;ANNA URCIUOLO;PAOLO BONALDO;PAOLO GRUMATI;NADIR M. MARALDI;MARCO VICECONTI;ALESSANDRO DI MARTINO;FRANCESCA VANNINI","1225;1222;1219;1198;979;794;793;774;703;633;597;597;594;578;578;578;544;517;502;499","GIUSEPPE FILARDO;ELIZAVETA KON;MAURILIO MARCACCI;SANDRO GIANNINI;ROBERTO BUDA;ANNARITA CENACCHI;PIERO PICCI;MARIO MERCURI;MARCO ALBERGHINI;PATRIZIA SABATELLI;NADIR M. MARALDI;MARCO VICECONTI;ALESSANDRO DI MARTINO;COSTANTINO ERRANI;DAVIDE CAMPOCCIA;PIETRO RUGGIERI;FRANCESCA VANNINI;MARCO CAVALLO;CARLA RENATA ARCIOLA;ANTONIO TIMONCINI","1225;1219;1198;1147;874;794;774;667;633;594;544;517;502;487;473;445;443;443;440;431","MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;MARCO ALBERGHINI;NICOLA BALDINI;SANDRO GIANNINI;GIUSEPPE FILARDO;MARIO MERCURI;ELIZAVETA KON;PIETRO RUGGIERI;STEFANO BORIANI;ALBERTO LEARDINI;D. VANEL;STEFANO ZAFFAGNINI;EUGENIO RIMONDI;GIORDANO NICOLETTI;COSTANTINO ERRANI;MARIA GRAZIA BENEDETTI;ANDREA ANGELINI;MILENA FINI","19;16;14;14;12;12;12;11;10;9;9;8;8;8;7;7;7;7;6;6","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATERIALS SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;PSYCHOLOGY;ART;ECONOMICS;POLITICAL SCIENCE;GEOLOGY;BUSINESS;HISTORY","169;84;36;31;28;27;20;19;9;6;3;3;3;2;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;CELL BIOLOGY;BIOCHEMISTRY;GENETICS;ANATOMY;CANCER RESEARCH;RADIOLOGY;IMMUNOLOGY;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;PHYSICAL THERAPY;ONCOLOGY;ORTHODONTICS;QUANTUM MECHANICS;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;ENDOCRINOLOGY","92;65;54;45;38;37;34;30;24;20;18;18;18;14;14;13;12;11;10;9","GENE;ALTERNATIVE MEDICINE;CANCER;ORTHOPEDIC SURGERY;IN VITRO;RADIOGRAPHY;SIGNAL TRANSDUCTION;ARTHROPLASTY;CARTILAGE;OSTEOSARCOMA;POPULATION;RECEPTOR;APOPTOSIS;CHEMOTHERAPY;FEMUR;SARCOMA;IMMUNOHISTOCHEMISTRY;MYOCYTE;OSTEOPOROSIS;DISEASE;IMPLANT;REGENERATION (BIOLOGY);SOFT TISSUE;SPORTS MEDICINE","33;23;19;19;16;16;15;13;11;11;11;11;10;10;10;10;9;9;9;8;8;8;8;8","OSTEOARTHRITIS;TRANSCRIPTION FACTOR;METASTASIS;GENE EXPRESSION;ARTHRODESIS;FIXATION (POPULATION GENETICS);MYOGENESIS;OSTEOCLAST;PLATELET-RICH PLASMA;PROGRAMMED CELL DEATH;CARCINOGENESIS;CHONDROCYTE;BONE CEMENT;BONE MINERAL;CELLULAR DIFFERENTIATION;EWING'S SARCOMA;GAIT ANALYSIS;WNT SIGNALING PATHWAY;ACID PHOSPHATASE;ACTIVATOR (GENETICS);BREAST CANCER;CD34;CELL CYCLE;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DOXORUBICIN;EXTERNAL FIXATION;FEMORAL NECK;GENE KNOCKDOWN;KNEE REPLACEMENT;MICRORNA;OSTEOBLAST;PERIPROSTHETIC;PI3K/AKT/MTOR PATHWAY;PROTEIN KINASE A;PROTEIN KINASE C;PROTOCOL (SCIENCE);STAPHYLOCOCCUS AUREUS;TENDINOPATHY;TUMOR PROGRESSION;VALGUS DEFORMITY","11;10;8;7;6;6;6;6;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;C2C12;CD99;NUCLEAR PROTEIN;DNA-BINDING PROTEIN;IFOSFAMIDE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PROMOTER;VINCRISTINE;BETA-CATENIN;BONE METASTASIS;DKK1;GENE EXPRESSION PROFILING;IMATINIB MESYLATE;INSULIN RECEPTOR;INTERFACE (MATTER);MITOGEN-ACTIVATED PROTEIN KINASE KINASE;RANKL;TARTRATE-RESISTANT ACID PHOSPHATASE;ABDOMINAL OBESITY;ADJUVANT CHEMOTHERAPY;ADULT STEM CELL;ANNEXIN A2;BACTERIAL ADHESIN;BONE DENSITY CONSERVATION AGENTS;CANCER VACCINE;CANDIDA KRUSEI;CASPASE;CATENIN;CAVEOLIN 3;CD28;CD40;CENTROSOME;CHROMOSOME INSTABILITY;CLINKER (CEMENT);CYCLIN-DEPENDENT KINASE 2;CYTOGENETICS;DBM;DEBULKING;DEFENSIVE MEDICINE;DIACYLGLYCEROL KINASE;DNA FRAGMENTATION;DNA-BINDING DOMAIN;DYSKINESIA;ENTHESITIS;FEBRILE NEUTROPENIA;FLUORESCENCE IN SITU HYBRIDIZATION;FRIZZLED;GENE PRODUCT;GERIATRIC DEPRESSION SCALE;GIANT CELL ARTERITIS;HLA-B27;HSP70;IMPLANT STABILITY QUOTIENT;IRREVERSIBLE ELECTROPORATION;JURKAT CELLS;LACHMAN TEST;LOCALIZED DISEASE;LRP5;LRP6;MAGNETITE NANOPARTICLES;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MICROSATELLITE;MICROVESICLES;MMP2;MTORC1;NATIONAL CHOLESTEROL EDUCATION PROGRAM;NECROPTOSIS;NEOPLASTIC TRANSFORMATION;NFKB1;NILOTINIB;NUCLEAR EXPORT SIGNAL;NUCLEAR TRANSPORT;ONCOGENE;OSTEONECROSIS OF THE JAW;OSWESTRY DISABILITY INDEX;PHOSPHOINOSITIDE 3-KINASE;PIVOT-SHIFT TEST;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POLYMORPHISM (COMPUTER SCIENCE);PRIMARY TUMOR;PTEN;QUANTITATIVE COMPUTED TOMOGRAPHY;REPORTER GENE;RESONANCE FREQUENCY ANALYSIS;RIBOTYPING;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL HAIRPIN RNA;SOLITARY FIBROUS TUMOR;SOX9;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;STAUROSPORINE;THORACIC VERTEBRAE;TRANSACTIVATION;TRIPLE ARTHRODESIS;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VASCULAR DEMENTIA;WNT3A;ZINC FINGER","7;6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;BONE NEOPLASMS;FEMALE;MALE;ADULT;MIDDLE AGED;;AGED;TREATMENT OUTCOME;ANIMALS;ADOLESCENT;OSTEOSARCOMA;YOUNG ADULT;CELL DIFFERENTIATION;CHILD;CHONDROCYTES;KNEE JOINT;MICE;AGED, 80 AND OVER;RANGE OF MOTION, ARTICULAR","147;89;84;84;61;53;50;47;38;33;31;29;27;24;24;21;21;21;20;20","HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;OSTEOARTHRITIS AND CARTILAGE REPAIR;BIOMECHANICS OF RUNNING-RELATED INJURIES;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;MANAGEMENT OF SPINAL METASTATIC TUMORS;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;EPIDEMIOLOGY AND TREATMENT OF CLAVICLE AND ACROMIOCLAVICULAR INJURIES;OSTEOPOROSIS;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH","14;14;12;11;9;7;7;6;6;5;5;5;3;3;3;3;3;2;2;2","TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;EWING'S SARCOMA;SPORTS MEDICINE;C2C12;PLATELET-RICH PLASMA;BONE TISSUE;METASTATIC SPINE TUMORS;SPINAL FUSION;ANEURYSMAL BONE CYST;BIOMECHANICS;BONE CEMENT;BONE REMODELING;CD99;EXTRACELLULAR MATRIX;FOOT (PROSODY);FOOT STRIKE PATTERNS;GIANT CELL TUMOR;HIP ARTHROPLASTY","14;12;9;8;8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","TOTAL KNEE;KNEE ARTHROPLASTY;STEM CELLS;GIANT CELL;EWINGS SARCOMA;SURGICAL TREATMENT;AUTOLOGOUS CHONDROCYTE;BONE TISSUE;BONE TUMORS;COLLAGEN VI;KNEE REPLACEMENT;MESENCHYMAL STEM;OSTEOCHONDRAL LESIONS;PHYSIOLOGICAL HUMAN;PLATELET-RICH PLASMA;STROMAL CELLS;TOTAL HIP;VIRTUAL PHYSIOLOGICAL;ADULT PATIENTS;ADULT SUBJECTS;ANIMAL PET;BIOMEDICAL DATA;BONE CYST;BONE GRAFTING;BONE MARROW;BONE MINERAL;BONE PLATE;BONE REGENERATION;BONE STEM;BONE-MARROW-DERIVED CELLS","7;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","GIANT CELL;GIANT CELL-RICH;CELL TUMOR;CELL-RICH OSTEOSARCOMA;PUBMED SCOPUS;GIANT CELLS;CROSSREF PUBMED;MINT MINT;OSTEOGENIC SARCOMA;RADIOL -CROSSREF;OSTEOCLAST-LIKE GIANT;CC CELLS;CELL-RICH OSTEOSARCOMAORTHOPEDICS;CONVENTIONAL OSTEOSARCOMA;EL GIANT;MONTHS RANGE;OSTEOSARCOMAORTHOPEDICS -PUBMED;PAROSTAL OSTEOSARCOMA;PUBMED GOOGLE;STAALS EL;PROTEIN KINASE;STROMAL CELLS;CELL CYCLE;DAHLIN DC;DEDIFFERENTIATED PAROSTAL;DIFFERENTIAL DIAGNOSIS;GIANT-CELL TUMOR;HIGH-GRADE OSTEOCLAST-RICH;MALIGNANT COMPONENT;OSTEOCLAST-RICH OSTEOGENIC","75;60;55;44;44;39;34;28;22;18;16;13;12;12;12;12;12;12;12;12;11;11;9;9;9;9;9;9;9;9",217,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2011,318,7.67610062893082,3.77358490566038,0.265,0.556603773584906,0.569182389937107,0.179245283018868,0.279874213836478,5,133,89,37,37,0.42,0.28,0.12,0.12,48.31,1.13567276844585,0.361635220125786,0.811320754716981,NA,0.527674854483702,0.501253463517614,0.518957011980268,0.454565456545654,"MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;KATIA SCOTLANDI;MARCO ALBERGHINI;MASSIMO SERRA;GIULIO MARIA MARCHEGGIANI MUCCIOLI;D. VANEL;EUGENIO RIMONDI;MARIA GRAZIA BENEDETTI;PANCRAS C.W. HOGENDOORN;FRANCESCO TRAINA","30;27;24;23;23;20;19;18;18;17;17;15;14;13;12;11;11;11;10;10","MARCO VICECONTI;MAURILIO MARCACCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ANDREAS F. MAVROGENIS;SANDRO GIANNINI;MILENA FINI;ELIZAVETA KON;ALBERTO LEARDINI;PIERO PICCI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;FRANCESCO TRAINA;ALDO TONI;D. VANEL;MARIA GRAZIA BENEDETTI;LUCA CRISTOFOLINI;EUGENIO RIMONDI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;MARIO MERCURI","8.54;4.27;4.11;3.77;3.73;3.44;3.34;2.95;2.77;2.54;2.51;1.98;1.97;1.84;1.81;1.81;1.75;1.65;1.62;1.59","MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;KATIA SCOTLANDI;MARCO ALBERGHINI;MASSIMO SERRA;GIULIO MARIA MARCHEGGIANI MUCCIOLI;D. VANEL;EUGENIO RIMONDI;MARIA GRAZIA BENEDETTI;PANCRAS C.W. HOGENDOORN;FRANCESCO TRAINA","30;27;24;23;23;20;19;18;18;17;17;15;14;13;12;11;11;11;10;10","MARCO VICECONTI;MAURILIO MARCACCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ANDREAS F. MAVROGENIS;SANDRO GIANNINI;MILENA FINI;ELIZAVETA KON;ALBERTO LEARDINI;PIERO PICCI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;FRANCESCO TRAINA;ALDO TONI;D. VANEL;MARIA GRAZIA BENEDETTI;LUCA CRISTOFOLINI;EUGENIO RIMONDI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;MARIO MERCURI","8.54;4.27;4.11;3.77;3.73;3.44;3.34;2.95;2.77;2.54;2.51;1.98;1.97;1.84;1.81;1.81;1.75;1.65;1.62;1.59","GIUSEPPE FILARDO;MAURILIO MARCACCI;ELIZAVETA KON;PIERO PICCI;SANDRO GIANNINI;MASSIMO SERRA;ANNE‚ÄêMARIE CLETON‚ÄêJANSEN;PANCRAS C.W. HOGENDOORN;MILENA FINI;PIER MARIA FORNASARI;ALESSANDRO DI MARTINO;MARIEKE L. KUIJJER;STEFANO ZAFFAGNINI;LUCA SANGIORGI;K√ÅROLY SZUHAI;MARCO ALBERGHINI;KATIA SCOTLANDI;MARCO VICECONTI;JUDITH V.M.G. BOV√âE;MARCO DELCOGLIANO","2492;2270;2130;1229;1218;1199;1128;1024;1018;984;959;947;924;876;832;785;777;757;736;732","GIUSEPPE FILARDO;MAURILIO MARCACCI;ELIZAVETA KON;PIERO PICCI;SANDRO GIANNINI;MASSIMO SERRA;MILENA FINI;PIER MARIA FORNASARI;ALESSANDRO DI MARTINO;STEFANO ZAFFAGNINI;KATIA SCOTLANDI;MARCO VICECONTI;LUCA SANGIORGI;MARCO DELCOGLIANO;MARCO ALBERGHINI;STEFANO FERRARI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;ROBERTO BUDA;ANTONIO TIMONCINI;ELEONORA OLIVOTTO","2492;2270;2130;1229;1218;1199;1018;984;959;924;777;757;739;732;724;716;711;644;547;541","MARCO VICECONTI;MAURILIO MARCACCI;PIERO PICCI;SANDRO GIANNINI;MILENA FINI;GIUSEPPE FILARDO;ELIZAVETA KON;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;KATIA SCOTLANDI;PIETRO RUGGIERI;MASSIMO SERRA;MARCO ALBERGHINI;ANDREAS F. MAVROGENIS;GIULIO MARIA MARCHEGGIANI MUCCIOLI;D. VANEL;MARIA GRAZIA BENEDETTI;FRANCESCO TRAINA;ALDO TONI;MARIA CRISTINA MANARA","30;27;24;23;23;20;18;17;17;15;14;13;13;11;11;11;11;10;9;9","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;ECONOMICS;GEOLOGY;ART;BUSINESS;SOCIOLOGY;GEOGRAPHY","269;116;63;45;35;35;29;18;13;6;5;4;4;2;2;2;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;CELL BIOLOGY;RADIOLOGY;GENETICS;CANCER RESEARCH;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;PHYSICAL THERAPY;PHYSICAL MEDICINE AND REHABILITATION;ENDOCRINOLOGY;ORTHODONTICS;IMMUNOLOGY;ORGANIC CHEMISTRY;DENTISTRY;ENVIRONMENTAL HEALTH;QUANTUM MECHANICS","152;117;95;54;54;49;47;43;36;26;26;25;24;22;21;20;20;19;16;14","ALTERNATIVE MEDICINE;GENE;SARCOMA;ORTHOPEDIC SURGERY;IN VITRO;OSTEOSARCOMA;RADIOGRAPHY;CARTILAGE;PROSTHESIS;OSTEOPOROSIS;CANCER;RECEPTOR;IMPLANT;CHEMOTHERAPY;ARTHROPLASTY;POPULATION;FEMUR;IMMUNOHISTOCHEMISTRY;MESENCHYMAL STEM CELL;STEM CELL","44;43;29;25;23;23;22;21;20;19;18;18;17;15;14;14;13;13;13;13","OSTEOARTHRITIS;METASTASIS;EWING'S SARCOMA;TRANSCRIPTION FACTOR;CELLULAR DIFFERENTIATION;GAIT ANALYSIS;PROGRAMMED CELL DEATH;STAPHYLOCOCCUS AUREUS;CHONDROCYTE;FEMORAL NECK;GENE EXPRESSION;MENISCUS;OSSEOINTEGRATION;OSTEOBLAST;OSTEOCLAST;PHENOTYPE;PLATELET-RICH PLASMA;ALKALINE PHOSPHATASE;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;ARTERIAL EMBOLIZATION;CHROMOSOME;FIXATION (POPULATION GENETICS);GROWTH FACTOR;HARRIS HIP SCORE;TENDINOPATHY","32;9;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;MEDIAL MENISCUS;OSTEOCALCIN;RANKL;RUNX2;ADENOSINE RECEPTOR;CD99;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;CYTOGENETICS;CYTOLYSIS;DBM;ENTEROCOCCUS FAECALIS;EXTRACELLULAR POLYMERIC SUBSTANCE;FLI1;GENE EXPRESSION PROFILING;GLUTATHIONE S-TRANSFERASE;INSULIN-LIKE GROWTH FACTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INTRA ARTICULAR;KRAS;LOSS OF HETEROZYGOSITY;MITOCHONDRIAL MYOPATHY;NUCLEAR PROTEIN;OSTEOPROTEGERIN;PIVOT-SHIFT TEST;PRIMARY TUMOR;PROMOTER;PROPIDIUM IODIDE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SINGLE-NUCLEOTIDE POLYMORPHISM;STAPHYLOCOCCUS EPIDERMIDIS;SYNOVIAL FLUID;TRANSACTIVATION;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VINCRISTINE","12;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;BONE NEOPLASMS;MIDDLE AGED;ADULT;;AGED;TREATMENT OUTCOME;OSTEOSARCOMA;YOUNG ADULT;ADOLESCENT;CHILD;KNEE JOINT;RETROSPECTIVE STUDIES;CHONDROCYTES;SARCOMA, EWING;ANIMALS;OSTEOARTHRITIS;FOLLOW-UP STUDIES","214;134;130;124;99;95;82;74;54;53;46;43;39;37;34;33;33;32;31;30","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TISSUE ENGINEERING AND BIOMATERIALS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;MANAGEMENT OF SPINAL METASTATIC TUMORS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES;DENTAL RESTORATIVE MATERIALS;ENDODONTIC RESEARCH AND PRACTICE;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY","30;25;20;18;13;12;8;7;7;5;5;5;5;5;4;4;4;4;4;4","EWING'S SARCOMA;KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;OSTEOSARCOMA;HIP ARTHROPLASTY;BIOMECHANICS;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;SOFT TISSUE SARCOMA;AUTOLOGOUS CHONDROCYTE IMPLANTATION;HIP ARTHROSCOPY;HIP DYSPLASIA;MATRIX (CHEMICAL ANALYSIS);MENISCUS;MESENCHYMAL STEM CELLS;MUSCULOSKELETAL MODELING;ANEURYSMAL BONE CYST;ARTERIAL EMBOLIZATION;BONE METASTASES","19;19;19;14;12;10;9;9;9;9;7;6;5;5;5;5;5;4;4;4","EWINGS SARCOMA;MESENCHYMAL STEM;STEM CELLS;TOTAL HIP;HIP ARTHROPLASTY;AUTOLOGOUS CHONDROCYTE;BONE TUMORS;HIP PROSTHESIS;CELL LINES;CHONDROCYTE IMPLANTATION;COLLAGEN VI;GAIT ANALYSIS;GIANT CELL;KNEE ARTHROPLASTY;PHYSIOLOGICAL HUMAN;TOTAL KNEE;VIRTUAL PHYSIOLOGICAL;ARTHROSCOPIC AUTOLOGOUS;BONE MARROW;CARTILAGE REPAIR;CELL TUMOR;CLINICAL RESULTS;ELECTROMAGNETIC FIELDS;EWING SARCOMA;HIP JOINT;IIN VITROI;LONG-TERM RESULTS;METAL-ON-METAL HIP;MOBILE SPINE;OLLIER DISEASE","8;7;7;7;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","CELL LINES;EWINGS SARCOMA;DYSPLASIA TYPE;HEARING LOSS;MANDIBULOACRAL DYSPLASIA;NK CELLS;CA RELEASE;Œë CHAIN;CARTILAGE REPAIR;HIGH-GRADE OSTEOSARCOMA;OLLIER DISEASE;GENE EXPRESSION;SARCOMA CELL;SURGICAL TREATMENT;ACRYLIC BONE;ARTICULAR CARTILAGE;BONE CEMENT;BONE MARROW;MAFFUCCI SYNDROME;MUSCULAR DYSTROPHY;OSTEOSARCOMA CELL;OSTEOSARCOMA CELLS;POSTOPERATIVE NEUROLOGIC;STEM CELLS;SYNOVIAL FLUID;TUMOR CELLS;CLINICAL OUTCOME;CO-CONTRACTION TIME;COLLAGEN VI;CONTROLLED STUDIES","29;16;13;13;13;13;12;12;11;9;9;8;8;7;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5",318,1,0,0.25,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,33,33,33,33,33,33
"IRCCS_RIZZOLI",2012,304,8.05263157894737,3.9078947368421,0.255892255892256,0.555921052631579,0.539473684210526,0.220394736842105,0.305921052631579,0,129,74,54,21,0.42,0.24,0.18,0.07,32.86,0.78668572180368,0.358552631578947,0.740131578947368,4.87507436049971,0.536079830946328,0.467979127134725,0.506951793599241,0.420040899795501,"MAURILIO MARCACCI;PIETRO RUGGIERI;SANDRO GIANNINI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;MILENA FINI;STEFANO ZAFFAGNINI;MARCO ALBERGHINI;ANDREAS F. MAVROGENIS;CLAUDIO BELVEDERE;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;D. VANEL;N. LOPOMO;GIANLUCA GIAVARESI;ALDO TONI;EUGENIO RIMONDI;SILVIA PANSERI","35;23;22;21;20;18;16;16;15;15;13;12;11;11;10;10;9;9;9;9","MAURILIO MARCACCI;PIETRO RUGGIERI;ALBERTO LEARDINI;SANDRO GIANNINI;GIUSEPPE FILARDO;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;PIERO PICCI;MILENA FINI;MARCO ALBERGHINI;MARIA GRAZIA BENEDETTI;CLAUDIO BELVEDERE;NICOLA BALDINI;ALDO TONI;SAVERIO AFFATATO;ANDREA ANGELINI;EUGENIO RIMONDI;FRANCESCO LOLLI;N. LOPOMO","5.23;4.11;3.32;3.18;3;2.72;2.52;2.29;2.02;2.02;2;1.96;1.8;1.69;1.68;1.65;1.61;1.52;1.5;1.45","MAURILIO MARCACCI;PIETRO RUGGIERI;SANDRO GIANNINI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;MILENA FINI;STEFANO ZAFFAGNINI;MARCO ALBERGHINI;ANDREAS F. MAVROGENIS;CLAUDIO BELVEDERE;NICOLA BALDINI;MARIA GRAZIA BENEDETTI;D. VANEL;N. LOPOMO;GIANLUCA GIAVARESI;ALDO TONI;EUGENIO RIMONDI;SILVIA PANSERI","35;23;22;21;20;18;16;16;15;15;13;12;11;11;10;10;9;9;9;9","MAURILIO MARCACCI;PIETRO RUGGIERI;ALBERTO LEARDINI;SANDRO GIANNINI;GIUSEPPE FILARDO;ELIZAVETA KON;ANDREAS F. MAVROGENIS;STEFANO ZAFFAGNINI;PIERO PICCI;MILENA FINI;MARCO ALBERGHINI;MARIA GRAZIA BENEDETTI;CLAUDIO BELVEDERE;NICOLA BALDINI;ALDO TONI;SAVERIO AFFATATO;ANDREA ANGELINI;EUGENIO RIMONDI;FRANCESCO LOLLI;N. LOPOMO","5.23;4.11;3.32;3.18;3;2.72;2.52;2.29;2.02;2.02;2;1.96;1.8;1.69;1.68;1.65;1.61;1.52;1.5;1.45","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;NICOLA BALDINI;MILENA FINI;SILVIA PANSERI;STEFANO FERRARI;GIANLUCA GIAVARESI;S. RUBINA BAGLIO;STEFANO ZAFFAGNINI;D. MICHIEL PEGTEL;ALESSANDRO DI MARTINO;ALESSANDRO RUSSO;SANDRO GIANNINI;MARCO ALBERGHINI;BERARDO DI MATTEO;CARLA CUNHA;FRANCA FAGIOLI","1674;1163;888;843;825;783;730;678;591;589;540;509;499;483;478;472;458;444;434;398","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;PIETRO RUGGIERI;ELIZAVETA KON;MILENA FINI;NICOLA BALDINI;SILVIA PANSERI;STEFANO FERRARI;GIANLUCA GIAVARESI;S. RUBINA BAGLIO;STEFANO ZAFFAGNINI;ALESSANDRO DI MARTINO;MARCO ALBERGHINI;SANDRO GIANNINI;ALESSANDRO RUSSO;BERARDO DI MATTEO;CARLA CUNHA;PIER MARIA FORNASARI;MASSIMO SERRA","1674;1123;888;827;825;730;725;678;591;589;540;509;483;458;458;456;444;434;384;365","MAURILIO MARCACCI;PIETRO RUGGIERI;ALBERTO LEARDINI;PIERO PICCI;SANDRO GIANNINI;GIUSEPPE FILARDO;MILENA FINI;ELIZAVETA KON;MARCO ALBERGHINI;STEFANO ZAFFAGNINI;STEFANO FERRARI;CLAUDIO BELVEDERE;MARIA GRAZIA BENEDETTI;D. VANEL;N. LOPOMO;GIANLUCA GIAVARESI;ALDO TONI;SILVIA PANSERI;NICOLA BALDINI;EMANUELA PALMERINI","34;20;20;20;19;18;16;16;15;14;12;12;11;10;9;9;9;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;GEOLOGY;PHILOSOPHY;ART;ECONOMICS;HISTORY;BUSINESS;POLITICAL SCIENCE;SOCIOLOGY;GEOGRAPHY","255;109;59;46;46;41;28;12;8;6;5;3;3;3;2;2;2;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;CELL BIOLOGY;ANATOMY;BIOCHEMISTRY;RADIOLOGY;GENETICS;CANCER RESEARCH;BIOMEDICAL ENGINEERING;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;PHYSICAL MEDICINE AND REHABILITATION;IMMUNOLOGY;ARTIFICIAL INTELLIGENCE;OPTICS;ONCOLOGY;ORGANIC CHEMISTRY;CLASSICAL MECHANICS;ENDOCRINOLOGY","140;91;85;57;54;49;45;42;41;33;27;26;25;20;18;17;17;16;16;14;14","GENE;ALTERNATIVE MEDICINE;CANCER;IN VITRO;MESENCHYMAL STEM CELL;ORTHOPEDIC SURGERY;STEM CELL;CHEMOTHERAPY;OSTEOSARCOMA;REGENERATION (BIOLOGY);IMPLANT;RADIOGRAPHY;SOFT TISSUE;SCAFFOLD;TISSUE ENGINEERING;ARTHROPLASTY;CARTILAGE;KINEMATICS;SARCOMA;POPULATION","38;34;25;24;23;23;21;18;18;18;16;16;16;15;15;14;14;14;14;13","OSTEOARTHRITIS;BREAST CANCER;GAIT ANALYSIS;CHONDROCYTE;METASTASIS;OSTEOBLAST;CELL CYCLE;GENE EXPRESSION;GENOTYPE;CANCER CELL;CD34;CISPLATIN;FIXATION (POPULATION GENETICS);MICRORNA;PROTEIN KINASE B;ANKLE REPLACEMENT;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;CELLULAR DIFFERENTIATION;DYSTROPHIN;LOW BACK PAIN;MENISCUS;MUTATION;OSTEOCLAST;PLATELET-RICH PLASMA;PROGENITOR CELL;REGENERATIVE MEDICINE;SOFT TISSUE SARCOMA;TRANSFECTION","24;9;8;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;GENE EXPRESSION PROFILING;IFOSFAMIDE;COMPARATIVE GENOMIC HYBRIDIZATION;MEDIAL MENISCUS;MICROARRAY;SINGLE-NUCLEOTIDE POLYMORPHISM;ADULT STEM CELL;ALTERNATIVE SPLICING;CELL CYCLE CHECKPOINT;COPY-NUMBER VARIATION;CYANOACRYLATE;CYCLIN D1;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;METASTATIC BREAST CANCER;MICROARRAY ANALYSIS TECHNIQUES;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;OSWESTRY DISABILITY INDEX;OXFORD KNEE SCORE;PIVOT-SHIFT TEST;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBOSOME;SMALL INTERFERING RNA;SUPERPARAMAGNETISM;UNICOMPARTMENTAL KNEE ARTHROPLASTY","8;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;BONE NEOPLASMS;ADULT;MIDDLE AGED;AGED;OSTEOSARCOMA;TREATMENT OUTCOME;ADOLESCENT;KNEE JOINT;MESENCHYMAL STEM CELLS;YOUNG ADULT;CHILD;OSTEOBLASTS;RETROSPECTIVE STUDIES;SARCOMA;ANIMALS;CELL PROLIFERATION","171;115;110;107;94;77;74;54;45;41;36;35;34;34;31;31;31;27;26;26","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;MULTIPOTENT MESENCHYMAL STEM CELLS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BIOMECHANICS OF RUNNING-RELATED INJURIES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;MANAGEMENT OF SPINAL METASTATIC TUMORS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;OSTEOPOROSIS;ANALYSIS OF THREE-DIMENSIONAL SHAPE STRUCTURES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES","25;18;17;13;12;12;9;7;6;6;6;5;4;4;4;4;4;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;SPINAL FUSION;BIOCOMPATIBILITY;EWING'S SARCOMA;HIP JOINT MECHANICS;MESENCHYMAL STEM CELLS;SCAFFOLDS;SOFT TISSUE SARCOMA;BONE REGENERATION;OSTEOSARCOMA;CHONDROSARCOMA;LIMB RECONSTRUCTION;OSTEOBLAST ADHESION;BIOMECHANICS;KYPHOSIS;POLYMERIC SCAFFOLDS;TREATMENT;ADOLESCENT IDIOPATHIC SCOLIOSIS","19;19;17;10;9;8;8;8;8;8;7;7;6;6;6;5;5;5;5;4","STEM CELLS;MESENCHYMAL STEM;SOFT TISSUE;SURGICAL TREATMENT;TOTAL KNEE;BREAST CANCER;TISSUE ENGINEERING;TOTAL ANKLE;ANKLE REPLACEMENT;BONE MARROW;BONE REGENERATION;CANCER CELLS;EWING SARCOMA;GAIT ANALYSIS;HUMAN BONE;KNEE REPLACEMENT;ANEURYSMAL BONE;BONE CYST;CELL TUMOR;CLINICAL STUDY;ENGINEERING APPLICATIONS;FDG PETCT;FUNCTIONAL PERFORMANCE;HUMAN MESENCHYMAL;KNEE ARTHROPLASTY;KNEE JOINT;MOTION ANALYSIS;POTENTIAL ROLE;STEM CELL;TISSUE SARCOMA","14;12;10;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ORTHOPAEDIC INSTITUTE;RIZZOLI ORTHOPAEDIC;EXTRACELLULAR MATRIX;CELL LINES;INSTITUTE BOLOGNA;STEM CELLS;BOLOGNA ITALY;MIR- MIR-;TISSUE ENGINEERING;BOLOGNA ITALYSEARCH;CANCER CELLS;HIP FRACTURE;MESENCHYMAL STEM;SURGICAL STUDIES;CELL PROLIFERATION;CHOI CRITERIA;ROTATOR CUFF;SOFT TISSUE;ADVANCED THERAPIES;BIOCOMPATIBILITY TECHNOLOGICAL;BONE TISSUE;CODIVILLAPUTTI RESEARCH;DEPARTMENT RIZZOLI;GAIT ANALYSIS;INSTITUTE RIZZOLI;LABORATORY CODIVILLAPUTTI;RESEARCH INSTITUTE;RIT DEPARTMENT;STUDIES LABORATORY;TECHNOLOGICAL INNOVATIONS","18;18;17;16;16;14;11;11;11;10;10;10;10;10;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8;8",304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2013,300,8.15333333333333,3.94,0.253807106598985,0.566666666666667,0.536666666666667,0.21,0.406666666666667,1,121,81,34,27,0.4,0.27,0.11,0.09,37.17,1.06536546290299,0.37,0.743333333333333,5.04373650107991,0.544249599562638,0.522739820565907,0.532093630209608,0.479039269137258,"MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIERO PICCI;STEFANO ZAFFAGNINI;ELIZAVETA KON;FRANCESCA VANNINI;ROBERTO BUDA;MILENA FINI;ALBERTO LEARDINI;BERARDO DI MATTEO;NICOLA BALDINI;ALESSANDRO DI MARTINO;DAVIDE MAR√çA DONATI;PIETRO RUGGIERI;MARCO CAVALLO;FRANCESCO IACONO;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA FACCHINI","45;35;27;21;19;18;17;17;16;15;13;13;12;12;12;11;11;10;10;10","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;FRANCESCA VANNINI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;ROBERTO BUDA;ELIZAVETA KON;NICOLA BALDINI;BERARDO DI MATTEO;PIERO PICCI;ALBERTO BAZZOCCHI;MILENA FINI;ANDREAS F. MAVROGENIS;FULVIA TADDEI;DAVIDE MAR√çA DONATI;ALESSANDRO DI MARTINO;MARCO CAVALLO;FRANCESCO IACONO","6.63;6.04;3.73;2.9;2.86;2.79;2.79;2.52;2.51;2.29;2.02;1.96;1.95;1.92;1.89;1.75;1.67;1.6;1.57;1.53","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIERO PICCI;STEFANO ZAFFAGNINI;ELIZAVETA KON;FRANCESCA VANNINI;ROBERTO BUDA;MILENA FINI;ALBERTO LEARDINI;BERARDO DI MATTEO;NICOLA BALDINI;ALESSANDRO DI MARTINO;DAVIDE MAR√çA DONATI;PIETRO RUGGIERI;MARCO CAVALLO;FRANCESCO IACONO;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA FACCHINI","45;35;27;21;19;18;17;17;16;15;13;13;12;12;12;11;11;10;10;10","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;FRANCESCA VANNINI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;ROBERTO BUDA;ELIZAVETA KON;NICOLA BALDINI;BERARDO DI MATTEO;PIERO PICCI;ALBERTO BAZZOCCHI;MILENA FINI;ANDREAS F. MAVROGENIS;FULVIA TADDEI;DAVIDE MAR√çA DONATI;ALESSANDRO DI MARTINO;MARCO CAVALLO;FRANCESCO IACONO","6.63;6.04;3.73;2.9;2.86;2.79;2.79;2.52;2.51;2.29;2.02;1.96;1.95;1.92;1.89;1.75;1.67;1.6;1.57;1.53","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;ALINA BERAUDI;STEFANO FERRARI;ELIZAVETA KON;PIERO PICCI;ALLISON PIOVESAN;EVA BIANCONI;FEDERICA FACCHIN;FLAVIA FRABETTI;FRANCESCO PIVA;LORENZA VITALE;MARIA CHIARA PELLERI;PIERLUIGI STRIPPOLI;RAFFAELLA CASADEI;SILVIA CANAIDER;SIMONE TASSANI;SOLEDAD P√âREZ‚ÄêAMODIO;ANDREA FACCHINI","1514;1393;1323;1006;983;961;949;896;896;896;896;896;896;896;896;896;896;896;896;776","MAURILIO MARCACCI;GIUSEPPE FILARDO;SANDRO GIANNINI;ALINA BERAUDI;STEFANO FERRARI;ELIZAVETA KON;PIERO PICCI;MILENA FINI;ROBERTO BUDA;STEFANO ZAFFAGNINI;ALESSANDRO DI MARTINO;FRANCESCA VANNINI;ANDREA FACCHINI;NICOLA BALDINI;BERARDO DI MATTEO;MARCO CAVALLO;GINA LISIGNOLI;CRISTINA MANFERDINI;PIETRO RUGGIERI;EMANUELA PALMERINI","1429;1323;1270;1006;983;961;949;727;652;635;622;621;579;565;490;425;385;381;369;364","MAURILIO MARCACCI;SANDRO GIANNINI;GIUSEPPE FILARDO;PIERO PICCI;STEFANO ZAFFAGNINI;FRANCESCA VANNINI;ELIZAVETA KON;ROBERTO BUDA;MILENA FINI;ALBERTO LEARDINI;STEFANO FERRARI;BERARDO DI MATTEO;ALESSANDRO DI MARTINO;PIETRO RUGGIERI;DAVIDE MAR√çA DONATI;MARCO CAVALLO;FRANCESCO IACONO;NICOLA BALDINI;ANDREA FACCHINI;ALBERTO BAZZOCCHI","43;33;27;21;19;18;18;17;16;15;14;13;12;12;11;11;11;11;10;9","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;COMPUTER SCIENCE;PHILOSOPHY;GEOLOGY;HISTORY;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY;ART;ECONOMICS;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","248;105;54;52;45;29;27;24;10;6;6;5;5;4;3;2;1;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;CELL BIOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;BIOMEDICAL ENGINEERING;RADIOLOGY;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;NANOTECHNOLOGY;IMMUNOLOGY;ONCOLOGY;OPTICS;ORGANIC CHEMISTRY","146;110;91;62;56;49;43;36;33;29;25;25;24;19;17;16;14;14;14;14","ALTERNATIVE MEDICINE;GENE;ORTHOPEDIC SURGERY;CANCER;IMPLANT;IN VITRO;SARCOMA;CARTILAGE;MESENCHYMAL STEM CELL;STEM CELL;ARTHROPLASTY;CHEMOTHERAPY;OSTEOSARCOMA;POPULATION;RADIOGRAPHY;OSTEOPOROSIS;ANKLE;SCAFFOLD;FEMUR;CELL;PROSTHESIS;TRANSPLANTATION","52;34;25;23;22;22;22;21;20;20;18;16;16;16;16;15;14;14;13;12;12;12","OSTEOARTHRITIS;CHONDROCYTE;METASTASIS;PLATELET-RICH PLASMA;CELL CYCLE;FIXATION (POPULATION GENETICS);GENE EXPRESSION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;CHONDROGENESIS;OSTEOBLAST;BREAST CANCER;CD34;GAIT ANALYSIS;TRANSCRIPTION FACTOR;ALKALINE PHOSPHATASE;ARTHRODESIS;CELLULAR DIFFERENTIATION;CISPLATIN;GENOTYPE;MICRORNA;OSTEOCLAST;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;REGENERATIVE MEDICINE;RHABDOMYOSARCOMA;VASCULITIS","42;8;8;8;7;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;HIGH TIBIAL OSTEOTOMY;UNICOMPARTMENTAL KNEE ARTHROPLASTY;WOMAC;OSTEOCALCIN;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SYNOVIAL FLUID;BONE METASTASIS;CD99;DNA METHYLATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;IFOSFAMIDE;ONCOGENE;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;ADULT STEM CELL;ANTHRACYCLINE;DUAL ENERGY;ELECTROCHEMOTHERAPY;GIANT CELL ARTERITIS;KNEE PAIN;NUCLEAR PROTEIN;PATELLAR LIGAMENT;QUANTITATIVE COMPUTED TOMOGRAPHY;V-ATPASE","14;7;6;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;;ADULT;BONE NEOPLASMS;MIDDLE AGED;AGED;KNEE JOINT;TREATMENT OUTCOME;YOUNG ADULT;OSTEOSARCOMA;ADOLESCENT;SARCOMA;AGED, 80 AND OVER;CELL DIFFERENTIATION;CHONDROCYTES;FEMUR;ANIMALS;MESENCHYMAL STEM CELLS","183;115;113;95;92;83;78;60;49;46;44;43;42;33;32;32;31;31;30;30","SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TISSUE ENGINEERING AND BIOMATERIALS;MULTIPOTENT MESENCHYMAL STEM CELLS;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;BIOMECHANICS OF RUNNING-RELATED INJURIES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;OSTEOPOROSIS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ATP SYNTHASE FUNCTION AND REGULATION;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;INCIDENCE AND MANAGEMENT OF HIP FRACTURES","18;17;17;15;15;15;12;11;7;6;6;5;5;5;3;3;3;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;KNEE OSTEOARTHRITIS;SCAFFOLDS;CADAVERIC SPASM;SOFT TISSUE SARCOMA;BIOMECHANICS;EWING'S SARCOMA;HIGH TIBIAL OSTEOTOMY;OSTEOARTHRITIS TREATMENT;REVISION SURGERY;BONE MINERAL DENSITY;BONE REGENERATION;CHONDROGENESIS;MATRIX (CHEMICAL ANALYSIS);MESENCHYMAL STEM CELLS;METASTATIC SPINE TUMORS;OSTEOCHONDRAL LESIONS;OSTEOID OSTEOMA","33;25;15;11;10;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6","STEM CELLS;MESENCHYMAL STEM;BONE MARROW;OSTEOCHONDRAL ALLOGRAFT;TOTAL KNEE;ANTERIOR CRUCIATE;AUTOLOGOUS CHONDROCYTE;CRUCIATE LIGAMENT;FRESH OSTEOCHONDRAL;SOFT TISSUE;BIPOLAR FRESH;BONE METASTASIS;EWING SARCOMA;KNEE ARTHROPLASTY;KNEE OSTEOARTHRITIS;KNEE REPLACEMENT;STROMAL CELLS;TUMOR CELLS;ALLOGRAFT TRANSPLANTATION;CHONDROCYTE TRANSPLANTATION;GIANT CELL;HIP PROSTHESIS;HIP RESURFACING;II STUDY;IIN VITROI;KNEE IMPLANT;LUMBAR SPINE;MAGNETIC SCAFFOLDS;METAL-ON-METAL HIP;OSTEOGENIC DIFFERENTIATION","13;9;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","CELL LINES;PUBMED SCOPUS;DEDIFFERENTIATED CHONDROSARCOMA;CROSSREF PUBMED;SOFT TISSUE;STEM CELLS;OSTEOID OSTEOMA;MESENCHYMAL CHONDROSARCOMA;BONE TUMORS;CELL CHONDROSARCOMA;HEPARAN SULFATE;MESENCHYMAL STEM;BONE MARROW;CLINICAL OUTCOME;GOLD STANDARD;HOGENDOORN PCW;MOM HR;OSTEOSARCOMA CELL;TUMOR CELLS;CHONDROSARCOMA SUBTYPES;FRESH OSTEOCHONDRAL;MESENCHYMAL CHONDROSARCOMAS;MUSCLE STRENGTH;STEM CELL;STROMAL CELLS;BONE METASTASIS;CELL ADHESION;CELL VIABILITY;CHONDROCYTE DIFFERENTIATION;CHONDROSARCOMA CELL","28;28;25;22;17;17;13;12;10;10;10;10;9;9;9;9;9;9;9;8;8;8;8;8;8;7;7;7;7;7",300,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2014,300,8.40333333333333,3.94,0.253807106598985,0.566666666666667,0.543333333333333,0.32,0.42,4,144,82,32,17,0.48,0.27,0.11,0.06,31.51,0.833692736016197,0.366666666666667,0.803333333333333,5.08906098741529,0.566968722450947,0.458409926470588,0.497852795100639,0.507285513361463,"MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;STEFANO ZAFFAGNINI;STEFANO BORIANI;PAOLO CARAVAGGI;KATIA SCOTLANDI;MILENA FINI;MARCO GAMBAROTTI;MARIA GRAZIA BENEDETTI;LISA BERTI;ALBERTO RIGHI;LUCIANO MERLINI;NICOLA BALDINI;UGO ALBISINNI;DAVIDE MAR√çA DONATI;STEFANO FERRARI","41;30;27;25;24;21;15;14;13;12;12;12;12;11;10;10;10;10;10;10","MAURILIO MARCACCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;SANDRO GIANNINI;ELIZAVETA KON;PIERO PICCI;PAOLO CARAVAGGI;LUCIANO MERLINI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;LISA BERTI;NICOLA BALDINI;MILENA FINI;STEFANO BORIANI;ALBERTO RIGHI;MARCO GAMBAROTTI;BERARDO DI MATTEO;FRANCESCO PERDISA;DAVIDE MAR√çA DONATI","5.92;5.14;4.91;4.48;3.19;2.81;2.67;2.52;2.43;2.35;2.02;1.9;1.64;1.57;1.57;1.55;1.52;1.51;1.46;1.39","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;STEFANO ZAFFAGNINI;STEFANO BORIANI;PAOLO CARAVAGGI;KATIA SCOTLANDI;MILENA FINI;MARCO GAMBAROTTI;MARIA GRAZIA BENEDETTI;LISA BERTI;ALBERTO RIGHI;LUCIANO MERLINI;NICOLA BALDINI;UGO ALBISINNI;DAVIDE MAR√çA DONATI;STEFANO FERRARI","41;30;27;25;24;21;15;14;13;12;12;12;12;11;10;10;10;10;10;10","MAURILIO MARCACCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;SANDRO GIANNINI;ELIZAVETA KON;PIERO PICCI;PAOLO CARAVAGGI;LUCIANO MERLINI;STEFANO ZAFFAGNINI;SAVERIO AFFATATO;MARIA GRAZIA BENEDETTI;LISA BERTI;NICOLA BALDINI;MILENA FINI;STEFANO BORIANI;ALBERTO RIGHI;MARCO GAMBAROTTI;BERARDO DI MATTEO;FRANCESCO PERDISA;DAVIDE MAR√çA DONATI","5.92;5.14;4.91;4.48;3.19;2.81;2.67;2.52;2.43;2.35;2.02;1.9;1.64;1.57;1.57;1.55;1.52;1.51;1.46;1.39","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ELIZAVETA KON;STEFANO FERRARI;MARCO GAMBAROTTI;STEFANO BORIANI;ALBERTO LEARDINI;NICOLA BALDINI;SANDRO GIANNINI;EMANUELA PALMERINI;FULVIA TADDEI;PIETRO RUGGIERI;ANDREA FACCHINI;ANTONIO LLOMBART‚ÄêBOSCH;ISIDRO MACHADO;PAOLO G. CASALI;CHARLES G. FISHER;JEREMY REYNOLDS;LAURENCE D. RHINES","1401;1399;956;858;751;643;625;608;551;545;528;523;481;447;442;442;414;412;412;412","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ELIZAVETA KON;STEFANO FERRARI;MARCO GAMBAROTTI;STEFANO BORIANI;ALBERTO LEARDINI;NICOLA BALDINI;SANDRO GIANNINI;EMANUELA PALMERINI;FULVIA TADDEI;PIETRO RUGGIERI;STEFANO ZAFFAGNINI;DONATELLA GRANCHI;FRANCESCO PERDISA;ANDREA FACCHINI;ALBERTO BAZZOCCHI;KATIA SCOTLANDI;EMANUELA MARCHESI","1392;1360;956;858;751;643;625;608;551;545;528;523;481;366;355;332;330;321;318;302","MAURILIO MARCACCI;PIERO PICCI;GIUSEPPE FILARDO;ALBERTO LEARDINI;SANDRO GIANNINI;ELIZAVETA KON;STEFANO BORIANI;STEFANO ZAFFAGNINI;STEFANO FERRARI;PAOLO CARAVAGGI;MILENA FINI;MARCO GAMBAROTTI;KATIA SCOTLANDI;LISA BERTI;ALBERTO RIGHI;MARIA GRAZIA BENEDETTI;NICOLA BALDINI;GIULIO MARIA MARCHEGGIANI MUCCIOLI;ALBERTO GRASSI;BERARDO DI MATTEO","39;29;27;25;25;21;14;14;13;13;12;12;11;11;10;10;10;10;9;9","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;ART;ECONOMICS;POLITICAL SCIENCE;GEOLOGY;BUSINESS;HISTORY;SOCIOLOGY;GEOGRAPHY","258;115;51;48;40;33;28;22;14;10;7;7;7;6;4;4;3;2","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;CELL BIOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;ORTHODONTICS;PHYSICAL MEDICINE AND REHABILITATION;BIOMEDICAL ENGINEERING;PHYSICAL THERAPY;COMPOSITE MATERIAL;RADIOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;CLASSICAL MECHANICS;ONCOLOGY;IMMUNOLOGY;QUANTUM MECHANICS","138;107;98;55;53;52;46;46;33;33;29;27;24;24;23;22;21;20;17;16","GENE;ALTERNATIVE MEDICINE;CANCER;MESENCHYMAL STEM CELL;POPULATION;SARCOMA;ARTHROPLASTY;CARTILAGE;KINEMATICS;ANKLE;GAIT;IN VITRO;RADIOGRAPHY;CHEMOTHERAPY;CELL CULTURE;IMPLANT;OSTEOSARCOMA;SCAFFOLD;STEM CELL;ANTERIOR CRUCIATE LIGAMENT","52;49;39;22;22;21;20;20;20;19;18;18;18;14;13;13;13;13;13;12","OSTEOARTHRITIS;GENE EXPRESSION;CELL CYCLE;GAIT ANALYSIS;FIXATION (POPULATION GENETICS);CHONDROCYTE;METASTASIS;PLATELET-RICH PLASMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;HAZARD RATIO;BREAST CANCER;CARCINOGENESIS;DOXORUBICIN;PROGRAMMED CELL DEATH;ARTHRODESIS;BONE MINERAL;CLINICAL ENDPOINT;MICRORNA;RELIABILITY (SEMICONDUCTOR);VIABILITY ASSAY","42;16;14;13;12;9;9;8;7;7;6;6;6;6;5;5;5;5;5;5","ARTICULAR CARTILAGE;GENE EXPRESSION PROFILING;ONCOGENE;UNICOMPARTMENTAL KNEE ARTHROPLASTY;CD99;PIVOT-SHIFT TEST;BONE METASTASIS;GENETICALLY MODIFIED MOUSE;MAMMARY TUMOR;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;ACHILLES TENDON RUPTURE;ADJUVANT CHEMOTHERAPY;ANTEROLATERAL LIGAMENT;CYCLIN D1;DECORIN;DNA METHYLATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;EXOME SEQUENCING;FLUORESCENCE IN SITU HYBRIDIZATION;HYDROXYTYROSOL;INDUCED PLURIPOTENT STEM CELL;LACHMAN TEST;MESODERM;MITOCHONDRIAL MYOPATHY;MITOCHONDRIAL PERMEABILITY TRANSITION PORE;PEPTIDYLPROLYL ISOMERASE;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;QUANTITATIVE COMPUTED TOMOGRAPHY;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME","10;7;7;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;ADULT;;MIDDLE AGED;KNEE JOINT;BONE NEOPLASMS;AGED;MESENCHYMAL STEM CELLS;YOUNG ADULT;OSTEOSARCOMA;ARTHROPLASTY, REPLACEMENT, KNEE;ADOLESCENT;OSTEOARTHRITIS, KNEE;CARTILAGE, ARTICULAR;APOPTOSIS;BIOMECHANICAL PHENOMENA;TREATMENT OUTCOME;SPINAL NEOPLASMS","198;120;113;89;88;83;73;66;54;42;42;41;37;33;32;29;28;27;27;26","PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TISSUE ENGINEERING AND BIOMATERIALS;BIOMECHANICS OF RUNNING-RELATED INJURIES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;MANAGEMENT OF SPINAL METASTATIC TUMORS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;MULTIPOTENT MESENCHYMAL STEM CELLS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;PATHOGENESIS AND TREATMENT OF OSTEONECROSIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ADVANCEMENTS IN PROSTATE CANCER RESEARCH","21;20;16;16;15;15;10;10;8;7;7;6;5;5;4;4;3;3;3;2","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;FOOT (PROSODY);MESENCHYMAL STEM CELLS;OSTEOSARCOMA;SOFT TISSUE SARCOMA;BIOMECHANICS;OSTEOCHONDRAL LESIONS;PLATELET-RICH PLASMA;CHONDROSARCOMA;FOOT STRIKE PATTERNS;METASTATIC SPINE TUMORS;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;POLYMERIC SCAFFOLDS;SCAFFOLDS;ANEURYSMAL BONE CYST;BIOMATERIAL","27;24;17;11;10;9;9;9;8;8;8;7;7;7;6;6;6;6;5;5","STEM CELLS;EWING SARCOMA;MESENCHYMAL STEM;KNEE ARTHROPLASTY;PLATELET-RICH PLASMA;TOTAL KNEE;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;FINITE ELEMENT;LIGAMENT RECONSTRUCTION;MESENCHYMAL STROMAL;MUSCULAR DYSTROPHY;STROMAL CELLS;BONE MARROW;BONE METASTASIS;COLLAGEN VI;GAIT ANALYSIS;KNEE PROSTHESES;OSTEOCHONDRAL ALLOGRAFT;SOFT TISSUE;SURGICAL TREATMENT;UNICOMPARTMENTAL KNEE;ANEURYSMAL BONE;BIPOLAR FRESH;BONE REGENERATION;CELL LINES;COMBINED EFFECT;COMPARATIVE EVALUATION;CONGENITAL MUSCULAR;HIGH-GRADE OSTEOSARCOMA","10;9;9;8;8;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","TOTAL KNEE;RIZZOLI ORTHOPAEDIC;BOLOGNA ITALY;EWING SARCOMA;TOTAL HIP;MUSCULAR DYSTROPHY;GENE EXPRESSION;CELL LINES;HUMAN BODY;KNEE ARTHROPLASTY;CELL DEATH;STEM CELLS;CROSS-LINKED POLYETHYLENE;DATA NETWORK;OSTEOARTHRITIS OA;CONFIDENCE INTERVAL;GSKŒí INHIBITION;HAZARD RATIO;HEAD SIZE;MESENCHYMAL STEM;ORTHOPAEDIC INSTITUTE;OXIDATIVE STRESS;SKELETAL MUSCLE;COLLAGEN VI;DISTRIBUTED HEALTH;GROWTH FACTOR;HEALTH DATA;HIP ARTHROPLASTY;KNEE LAXITY;CLINICAL PRACTICE","22;20;17;17;17;15;14;13;13;13;12;12;11;11;11;10;10;10;10;10;10;10;10;9;9;9;9;9;9;8",300,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2015,291,8.5979381443299,3.68041237113402,0.271708683473389,0.54639175257732,0.512027491408935,0.281786941580756,0.460481099656357,8,121,80,35,17,0.42,0.27,0.12,0.06,29.95,0.80368474209076,0.34020618556701,0.790378006872852,4.81524249422632,0.507395984542088,0.429087397392564,0.506259426847662,0.421382093731982,"MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;STEFANO BORIANI;SANDRO GIANNINI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;N. LOPOMO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;PAOLO CARAVAGGI;MARIA SERENA BENASSI;P√âTER VARGA;MARCO GAMBAROTTI;MICHAEL G. FEHLINGS;LAURENCE D. RHINES;CHARLES G. FISHER","32;26;25;19;17;16;16;16;13;12;11;11;10;10;10;10;10;9;9;9","MAURILIO MARCACCI;ALBERTO LEARDINI;MILENA FINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;PIERO PICCI;SANDRO GIANNINI;PAOLO CARAVAGGI;LORENZO CAVAZZUTI;SAVERIO AFFATATO;STEFANO BORIANI;GIOVANNA LATTANZI;COSTANTINO ERRANI;GIANLUCA GIAVARESI;N. LOPOMO;PAOLA TORRICELLI;KATIA SCOTLANDI;CLAUDIO BELVEDERE;DAVIDE MAR√çA DONATI;LISA BERTI","4.27;3.62;3.47;3.47;3.18;2.66;2.51;2.06;2;1.83;1.57;1.52;1.52;1.51;1.44;1.42;1.4;1.27;1.25;1.23","MAURILIO MARCACCI;PIERO PICCI;MILENA FINI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;STEFANO BORIANI;SANDRO GIANNINI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;N. LOPOMO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;PAOLO CARAVAGGI;MARIA SERENA BENASSI;MARCO GAMBAROTTI;PAOLA TORRICELLI;STEFANO FERRARI;ELIZAVETA KON;MARK B. DEKUTOSKI","32;26;25;19;17;16;16;16;13;12;11;11;10;10;10;10;9;9;8;8","MAURILIO MARCACCI;ALBERTO LEARDINI;MILENA FINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;PIERO PICCI;SANDRO GIANNINI;PAOLO CARAVAGGI;LORENZO CAVAZZUTI;SAVERIO AFFATATO;STEFANO BORIANI;GIOVANNA LATTANZI;COSTANTINO ERRANI;GIANLUCA GIAVARESI;N. LOPOMO;PAOLA TORRICELLI;KATIA SCOTLANDI;CLAUDIO BELVEDERE;DAVIDE MAR√çA DONATI;LISA BERTI","4.27;3.62;3.47;3.47;3.18;2.66;2.51;2.06;2;1.83;1.57;1.52;1.52;1.51;1.44;1.42;1.4;1.27;1.25;1.23","MAURILIO MARCACCI;MILENA FINI;NICOLA BALDINI;PIERO PICCI;GIUSEPPE FILARDO;NICOLETTA ZINI;FRANCESCA PERUT;MARIA SERENA BENASSI;BENNO A. NAAIJKENS;D. MICHIEL PEGTEL;DANIJELA KOPPERS‚ÄêLALIC;FREDERIK J. VERWEIJ;HANS W.M. NIESSEN;KOOS ROOIJERS;M P√âREZ LANZ√ìN;S. RUBINA BAGLIO;LUCA SANGIORGI;ANDREA SUPERTI‚ÄêFURGA;CHRISTINE M HALL;DAVID SILLENCE","894;876;842;759;710;698;681;651;650;650;650;650;650;650;650;650;542;534;534;534","MILENA FINI;NICOLA BALDINI;MAURILIO MARCACCI;GIUSEPPE FILARDO;NICOLETTA ZINI;FRANCESCA PERUT;S. RUBINA BAGLIO;MARIA SERENA BENASSI;PIERO PICCI;LUCA SANGIORGI;ELIZAVETA KON;STEFANO FERRARI;GIANLUCA GIAVARESI;BERARDO DI MATTEO;ALESSANDRO DI MARTINO;PAOLA TORRICELLI;GIOVANNI ZITO;ANNARITA CENACCHI;KATIA SCOTLANDI;PIERMARIA FORNASARI","876;824;811;702;698;681;650;609;565;534;511;489;425;419;384;337;331;322;318;313","MAURILIO MARCACCI;MILENA FINI;PIERO PICCI;STEFANO ZAFFAGNINI;STEFANO BORIANI;GIUSEPPE FILARDO;ALBERTO LEARDINI;STEFANO FERRARI;SANDRO GIANNINI;GIANLUCA GIAVARESI;KATIA SCOTLANDI;N. LOPOMO;DAVIDE MAR√çA DONATI;MARIA SERENA BENASSI;PAOLO CARAVAGGI;ALBERTO RIGHI;PAOLA TORRICELLI;MARCO GAMBAROTTI;ALBERTO BAZZOCCHI;ALESSANDRO RUSSO","29;25;21;18;16;16;15;14;14;11;11;11;9;9;9;9;9;9;8;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;GEOLOGY;PHILOSOPHY;BUSINESS;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;ART;GEOGRAPHY;HISTORY;ENVIRONMENTAL SCIENCE","242;99;63;42;39;33;26;16;15;7;5;4;4;4;4;2;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;ANATOMY;CANCER RESEARCH;CELL BIOLOGY;GENETICS;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;RADIOLOGY;BIOMEDICAL ENGINEERING;PHYSICAL MEDICINE AND REHABILITATION;ONCOLOGY;IMMUNOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;ORGANIC CHEMISTRY;OPTICS","136;96;92;57;47;41;40;40;28;26;25;24;23;22;21;17;15;15;14;13","ALTERNATIVE MEDICINE;GENE;CANCER;ORTHOPEDIC SURGERY;IN VITRO;OSTEOSARCOMA;SARCOMA;CHEMOTHERAPY;RADIOGRAPHY;ANKLE;CARTILAGE;POPULATION;RANGE OF MOTION;RECEPTOR;CELL;ENZYME;ANTERIOR CRUCIATE LIGAMENT;ARTHROPLASTY;IMPLANT;KINEMATICS;MESENCHYMAL STEM CELL;STEM CELL","43;41;33;27;25;20;20;17;16;14;13;13;13;13;12;12;11;11;11;11;11;11","OSTEOARTHRITIS;METASTASIS;OSTEOBLAST;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;CHONDROCYTE;SOFT TISSUE SARCOMA;MICRORNA;FIXATION (POPULATION GENETICS);GENE EXPRESSION;LAMIN;ARTHRODESIS;BREAST CANCER;ETOPOSIDE;PROSTATE CANCER;TRANSCRIPTION FACTOR;VIABILITY ASSAY;ACTIVATOR (GENETICS);ALKALINE PHOSPHATASE;CELL CYCLE;CHEMOKINE;CUBIC ZIRCONIA;CYCLOPHOSPHAMIDE;DOXORUBICIN;EWING'S SARCOMA;FOREFOOT;OSTEOCLAST;UNIVARIATE ANALYSIS","31;12;12;9;8;8;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;BONE METASTASIS;IFOSFAMIDE;ARTHROPATHY;CD99;MICROVESICLES;OSTEOPROTEGERIN;PIVOT-SHIFT TEST;PRIMARY TUMOR;WOMAC;ACETABULAR LABRUM;ANTEROLATERAL LIGAMENT;CATHEPSIN K;CELL CYCLE CHECKPOINT;COMPOUND HETEROZYGOSITY;CXCR4;CYCLIC VOLTAMMETRY;DYSTHYMIC DISORDER;ELECTROCHEMOTHERAPY;ENTEROCOCCUS FAECALIS;FLUOXETINE;HISTONE DEACETYLASE;IRREVERSIBLE ELECTROPORATION;JOINT DISEASE;KNEE SURGERY;LACHMAN TEST;LMNA;MAGNETIC HYPERTHERMIA;MEDIAL MENISCUS;RANKL;RUNX2;RYR1;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;STERILIZATION (ECONOMICS);VINCRISTINE","6;5;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;BONE NEOPLASMS;MIDDLE AGED;ADULT;AGED;OSTEOBLASTS;OSTEOSARCOMA;ANIMALS;KNEE JOINT;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;FEMUR;FOLLOW-UP STUDIES;OSTEOARTHRITIS, KNEE;CELL DIFFERENTIATION;YOUNG ADULT;ADOLESCENT","159;106;101;101;82;59;56;51;44;33;31;31;31;31;30;30;29;28;28;27","SARCOMA RESEARCH AND TREATMENT;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;APPLICATIONS OF ELECTROPORATION IN BIOTECHNOLOGY AND FOOD PROCESSING;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BIOMECHANICS OF RUNNING-RELATED INJURIES","26;17;15;13;13;13;12;11;6;6;4;4;4;4;4;4;3;3;3;3","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;EWING'S SARCOMA;SOFT TISSUE SARCOMA;OSTEOSARCOMA;BIOMECHANICS;BONE REGENERATION;SPINAL FUSION;ATHLETIC REHABILITATION;FOOT STRIKE PATTERNS;OSTEOBLAST ADHESION;ANTERIOR CRUCIATE LIGAMENT;CHORDOMA;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;LIGAMENT RECONSTRUCTION;OSTEOARTHRITIS TREATMENT;OSTEOBLAST DIFFERENTIATION;OSTEOLYSIS","19;14;13;12;12;10;9;7;7;6;6;6;5;5;5;5;5;5;5;5","TOTAL KNEE;EWING SARCOMA;KNEE ARTHROPLASTY;BONE MARROW;CRUCIATE LIGAMENT;LIGAMENT RECONSTRUCTION;STEM CELLS;ANTERIOR CRUCIATE;BONE METASTASES;MESENCHYMAL STEM;SOFT TISSUE;SURGICAL TREATMENT;CLINICAL TRIAL;GIANT CELL;LOCAL RECURRENCE;MULTICENTER STUDY;OSTEOARTHRITIC CHONDROCYTES;PROGNOSTIC VARIABLES;BONE TISSUE;CELL TUMOR;CELLS TRANSPLANTATION;GROWTH HORMONE;ITALIAN SARCOMA;KNEE OSTEOARTHRITIS;MARROW CONCENTRATE;MINIMALLY INVASIVE;OSTEOSARCOMA CELLS;PLASMA DEPOSITION;PROSTATE CANCER;PULSED PLASMA","9;7;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","LOCAL RECURRENCE;BOLOGNA ITALY;STEM CELLS;CELL LINES;FATTY ACID;PIVOT SHIFT;ANATOMICAL THEATRE;EWING SARCOMA;SURGICALLY TREATED;SURGICAL TREATMENT;TISSUE ENGINEERING;BONE EROSIONS;PRIMARY SPINAL;SIDEWAYS FALL;STROMAL CELLS;EN BLOC;MEMBRANE FATTY;OA CHONDROCYTES;PATIENTS UNDERWENT;ACID PROFILES;BLOC RESECTION;BONE TUMORS;COLLAGEN TYPE;DNA DAMAGE;GIANT CELL;LS BMD;OSTEOARTHRITIS OA;PATIENTS AFFECTED;SUBCHONDRAL BONE;ARCHIGINNASIO PALACE","37;16;16;15;14;14;13;13;13;12;12;11;11;11;11;10;10;10;10;9;9;9;9;9;9;9;9;9;9;8",291,2,0.01,3.125,3,3,3,0,0,0,0,0,0,0,0,0,0,0,0,2,2,2,0,0,0,0,0,0,3,3,3,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,50,50,50,50,50,50
"IRCCS_RIZZOLI",2016,309,8.74433656957929,3.89644012944984,0.256644518272425,0.563106796116505,0.546925566343042,0.491909385113269,0.40453074433657,0,138,84,38,12,0.45,0.27,0.12,0.04,29.15,0.897357332386841,0.394822006472492,0.779935275080906,4.67565290648694,0.493679610739397,0.456918081918082,0.489398907103825,0.469300278035218,"MAURILIO MARCACCI;PIERO PICCI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;MILENA FINI;ELIZAVETA KON;DAVIDE MAR√çA DONATI;ALBERTO GRASSI;N. LOPOMO;NICOLA BALDINI;STEFANO BORIANI;GIANLUCA GIAVARESI;FRANCESCO TRAINA;SAVERIO AFFATATO;STEFANO FERRARI;CESARE FALDINI;CECILIA SIGNORELLI;EMANUELA PALMERINI;MARIA GRAZIA BENEDETTI","34;27;25;21;18;18;17;17;14;14;13;13;12;12;11;11;10;10;10;10","MAURILIO MARCACCI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;PIERO PICCI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO GRASSI;MARIA GRAZIA BENEDETTI;PAOLO CARAVAGGI;NICOLA BALDINI;N. LOPOMO;FRANCESCO TRAINA;ANTONIO MAZZOTTI;STEFANO BORIANI;CESARE FALDINI;BERARDO DI MATTEO;DANTE DALLARI","4.45;3.67;3.6;3.44;2.84;2.6;2.48;2.26;2.1;2.06;1.94;1.88;1.82;1.6;1.58;1.5;1.45;1.35;1.24;1.24","MAURILIO MARCACCI;PIERO PICCI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO LEARDINI;MILENA FINI;ELIZAVETA KON;DAVIDE MAR√çA DONATI;ALBERTO GRASSI;N. LOPOMO;NICOLA BALDINI;STEFANO BORIANI;GIANLUCA GIAVARESI;FRANCESCO TRAINA;SAVERIO AFFATATO;STEFANO FERRARI;CESARE FALDINI;CECILIA SIGNORELLI;EMANUELA PALMERINI;MARIA GRAZIA BENEDETTI","34;27;25;21;18;18;17;17;14;14;13;13;12;12;11;11;10;10;10;10","MAURILIO MARCACCI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;PIERO PICCI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO GRASSI;MARIA GRAZIA BENEDETTI;PAOLO CARAVAGGI;NICOLA BALDINI;N. LOPOMO;FRANCESCO TRAINA;ANTONIO MAZZOTTI;STEFANO BORIANI;CESARE FALDINI;BERARDO DI MATTEO;DANTE DALLARI","4.45;3.67;3.6;3.44;2.84;2.6;2.48;2.26;2.1;2.06;1.94;1.88;1.82;1.6;1.58;1.5;1.45;1.35;1.24;1.24","MAURILIO MARCACCI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;NICOLA BALDINI;PIERO PICCI;DAVIDE MAR√çA DONATI;ELIZAVETA KON;SOFIA AVNET;GINA LISIGNOLI;SANDRINE FLEURY‚ÄêCAPPELLESSO;GIANLUCA GIAVARESI;N. LOPOMO;MILENA FINI;STEFANO BORIANI;STEFANO FERRARI;C. CYTEVAL;CHRISTIAN J√òRGENSEN;CHRISTOPHE DELFOUR;DANIEL HADDAD;DANI√àLE NO√ãL","1091;927;847;807;756;747;715;603;539;535;509;483;471;447;446;436;436;436;436;436","MAURILIO MARCACCI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;NICOLA BALDINI;PIERO PICCI;DAVIDE MAR√çA DONATI;ELIZAVETA KON;SOFIA AVNET;GINA LISIGNOLI;MILENA FINI;STEFANO FERRARI;N. LOPOMO;ERMINIA MARIANI;NICOLETTA ZINI;GIANLUCA GIAVARESI;STEFANO BORIANI;BRUNELLA GRIGOLO;ALBERTO GRASSI;CAROLA CAVALLO;GEMMA DI POMPO","957;927;802;800;756;729;670;603;539;471;446;431;429;429;414;370;361;328;328;325","MAURILIO MARCACCI;PIERO PICCI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;STEFANO FERRARI;DAVIDE MAR√çA DONATI;ELIZAVETA KON;ALBERTO GRASSI;CESARE FALDINI;NICOLA BALDINI;FRANCESCO TRAINA;N. LOPOMO;STEFANO BORIANI;SAVERIO AFFATATO;GIANLUCA GIAVARESI;EMANUELA PALMERINI;KATIA SCOTLANDI;ALESSANDRO RUSSO","30;27;24;21;18;18;16;16;15;14;13;13;12;12;12;11;10;10;9;9","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATERIALS SCIENCE;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;ECONOMICS;SOCIOLOGY;GEOLOGY;ART;POLITICAL SCIENCE;BUSINESS;HISTORY","266;102;51;47;46;34;33;22;20;8;7;4;3;2;2;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;CELL BIOLOGY;GENETICS;CANCER RESEARCH;ORTHODONTICS;PHYSICAL THERAPY;COMPOSITE MATERIAL;RADIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;BIOMEDICAL ENGINEERING;ONCOLOGY;IMMUNOLOGY;OPTICS;ENDOCRINOLOGY;CLASSICAL MECHANICS;ENVIRONMENTAL HEALTH;ORGANIC CHEMISTRY","156;99;97;53;51;42;37;36;35;32;31;28;26;25;22;20;20;19;15;15;15","ALTERNATIVE MEDICINE;GENE;CANCER;ORTHOPEDIC SURGERY;SARCOMA;IN VITRO;CARTILAGE;CHEMOTHERAPY;MESENCHYMAL STEM CELL;IMPLANT;PROSTHESIS;ANTERIOR CRUCIATE LIGAMENT;BONE MARROW;CELL;POPULATION;RETROSPECTIVE COHORT STUDY;IMMUNOHISTOCHEMISTRY;KINEMATICS;RADIOGRAPHY;REHABILITATION","46;30;27;24;21;20;19;18;18;16;16;15;15;15;15;15;14;14;14;14","OSTEOARTHRITIS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;SOFT TISSUE SARCOMA;METASTASIS;CHONDROCYTE;CUBIC ZIRCONIA;GENE EXPRESSION;MENISCUS;BREAST CANCER;CANCER CELL;MICRORNA;ACL INJURY;DOXORUBICIN;GAIT ANALYSIS;OSTEOCLAST;POLYPHENOL;TUMOR MICROENVIRONMENT;AUTOPHAGY;BONE MINERAL;BONE SARCOMA;CELL CYCLE;CLINICAL ENDPOINT;COLLAGEN VI;DOWNREGULATION AND UPREGULATION;ETOPOSIDE;FIXATION (POPULATION GENETICS);GENOTYPE;PLATELET-RICH PLASMA;PROGRAMMED CELL DEATH;RETURN TO SPORT;TISSUE MICROARRAY","36;12;11;8;7;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;IFOSFAMIDE;HYDROXYTYROSOL;SIRTUIN;SYNOVIAL FLUID;WOMAC;ANTEROLATERAL LIGAMENT;BONE METASTASIS;CD99;DIFFERENTIAL ITEM FUNCTIONING;EPIRUBICIN;HIGH TIBIAL OSTEOTOMY;INTRA ARTICULAR;KNEE PAIN;MICROVESICLES;MISSENSE MUTATION;MITOPHAGY;MYELOPROLIFERATIVE NEOPLASM;ONCOGENE;OSTEOCALCIN;OSWESTRY DISABILITY INDEX;PRIMARY TUMOR;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;SIRTUIN 1;TAQMAN;TRABECTEDIN","8;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;BONE NEOPLASMS;KNEE JOINT;OSTEOSARCOMA;AGED;TREATMENT OUTCOME;YOUNG ADULT;ADOLESCENT;RETROSPECTIVE STUDIES;ANTERIOR CRUCIATE LIGAMENT INJURIES;MESENCHYMAL STEM CELLS;OSTEOARTHRITIS, KNEE;FEMUR;SARCOMA, EWING;TIBIA","172;121;115;114;75;74;57;57;57;56;52;41;39;36;33;33;31;29;28;27","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;BIOMECHANICS OF RUNNING-RELATED INJURIES;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;MANAGEMENT OF SPINAL METASTATIC TUMORS;MULTIPOTENT MESENCHYMAL STEM CELLS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;ROLE OF AUTOPHAGY IN DISEASE AND HEALTH","27;25;24;15;13;13;11;9;9;6;6;5;5;5;4;4;4;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;ATHLETIC REHABILITATION;SOFT TISSUE SARCOMA;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;MESENCHYMAL STEM CELLS;OSTEOSARCOMA;MENISCUS;TUMOR MICROENVIRONMENT;ACL INJURY;BIOMECHANICS;FOOT STRIKE PATTERNS;HIP ARTHROSCOPY;HIP JOINT MECHANICS;METASTATIC SPINE TUMORS;ANTERIOR CRUCIATE LIGAMENT;CANCER CELL METABOLISM","28;20;19;12;11;11;8;8;8;8;7;7;6;6;6;6;6;6;5;5","ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;LIGAMENT RECONSTRUCTION;SOFT TISSUE;TOTAL KNEE;MESENCHYMAL STROMAL;EWING SARCOMA;RANDOMIZED CONTROLLED;BONE MARROW;CONTROLLED TRIAL;KNEE ARTHROPLASTY;PRELIMINARY RESULTS;STROMAL CELLS;TISSUE SARCOMAS;TOTAL HIP;FEMORAL HEADS;ITALIAN SARCOMA;OSTEOSARCOMA CELLS;PLATELET-RICH PLASMA;STEM CELLS;ADULT SOFT;ANEURYSMAL BONE;BONE SARCOMA;BREAST CANCER;CHEMOTHERAPY CT;FINITE ELEMENT;HIGH-RISK ADULT;HIP REPLACEMENT;IIN VITROI;JOINT KINEMATICS","8;8;8;8;8;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","LOCAL RECURRENCE;SYNOVIAL CELLS;CD CD;COLLAGEN VI;BOLOGNA ITALY;GENE EXPRESSION;OSTEOARTHRITIS OA;VASCULARIZED FIBULA;CANONICAL WNT;PATIENTS UNDERWENT;STROMAL CELLS;NICOLAES TULP;SYNOVIAL INFLAMMATION;SYNOVIAL MEMBRANE;CELL LINE;EXTRACELLULAR MATRIX;PATIENTS AFFECTED;STEM CELLS;SURGICALLY TREATED;BONE MARROW;PATIENTS UNDERGOING;RESIDUAL THIGH-SHANK;ADVERSE EVENTS;BONE METASTASES;CCL CCL;DNA DAMAGE;DR NICOLAES;EWS PATIENTS;HR CI;KNEE OA","22;19;18;18;17;15;14;13;12;12;12;11;11;11;10;10;10;10;10;9;9;9;8;8;8;8;8;8;8;8",309,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2017,264,9.52651515151515,3.5719696969697,0.279957582184517,0.503787878787879,0.458333333333333,0.439393939393939,0.446969696969697,3,107,88,25,24,0.41,0.33,0.09,0.09,25.67,0.870793657978177,0.371212121212121,0.825757575757576,4.71331467413035,0.489110214947354,0.411514945652174,0.423905291684496,0.363330057560017,"PIERO PICCI;MAURILIO MARCACCI;MILENA FINI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;ELIZAVETA KON;EMANUELA PALMERINI;ALBERTO RIGHI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;NICOLA BALDINI;GIOVANNI GRIGNANI;STEFANO BORIANI;ALESSANDRO GASBARRINI;MARCO GAMBAROTTI;ALBERTO BAZZOCCHI;SAVERIO AFFATATO;STEFANO FERRARI;KATIA SCOTLANDI;MICHELE BIANCHI","21;20;19;19;14;13;13;12;11;11;11;11;11;11;11;10;10;10;9;9","SAVERIO AFFATATO;MILENA FINI;MAURILIO MARCACCI;ALESSANDRA LONGHI;DAVIDE MAR√çA DONATI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;ALESSANDRO GASBARRINI;STEFANO ZAFFAGNINI;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA SAMBRI;ALBERTO RIGHI;ANTONIO MAZZOTTI;NICOLA BALDINI;CESARE FALDINI;MARCO GAMBAROTTI;MARCO BONTEMPI","2.89;2.63;2.36;2.32;2.1;1.9;1.82;1.8;1.64;1.63;1.49;1.49;1.41;1.37;1.34;1.32;1.28;1.19;1.14;1.12","PIERO PICCI;MAURILIO MARCACCI;MILENA FINI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;ELIZAVETA KON;EMANUELA PALMERINI;ALBERTO RIGHI;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;NICOLA BALDINI;STEFANO BORIANI;ALESSANDRO GASBARRINI;MARCO GAMBAROTTI;ALBERTO BAZZOCCHI;SAVERIO AFFATATO;STEFANO FERRARI;KATIA SCOTLANDI;MICHELE BIANCHI;GINA LISIGNOLI","21;20;19;19;14;13;13;12;11;11;11;11;11;11;10;10;10;9;9;9","SAVERIO AFFATATO;MILENA FINI;MAURILIO MARCACCI;ALESSANDRA LONGHI;DAVIDE MAR√çA DONATI;PIERO PICCI;ALBERTO LEARDINI;GIUSEPPE FILARDO;ELIZAVETA KON;ALESSANDRO GASBARRINI;STEFANO ZAFFAGNINI;ALBERTO BAZZOCCHI;STEFANO BORIANI;ANDREA SAMBRI;ALBERTO RIGHI;ANTONIO MAZZOTTI;NICOLA BALDINI;CESARE FALDINI;MARCO GAMBAROTTI;MARCO BONTEMPI","2.89;2.63;2.36;2.32;2.1;1.9;1.82;1.8;1.64;1.63;1.49;1.49;1.41;1.37;1.34;1.32;1.28;1.19;1.14;1.12","PIERO PICCI;DAVIDE MAR√çA DONATI;STEFANO FERRARI;EMANUELA PALMERINI;GIOVANNI GRIGNANI;MAURILIO MARCACCI;ANGELO PAOLO DEI TOS;EMANUELA MARCHESI;ALESSANDRO GRONCHI;VIRGINIA FERRARESI;GIUSEPPE FILARDO;NICOLA BALDINI;ELIZAVETA KON;PAOLO G. CASALI;SILVIA STACCHIOTTI;CARLO MOROSI;STEFANO ZAFFAGNINI;JEAN‚ÄêYVES BLAY;JAVIER MART√çN‚ÄêBROTO;ELENA PALASSINI","1068;953;900;769;687;608;599;592;527;509;503;489;468;466;465;441;427;423;421;414","PIERO PICCI;DAVIDE MAR√çA DONATI;STEFANO FERRARI;EMANUELA PALMERINI;EMANUELA MARCHESI;GIUSEPPE FILARDO;NICOLA BALDINI;STEFANO ZAFFAGNINI;MILENA FINI;MAURILIO MARCACCI;ALESSANDRO GASBARRINI;ALBERTO RIGHI;MICHELE BIANCHI;MARCO GAMBAROTTI;GINA LISIGNOLI;ANNA PAIOLI;CRISTINA MANFERDINI;ALESSANDRO RUSSO;ALESSANDRA LONGHI;GIUSEPPE TEDESCO","1068;953;890;769;592;503;489;427;376;328;327;326;308;298;296;277;277;250;247;239","PIERO PICCI;DAVIDE MAR√çA DONATI;MILENA FINI;STEFANO FERRARI;GIUSEPPE FILARDO;MAURILIO MARCACCI;EMANUELA PALMERINI;CESARE FALDINI;ALBERTO LEARDINI;NICOLA BALDINI;STEFANO ZAFFAGNINI;ALESSANDRO GASBARRINI;MICHELE BIANCHI;ALBERTO BAZZOCCHI;ALBERTO RIGHI;MARCO GAMBAROTTI;KATIA SCOTLANDI;SAVERIO AFFATATO;STEFANO BORIANI;ALESSANDRO RUSSO","21;19;18;15;14;13;13;12;11;11;11;11;10;10;10;10;9;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;ENGINEERING;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;BUSINESS;ECONOMICS;GEOGRAPHY;HISTORY;ART","236;96;57;47;31;29;25;13;9;6;6;5;4;3;2;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;GENETICS;CANCER RESEARCH;COMPOSITE MATERIAL;ANATOMY;CELL BIOLOGY;RADIOLOGY;ORTHODONTICS;PHYSICAL THERAPY;BIOMEDICAL ENGINEERING;IMMUNOLOGY;ORGANIC CHEMISTRY;ONCOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;NANOTECHNOLOGY;PALEONTOLOGY","123;105;99;53;34;32;32;30;30;28;25;25;24;20;20;16;14;13;13;12","ALTERNATIVE MEDICINE;CANCER;GENE;SARCOMA;IN VITRO;OSTEOPOROSIS;MESENCHYMAL STEM CELL;ORTHOPEDIC SURGERY;ARTHROPLASTY;IMPLANT;CHEMOTHERAPY;OSTEOSARCOMA;POPULATION;CARTILAGE;RECEPTOR;STEM CELL;STROMAL CELL;SOFT TISSUE;ANTERIOR CRUCIATE LIGAMENT;CLINICAL TRIAL;PROSPECTIVE COHORT STUDY;RADIOGRAPHY","31;31;29;25;21;19;18;17;15;15;14;14;14;13;11;11;11;10;9;9;9;9","OSTEOARTHRITIS;METASTASIS;SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;BREAST CANCER;OSTEOBLAST;GIANT-CELL TUMOR OF BONE;OSTEOCLAST;GENE EXPRESSION;MUTATION;STAPHYLOCOCCUS AUREUS;ALKALINE PHOSPHATASE;CANCER CELL;CD34;CROSS-LINKED POLYETHYLENE;DENOSUMAB;SUNITINIB;ACTIVATOR (GENETICS);ALLELE;ANKLE REPLACEMENT;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DEPOSITION (GEOLOGY);DNA DAMAGE;DOWNREGULATION AND UPREGULATION;FIXATION (POPULATION GENETICS);GIANT CELL TUMORS;HIP FRACTURE;MICRORNA;PEEK;PERIPROSTHETIC;PHENOTYPE;RETURN TO SPORT;UNIVARIATE ANALYSIS;VIABILITY ASSAY","21;11;11;8;8;8;8;7;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;DUAL-ENERGY X-RAY ABSORPTIOMETRY;TRABECTEDIN;BONE METASTASIS;EPIRUBICIN;IFOSFAMIDE;PAZOPANIB;PRIMARY TUMOR;RANKL;ANTEROLATERAL LIGAMENT;CD99;CYSTATHIONINE BETA SYNTHASE;LOW-INTENSITY PULSED ULTRASOUND;OSWESTRY DISABILITY INDEX;PIVOT-SHIFT TEST;SYNOVIAL FLUID;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;WOMAC;ACHILLES TENDON RUPTURE;ADAMANTINOMA;ADIPOKINE;ALPHA (FINANCE);AMPK;ANTHRACYCLINE;ARTHROPATHY;ARTHROSPIRA;BREAST CARCINOMA;CD163;CD40;CD90;CEFTAZIDIME;CELL CYCLE CHECKPOINT;CHEMOKINE RECEPTOR;CLOFARABINE;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);CXCR4;CYCLIN;CYCLIN D1;DBM;DISKECTOMY;DISTANT METASTASIS;DNA METHYLATION;DUAL ENERGY;ENSTROPHY;ENTHESITIS;ESTROGEN RECEPTOR;EXOME SEQUENCING;EXTERNAL BEAM RADIOTHERAPY;FANCONI ANEMIA;FUSION PROTEIN;GENEXPERT MTB/RIF;GENOME INSTABILITY;GENOTYPE-PHENOTYPE DISTINCTION;GERMLINE MUTATION;GIANT CELL ARTERITIS;GOLIMUMAB;GRANZYME B;IMIPENEM;IMMUNE CHECKPOINT;INSULIN-LIKE GROWTH FACTOR;IRINOTECAN;KLEBSIELLA PNEUMONIAE;KNEE PAIN;LEISHMANIA INFANTUM;LMNA;M2 MACROPHAGE;MEROPENEM;MESALAZINE;METASTATIC BREAST CANCER;METHYLTRANSFERASE;MIRBASE;NEOADJUVANT THERAPY;ONCOGENE;ONCOGENE PROTEINS;OSTEOCALCIN;OSTEOCYTE;OSTEOPENIA;PENCIL-BEAM SCANNING;PITUITARY APOPLEXY;POLY ADP RIBOSE POLYMERASE;PONSETI METHOD;POSTERIOR INTEROSSEOUS NERVE;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;REFERENCE GENES;REPORTER GENE;RNA EXTRACTION;RNA INTERFERENCE;ROCK1;ROCK2;RUNX2;SANGER SEQUENCING;SINGLE-NUCLEOTIDE POLYMORPHISM;SOLITARY FIBROUS TUMOR;SOX2;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;SYSTEMIC THERAPY;TAKAYASU ARTERITIS;TERIPARATIDE;THROMBOSPONDIN;TRANSCRIPTOME;TRANSLATION (BIOLOGY);TRANSSPHENOIDAL SURGERY;TRASTUZUMAB;TUMOR-INFILTRATING LYMPHOCYTES;UNICOMPARTMENTAL KNEE ARTHROPLASTY;VANCOMYCIN;VASCULOGENESIS;VASCULOGENIC MIMICRY;VIRUS-LIKE PARTICLE","5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;ADULT;BONE NEOPLASMS;MIDDLE AGED;AGED;YOUNG ADULT;ADOLESCENT;MESENCHYMAL STEM CELLS;OSTEOSARCOMA;CARTILAGE, ARTICULAR;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;KNEE JOINT;NEOPLASM RECURRENCE, LOCAL;FOLLOW-UP STUDIES;SPINAL NEOPLASMS;OSTEOCLASTS","157;103;95;94;72;65;64;54;43;38;37;36;32;31;31;30;28;25;25;24","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TISSUE ENGINEERING AND BIOMATERIALS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;MANAGEMENT OF SPINAL METASTATIC TUMORS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BIOMECHANICS OF RUNNING-RELATED INJURIES;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;MULTIPOTENT MESENCHYMAL STEM CELLS;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;BIOMEDICAL APPLICATIONS OF SILK BIOMATERIALS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING;TREATMENT AND OUTCOMES OF HAND INJURIES;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES","27;18;14;14;12;11;10;6;6;5;5;4;4;3;3;3;3;3;3;2","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;SOFT TISSUE SARCOMA;TOTAL KNEE REPLACEMENT;OSTEOBLAST ADHESION;EWING'S SARCOMA;GIANT CELL TUMOR;OSTEOSARCOMA;ATHLETIC REHABILITATION;BONE REGENERATION;BONE REMODELING;METASTATIC SPINE TUMORS;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;LIMB RECONSTRUCTION;OSTEOCLAST DIFFERENTIATION;REVISION SURGERY;SPINAL FUSION;BIOMATERIAL;BONE HEALING","15;13;12;11;10;9;9;8;7;7;7;7;6;6;5;5;5;5;4;4","ANTERIOR CRUCIATE;CELL TUMOR;CRUCIATE LIGAMENT;EWING SARCOMA;GIANT CELL;SOFT TISSUE;STROMAL CELLS;MESENCHYMAL STEM;LIGAMENT RECONSTRUCTION;STEM CELLS;TOTAL KNEE;CONTROLLED TRIAL;MESENCHYMAL STROMAL;BONE METASTASES;CALCIUM PHOSPHATE;CLINICAL TRIAL;COHORT STUDY;COMPUTED TOMOGRAPHY;CRITICAL ANALYSIS;FEMORAL HEADS;HAND OSTEOARTHRITIS;HIP ARTHROPLASTY;KNEE ARTHROPLASTY;KNEE REPLACEMENT;LOCAL RECURRENCE;MINIMUM FOLLOW-UP;MULTICENTRE RANDOMIZED;OSTEOSARCOMA PATIENTS;RANDOMIZED CONTROLLED;SPINE TUMORS","7;7;7;7;7;7;7;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","STEM CELLS;BOLOGNA ITALY;CELL LINES;DE LIUZZI;PRIMARY TUMOR;OSTEOGENIC DIFFERENTIATION;WEIGHT BEARING;BONE TISSUE;CELL VIABILITY;LOCAL RECURRENCE;STROMAL CELLS;LUNG METASTASES;MESENCHYMAL STEM;SOFT TISSUE;STATISTICALLY SIGNIFICANT;BONE METASTASES;CLINICAL TRIAL;CLINICAL TRIALS;KNEE LAXITY;MESENCHYMAL STROMAL;SYNOVIAL CELLS;ACL RECONSTRUCTION;CLINICAL RESEARCH;COORDINATION PATTERNS;GENE EXPRESSION;GIANT CELL;HIP FRACTURE;HUMAN BODY;HUMAN OSTEOSARCOMA;MECHANICAL PROPERTIES","16;13;11;11;11;10;10;9;9;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6",264,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2018,347,10.6599423631124,3.97406340057637,0.251631617113851,0.553314121037464,0.538904899135447,0.302593659942363,0.429394812680115,3,139,82,64,25,0.4,0.24,0.18,0.07,25.36,0.831352464878241,0.380403458213256,0.737752161383285,4.43272171253822,0.519920794928944,0.439842767295598,0.463944323327184,0.429680501642281,"PIERO PICCI;STEFANO ZAFFAGNINI;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO LEARDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;KATIA SCOTLANDI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;MAURILIO MARCACCI;SILVIA STACCHIOTTI;ALESSANDRO GASBARRINI;JAVIER MART√çN‚ÄêBROTO;ANGELO PAOLO DEI TOS;PAOLO CARAVAGGI;SAVERIO AFFATATO;PAOLO G. CASALI;GIOVANNI GRIGNANI","32;24;20;20;19;17;17;17;15;15;15;14;14;13;12;12;11;11;10;10","SAVERIO AFFATATO;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO BAZZOCCHI;SOFIA AVNET;MILENA FINI;PIERO PICCI;GIUSEPPE FILARDO;PAOLO CARAVAGGI;ALESSANDRO GASBARRINI;MAURILIO MARCACCI;ALBERTO GRASSI;CLAUDIO BELVEDERE;MASSIMILIANO BALEANI;MASSIMILIANO MEROLA;EMANUELA PALMERINI;PAOLO SPINNATO;KATIA SCOTLANDI","3.98;3.15;3.11;2.96;2.7;2.62;2.58;2.54;2.33;2.18;1.95;1.91;1.9;1.89;1.8;1.71;1.7;1.59;1.58;1.57","PIERO PICCI;STEFANO ZAFFAGNINI;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO LEARDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;KATIA SCOTLANDI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;MAURILIO MARCACCI;ALESSANDRO GASBARRINI;ANGELO PAOLO DEI TOS;PAOLO CARAVAGGI;SAVERIO AFFATATO;SOFIA AVNET;CLAUDIO BELVEDERE;STEFANO FERRARI;ALBERTO RIGHI","32;24;20;20;19;17;17;17;15;15;15;14;13;12;11;11;10;10;10;9","SAVERIO AFFATATO;STEFANO ZAFFAGNINI;ALBERTO LEARDINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO BAZZOCCHI;SOFIA AVNET;MILENA FINI;PIERO PICCI;GIUSEPPE FILARDO;PAOLO CARAVAGGI;ALESSANDRO GASBARRINI;MAURILIO MARCACCI;ALBERTO GRASSI;CLAUDIO BELVEDERE;MASSIMILIANO BALEANI;MASSIMILIANO MEROLA;EMANUELA PALMERINI;PAOLO SPINNATO;KATIA SCOTLANDI","3.98;3.15;3.11;2.96;2.7;2.62;2.58;2.54;2.33;2.18;1.95;1.91;1.9;1.89;1.8;1.71;1.7;1.59;1.58;1.57","PIERO PICCI;SILVIA STACCHIOTTI;ANGELO PAOLO DEI TOS;GIOVANNI GRIGNANI;PAOLO G. CASALI;JAVIER MART√çN‚ÄêBROTO;ALESSANDRO GRONCHI;JEAN‚ÄêYVES BLAY;HANS GELDERBLOM;ANTONIO L√ìPEZ‚ÄìPOUSA;PIOTR RUTKOWSKI;ENRIQUE DE √ÅLAVA;ROBIN L. JONES;XAVIER GARC√çA DEL MURO;R. BIAGINI;KIRSTEN SUNDBY HALL;ANNA MARIA FREZZA;RAIMONDO PIANA;VIRGINIA FERRARESI;SEBASTIAN BAUER","3318;2962;2906;2882;2856;2813;2753;2724;2709;2704;2683;2646;2641;2634;2628;2604;2594;2593;2574;2548","PIERO PICCI;STEFANO FERRARI;S. FERRARI;NICOLA BALDINI;EMANUELA PALMERINI;STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO GRASSI;SOFIA AVNET;KATIA SCOTLANDI;ALBERTO RIGHI;ALBERTO LEARDINI;MARCO GAMBAROTTI;ALESSANDRO DI MARTINO;ALBERTO BAZZOCCHI;ANNARITA CENACCHI;FILIPPO SELLERI;FRANCESCO TENTONI","3318;2270;688;512;500;437;434;389;371;361;321;310;280;249;234;232;223;204;204;204","PIERO PICCI;STEFANO ZAFFAGNINI;MILENA FINI;DAVIDE MAR√çA DONATI;NICOLA BALDINI;ALBERTO LEARDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;STEFANO FERRARI;ALBERTO BAZZOCCHI;ALBERTO GRASSI;KATIA SCOTLANDI;ALESSANDRO GASBARRINI;PAOLO CARAVAGGI;SAVERIO AFFATATO;CLAUDIO BELVEDERE;SOFIA AVNET;ALBERTO RIGHI;GINA LISIGNOLI;CESARE FALDINI","32;24;20;19;19;17;17;17;16;15;15;15;13;11;11;10;10;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;HISTORY;SOCIOLOGY;BUSINESS;GEOLOGY;ART;ECONOMICS;ENVIRONMENTAL SCIENCE","308;101;54;42;37;34;26;26;8;8;8;5;5;4;4;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;CANCER RESEARCH;BIOCHEMISTRY;ORTHODONTICS;CELL BIOLOGY;PHYSICAL THERAPY;GENETICS;RADIOLOGY;BIOMEDICAL ENGINEERING;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENVIRONMENTAL HEALTH;ONCOLOGY;COMPOSITE MATERIAL;ARTIFICIAL INTELLIGENCE;ORGANIC CHEMISTRY;STRUCTURAL ENGINEERING","176;127;123;51;49;48;45;43;43;42;37;27;25;25;24;24;23;16;16;14","ALTERNATIVE MEDICINE;GENE;CANCER;ORTHOPEDIC SURGERY;POPULATION;SARCOMA;ARTHROPLASTY;CHEMOTHERAPY;IMPLANT;OSTEOSARCOMA;ANTERIOR CRUCIATE LIGAMENT;MESENCHYMAL STEM CELL;OSTEOPOROSIS;REHABILITATION;IN VITRO;RADIOGRAPHY;IMMUNOHISTOCHEMISTRY;PROSTHESIS;RETROSPECTIVE COHORT STUDY;STEM CELL","53;43;42;28;24;24;22;22;21;20;19;19;19;17;15;15;14;13;13;13","OSTEOARTHRITIS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;METASTASIS;SOFT TISSUE SARCOMA;BREAST CANCER;FIXATION (POPULATION GENETICS);CISPLATIN;GENE EXPRESSION;GENOTYPE;OSTEOCLAST;TRANSCRIPTION FACTOR;BONE CEMENT;BONE MINERAL;CD34;CHEMOKINE;DOWNREGULATION AND UPREGULATION;HIP FRACTURE;LOW BACK PAIN;OSTEOBLAST;RETURN TO SPORT;SUNITINIB","31;16;16;9;8;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","ARTICULAR CARTILAGE;PIVOT-SHIFT TEST;GENETIC ARCHITECTURE;IFOSFAMIDE;LMNA;PAZOPANIB;SINGLE-NUCLEOTIDE POLYMORPHISM;UNICOMPARTMENTAL KNEE ARTHROPLASTY;BONE METASTASIS;CD99;DNA METHYLATION;FLI1;HISTONE DEACETYLASE;PRIMARY TUMOR;TRABECTEDIN;CLOFARABINE;CXCR4;ENTHESITIS;EPIRUBICIN;INFRAPATELLAR FAT PAD;INSULIN-LIKE GROWTH FACTOR;INTRA ARTICULAR;LUCIFERASE;METASTATIC BREAST CANCER;MICROVESICLES;NIVOLUMAB;OSWESTRY DISABILITY INDEX;POSTERIOR INTEROSSEOUS NERVE;RADIAL HEAD FRACTURE;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;TRANSCRIPTOME;VARUS DEFORMITY","6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;BONE NEOPLASMS;ADULT;AGED;YOUNG ADULT;ADOLESCENT;TREATMENT OUTCOME;KNEE JOINT;RETROSPECTIVE STUDIES;OSTEOSARCOMA;AGED, 80 AND OVER;TIBIA;SARCOMA, EWING;MESENCHYMAL STEM CELLS;CHILD;FOLLOW-UP STUDIES","173;164;111;110;80;79;70;68;45;43;38;35;34;33;31;27;26;24;22;22","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;MANAGEMENT OF SPINAL METASTATIC TUMORS;MULTIPOTENT MESENCHYMAL STEM CELLS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION","28;26;22;15;14;11;11;10;10;10;10;8;8;8;8;5;4;4;4;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;EWING'S SARCOMA;SOFT TISSUE SARCOMA;ATHLETIC REHABILITATION;HIP ARTHROPLASTY;BIOMECHANICS;METASTATIC SPINE TUMORS;REHABILITATION;HIP FRACTURE;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;OSTEOSARCOMA;PROXIMAL HUMERUS FRACTURES;ANTERIOR CRUCIATE LIGAMENT;BONE REGENERATION;FOOT (PROSODY);INTERNAL FIXATION;OSTEOARTHRITIS TREATMENT","27;20;19;17;13;11;10;9;8;8;7;7;7;7;7;6;6;6;6;6","EWING SARCOMA;GIANT CELL;STEM CELLS;TOTAL KNEE;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;TOTAL HIP;KNEE ARTHROPLASTY;SOFT TISSUE;CONTROLLED TRIAL;HIP ARTHROPLASTY;LIGAMENT RECONSTRUCTION;MESENCHYMAL STEM;OBSERVATIONAL STUDY;PRELIMINARY RESULTS;BREAST CANCER;CLINICAL TRIAL;MESENCHYMAL STROMAL;SURGICAL TREATMENT;ASSOCIATION STUDY;BONE MARROW;CALCIUM PHOSPHATE;CEMENTLESS TOTAL;COHORT STUDY;GENOME-WIDE ASSOCIATION;HYALURONIC ACID;RADIAL HEAD;RANDOMISED CONTROLLED;STROMAL CELLS;TENOSYNOVIAL GIANT","10;10;9;9;8;8;8;7;7;6;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","PUBMED SCOPUS;CROSSREF PUBMED;GASTROINTESTINAL STROMAL;ONCOL -CROSSREF;SOFT TISSUE;CLIN ONCOL;ACL RECONSTRUCTION;ONCOL -ABSTRACT;CD CD;EWING SARCOMA;CELL LINES;PATIENTS TREATED;STEM CELLS;BONE TUMORS;STANDARD TREATMENT;ANTERIOR CRUCIATE;BONE SARCOMAS;CRUCIATE LIGAMENT;GROWTH FACTOR;STATISTICALLY SIGNIFICANT;STROMAL TUMORS;GENE EXPRESSION;IKDC CLINICAL;LOCAL RECURRENCE;BONE SARCOMA;CLINICAL PRACTICE;OXIDATIVE STRESS;PATIENTS UNDERGOING;CANCER -ABSTRACT;CELL DEATH","123;87;33;32;28;26;23;22;20;17;15;15;15;14;14;13;13;13;13;13;13;12;12;12;11;11;11;11;10;10",347,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2019,289,10.2491349480969,3.82352941176471,0.261538461538462,0.484429065743945,0.508650519031142,0.58477508650519,0.512110726643599,3,101,101,19,35,0.35,0.35,0.07,0.12,24.19,0.994652438687755,0.439446366782007,0.892733564013841,4.59889540904383,0.499266702839496,0.408675202508492,0.463235294117647,0.44707429322814,"STEFANO ZAFFAGNINI;ALBERTO RIGHI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;PIERO PICCI;ALBERTO LEARDINI;BARBARA BORDINI;GIANLUCA GIAVARESI;ALESSANDRO GASBARRINI;GINA LISIGNOLI;NICOLA BALDINI;KATIA SCOTLANDI;PAOLO SPINNATO;ALESSANDRA LONGHI;SILVIA STACCHIOTTI;MATTEO BERNI","24;21;21;19;17;17;13;13;12;11;11;11;11;10;10;9;9;9;9;9","STEFANO ZAFFAGNINI;LEVENT √ñZ√áAKAR;VINCENZO RICCI;SAVERIO AFFATATO;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO LEARDINI;PAOLO SPINNATO;ALBERTO GRASSI;SOFIA AVNET;MILENA FINI;NICOLA BALDINI;ALBERTO BAZZOCCHI;COSTANTINO ERRANI;MARCO VICECONTI;ALESSANDRO GASBARRINI;ALESSANDRO RUGGIERO","3.07;2.75;2.75;2.5;2.39;2.31;1.79;1.78;1.75;1.73;1.72;1.62;1.59;1.56;1.51;1.45;1.38;1.37;1.35;1.33","STEFANO ZAFFAGNINI;ALBERTO RIGHI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;PIERO PICCI;ALBERTO LEARDINI;BARBARA BORDINI;GIANLUCA GIAVARESI;ALESSANDRO GASBARRINI;GINA LISIGNOLI;NICOLA BALDINI;KATIA SCOTLANDI;PAOLO SPINNATO;ALESSANDRA LONGHI;MATTEO BERNI;FRANCESCO TRAINA","24;21;21;19;17;17;13;13;12;11;11;11;11;10;10;9;9;9;9;9","STEFANO ZAFFAGNINI;VINCENZO RICCI;SAVERIO AFFATATO;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;ALBERTO RIGHI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO LEARDINI;PAOLO SPINNATO;ALBERTO GRASSI;SOFIA AVNET;MILENA FINI;NICOLA BALDINI;ALBERTO BAZZOCCHI;COSTANTINO ERRANI;MARCO VICECONTI;ALESSANDRO GASBARRINI;EMANUELA PALMERINI;FRANCESCO CASTAGNINI","3.07;2.75;2.5;2.39;2.31;1.79;1.78;1.75;1.73;1.72;1.62;1.59;1.56;1.51;1.45;1.38;1.37;1.35;1.31;1.26","EMANUELA PALMERINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;HANS GELDERBLOM;LUCA SANGIORGI;JEAN‚ÄêYVES BLAY;SILVIA STACCHIOTTI;ANDREA SUPERTI‚ÄêFURGA;CHRISTINE M HALL;DANIEL H. COHN;DAVID SILLENCE;DEBORAH KRAKOW;GEERT MORTIER;GEN NISHIMURA;MATTHEW L. WARMAN;RAVI SAVARIRAYAN;SHEILA UNGER;STEFAN MUNDLOS;STEPHEN P. ROBERTSON;VAL√âRIE CORMIER‚ÄêDAIRE","791;714;667;605;605;583;560;497;497;497;497;497;497;497;497;497;497;497;497;497","EMANUELA PALMERINI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;LUCA SANGIORGI;ALBERTO GRASSI;MILENA FINI;DAVIDE MAR√çA DONATI;LUCA MACCHIAROLA;ALBERTO RIGHI;GIANLUCA GIAVARESI;CARLA RENATA ARCIOLA;ALBERTO BAZZOCCHI;DAVIDE CAMPOCCIA;ALBERTO LEARDINI;STEFANO RAVAIOLI;BRUNELLA GRIGOLO;GINA LISIGNOLI;KATIA SCOTLANDI;ALESSANDRO GASBARRINI;PIERO PICCI","791;696;667;605;481;416;350;328;322;316;299;288;286;278;265;243;223;219;206;196","STEFANO ZAFFAGNINI;ALBERTO RIGHI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;ALBERTO GRASSI;ALBERTO BAZZOCCHI;ALBERTO LEARDINI;GIANLUCA GIAVARESI;BARBARA BORDINI;PIERO PICCI;ALESSANDRO GASBARRINI;GINA LISIGNOLI;ALESSANDRA LONGHI;CESARE FALDINI;KATIA SCOTLANDI;PAOLO SPINNATO;COSTANTINO ERRANI;NICOLA BALDINI","24;21;20;18;17;17;13;13;11;11;11;11;11;10;9;9;9;9;9;8","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;GEOLOGY;POLITICAL SCIENCE;BUSINESS;SOCIOLOGY;ART;ECONOMICS;HISTORY","248;82;53;40;38;33;27;26;9;9;8;7;5;5;4;4;3","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;BIOMEDICAL ENGINEERING;CANCER RESEARCH;CELL BIOLOGY;RADIOLOGY;COMPOSITE MATERIAL;GENETICS;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;ORTHODONTICS;ENVIRONMENTAL HEALTH;IMMUNOLOGY;OPTICS;ORGANIC CHEMISTRY;ARTIFICIAL INTELLIGENCE;ENDOCRINOLOGY","146;103;85;54;44;36;36;36;32;28;28;25;24;23;19;19;17;16;14;13","ALTERNATIVE MEDICINE;GENE;ARTHROPLASTY;POPULATION;CARTILAGE;OSTEOPOROSIS;CANCER;ORTHOPEDIC SURGERY;IN VITRO;MESENCHYMAL STEM CELL;SARCOMA;CHEMOTHERAPY;IMPLANT;INCIDENCE (GEOMETRY);ANTERIOR CRUCIATE LIGAMENT;COHORT;OSTEOSARCOMA;TENDON;RECEPTOR;RETROSPECTIVE COHORT STUDY;SCAFFOLD","42;36;21;20;19;18;16;16;15;15;14;13;13;13;12;12;12;12;11;11;11","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);MICRORNA;CHEMOKINE;MENISCUS;METASTASIS;BONE MINERAL;DENOSUMAB;GAIT ANALYSIS;HAZARD RATIO;MUTATION;NEURORADIOLOGY;SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;ETOPOSIDE;GENE EXPRESSION;GIANT-CELL TUMOR OF BONE;OSTEOBLAST;PERIPROSTHETIC;ACHILLES TENDON;ACL INJURY;BONE DENSITY;CHONDROCYTE;CHONDROGENESIS;EVIDENCE-BASED MEDICINE;GIANT CELL TUMORS;HARRIS HIP SCORE;KNEE REPLACEMENT;LAMIN;LOW BACK PAIN;OSSEOINTEGRATION;OSTEOCLAST;PATELLAR TENDON;PHASES OF CLINICAL RESEARCH;PHENOTYPE;RNA;SUBLUXATION;TUMOR MICROENVIRONMENT;UNIVARIATE ANALYSIS","27;10;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;MICROVESICLES;CXCR4;IFOSFAMIDE;ACHILLES TENDON RUPTURE;CD99;CHEMOKINE RECEPTOR;DIGITAL IMAGE;INDUCED PLURIPOTENT STEM CELL;MEDIAL MENISCUS;MERKEL CELL POLYOMAVIRUS;MULTIPLEX POLYMERASE CHAIN REACTION;RUNX2;TELOMERASE REVERSE TRANSCRIPTASE;TERIPARATIDE;WOMAC;ACTIN CYTOSKELETON;ADENOSINE KINASE;ADIPOSE TISSUE MACROPHAGES;AKT1;ANTIRETROVIRAL THERAPY;ATP7A;BONE DENSITY CONSERVATION AGENTS;BRILLOUIN SPECTROSCOPY;BUSULFAN;CARBONIC ANHYDRASE I;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CLASSIFICATION OF OBESITY;CLAUDICATION;COMPLEMENT COMPONENT 5;COMPLEMENT FACTOR B;COMPLEMENT MEMBRANE ATTACK COMPLEX;CONGENITAL MYOPATHY;CONGENITAL TALIPES EQUINOVARUS;CYCLIN-DEPENDENT KINASE 2;DEBULKING;DECORIN;DNA METHYLATION;DUAL-ENERGY X-RAY ABSORPTIOMETRY;ENTEROCOCCUS FAECALIS;EXCESSIVE DAYTIME SLEEPINESS;EXOME SEQUENCING;FACET (PSYCHOLOGY);FERROPORTIN;FLUORESCENCE IN SITU HYBRIDIZATION;GENE MUTATION;GENETICALLY MODIFIED MOUSE;GERMLINE MUTATION;HAMP;HISTONE DEACETYLASE;HYDROXYTYROSOL;IL-2 RECEPTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INTRA ARTICULAR;IRINOTECAN;IRON STATUS;ISCHEMIA-MODIFIED ALBUMIN;JOINT DISEASE;KNEE ARTHRITIS;LASER CAPTURE MICRODISSECTION;LENVATINIB;LMNA;LONG NON-CODING RNA;LOW-INTENSITY PULSED ULTRASOUND;MECHANOSENSITIVE CHANNELS;MENKES DISEASE;MERKEL CELL;METASTASECTOMY;METASTATIC BREAST CANCER;METATARSALGIA;METHYLTRANSFERASE;MINIMUM BACTERICIDAL CONCENTRATION;MISSENSE MUTATION;MITOGEN-ACTIVATED PROTEIN KINASE KINASE;MYOEPITHELIOMA;MYXOID LIPOSARCOMA;NEOADJUVANT THERAPY;NON-CODING RNA;NUCLEAR PROTEIN;OPHTHALMIC PATHOLOGY;OSWESTRY DISABILITY INDEX;OXFORD KNEE SCORE;OXYCODONE;P-GLYCOPROTEIN;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PATELLAR LIGAMENT;PAZOPANIB;PITTSBURGH SLEEP QUALITY INDEX;PIVOT-SHIFT TEST;PLACENTAL GROWTH FACTOR;POLYETHYLENIMINE;POROMECHANICS;PRDM16;PROBAND;RANKL;RNA EDITING;SOLITARY FIBROUS TUMOR;STAPHYLOCOCCUS EPIDERMIDIS;SYNDESMOSIS;SYNOVIAL FLUID;TETRAPLEGIA;TITIN;TOTAL IRON-BINDING CAPACITY;TRABECTEDIN;UNICOMPARTMENTAL KNEE ARTHROPLASTY;USUAL INTERSTITIAL PNEUMONIA;WILD TYPE","11;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;MALE;FEMALE;BONE NEOPLASMS;ADULT;MIDDLE AGED;AGED;MESENCHYMAL STEM CELLS;OSTEOSARCOMA;ARTHROPLASTY, REPLACEMENT, HIP;YOUNG ADULT;RETROSPECTIVE STUDIES;NEOPLASM RECURRENCE, LOCAL;KNEE JOINT;ADOLESCENT;ANTERIOR CRUCIATE LIGAMENT INJURIES;ANIMALS;CHONDROCYTES;ARTHROPLASTY, REPLACEMENT, KNEE","164;113;102;101;68;63;61;46;36;34;33;33;31;30;29;26;25;24;24;23","ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;SARCOMA RESEARCH AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TISSUE ENGINEERING AND BIOMATERIALS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;MULTIPOTENT MESENCHYMAL STEM CELLS;HISTORY OF MEDICINE AND MEDICAL PRACTICES;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;3D BIOPRINTING TECHNOLOGY;BIOMECHANICS OF RUNNING-RELATED INJURIES;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY","21;20;16;15;13;13;8;8;6;6;5;5;5;4;4;3;3;3;3;3","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;TOTAL HIP REPLACEMENT;GIANT CELL TUMOR;TISSUE ENGINEERING;HIP ARTHROPLASTY;ANTERIOR CRUCIATE LIGAMENT;BONE REGENERATION;REVISION SURGERY;TENOSYNOVIAL GIANT CELL TUMOR;BIOMECHANICS;EWING'S SARCOMA;HIP JOINT MECHANICS;KNEE OSTEOARTHRITIS;MENISCUS;ATHLETIC REHABILITATION;DENOSUMAB;3D PRINTING;BONE MINERAL DENSITY;BONE TISSUE","18;14;13;9;9;8;7;7;7;7;6;6;6;6;6;5;5;4;4;4","GIANT CELL;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;HIP ARTHROPLASTY;TOTAL HIP;CELL TUMOR;MESENCHYMAL STROMAL;EWING SARCOMA;KNEE ARTHROPLASTY;LIGAMENT RECONSTRUCTION;STROMAL CELLS;BONE TISSUE;COHORT STUDY;CONTROLLED TRIAL;TENOSYNOVIAL GIANT;BONE MARROW;MESENCHYMAL STEM;ROTATOR CUFF;SOFT TISSUE;STEM CELLS;TOTAL KNEE;ACHILLES TENDON;ACL RECONSTRUCTION;ADIPOSE TISSUE;ARTICULAR CARTILAGE;BODY COMPOSITION;BONE SARCOMA;BONE TUMORS;CELL LINES;CELL TUMORS","12;11;11;9;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","LOCAL RECURRENCE;FUNDING INSTITUTION;GRANT FUNDING;RESEARCH GRANT;SACROILIAC JOINT;ADVISORY CONSULTANCY;OA MILIEU;ADIPOSE TISSUE;LACRIMAL GLAND;ACCOMMODATION EXPENSES;CELL LINES;CXCR CXCR;JOINT ARTHRODESIS;STEM CELLS;TRAVEL ACCOMMODATION;ARTICULAR CARTILAGE;BONE MARROW;FINITE ELEMENT;MIR- EXPRESSION;OXIDATIVE STRESS;STATISTICALLY SIGNIFICANT;SUBCHONDRAL BONE;TOTAL KNEE;BONE TISSUE;CELL MIGRATION;CONSERVATIVE MANAGEMENT;EXPENSES PERSONAL;GENE EXPRESSION;GLAND ACC;GROWTH FACTOR","17;16;16;16;15;14;14;13;12;10;10;10;10;10;10;9;9;9;9;9;9;9;9;8;8;8;8;8;8;8",289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2020,365,9.6958904109589,3.52876712328767,0.283385093167702,0.468493150684932,0.413698630136986,0.375342465753425,0.580821917808219,4,146,110,17,23,0.4,0.3,0.05,0.06,20.53,0.814897408600371,0.356164383561644,0.86027397260274,5.25542091836734,0.525890102647839,0.489504524551254,0.499915483434753,0.452926785067053,"STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;ALESSANDRA LONGHI;EMANUELA PALMERINI;ALBERTO RIGHI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;ANDREA SAMBRI;PIERO PICCI;SILVIA STACCHIOTTI;GIUSEPPE BIANCHI;GIOVANNI GRIGNANI;GIOVANNI BARBANTI BR√íDANO;FRANCESCO TRAINA;MARCO GAMBAROTTI;KATIA SCOTLANDI","47;31;26;22;18;17;16;16;15;15;13;13;13;12;11;11;11;10;10;9","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;GIUSEPPE FILARDO;ALBERTO LEARDINI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;VINCENZO RICCI;ALESSANDRO RUGGIERO;ALESSANDRO GASBARRINI;ANDREA SAMBRI;TIZIANA GREGGI;ANDREA TOGN√ô;FRANCESCO TRAINA;MARCO VICECONTI;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;ALESSANDRA LONGHI;STEFANIA D‚ÄôADAMO","6.52;4.14;2.92;2.92;2.83;2.77;2.6;2.4;2.1;1.92;1.88;1.82;1.59;1.56;1.49;1.45;1.4;1.4;1.34;1.27","STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;ALESSANDRA LONGHI;EMANUELA PALMERINI;ALBERTO RIGHI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;ANDREA SAMBRI;PIERO PICCI;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;FRANCESCO TRAINA;MARCO GAMBAROTTI;KATIA SCOTLANDI;GIANLUCA GIAVARESI;NICOLA BALDINI","47;31;26;22;18;17;16;16;15;15;13;13;13;11;11;10;10;9;9;9","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;GIUSEPPE FILARDO;ALBERTO LEARDINI;SAVERIO AFFATATO;DAVIDE MAR√çA DONATI;MILENA FINI;VINCENZO RICCI;ALESSANDRO GASBARRINI;ANDREA SAMBRI;TIZIANA GREGGI;ANDREA TOGN√ô;FRANCESCO TRAINA;MARCO VICECONTI;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;ALESSANDRA LONGHI;STEFANIA D‚ÄôADAMO;NICOLA BALDINI","6.52;4.14;2.92;2.92;2.83;2.77;2.6;2.4;2.1;1.88;1.82;1.59;1.56;1.49;1.45;1.4;1.4;1.34;1.27;1.25","NICOLA BALDINI;SOFIA AVNET;ADINA WEINBERGER;ALEXANDRIA P. COGDILL;ALON BEN‚ÄêNUN;AMNON AMIT;ANAT RONAI;ARNON MELTSER;AVIRAM NISSAN;AVIVA ROTTER-MASKOWITZ;BELLA KAUFMAN;CHRISTIAN U. BLANK;DAN J. RAZ;DANIEL S. PEEPER;DEBORAH NEJMAN;EINAV NILI GAL‚ÄêYAM;EINAV YEHUDA‚ÄêSHNAIDMAN;ELINOR GIGI;ELISA A. ROZEMAN;ERAN SEGAL","1503;1415;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402;1402","NICOLA BALDINI;SOFIA AVNET;STEFANO ZAFFAGNINI;ALBERTO GRASSI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;PIERO PICCI;CLAUDIA MARIA HATTINGER;EMANUELA PALMERINI;MARCO VICECONTI;MASSIMO SERRA;CARLA RENATA ARCIOLA;GIUSEPPE BIANCHI;KATIA SCOTLANDI;FRANCESCO URSINI;MILENA FINI;ALBERTO LEARDINI;VERONICA BRUSI;ALESSANDRO DI MARTINO;RICCARDO MELIC√íNI","1503;1415;761;596;504;477;449;352;345;328;326;318;318;300;288;268;244;198;188;186","STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;GIUSEPPE FILARDO;MILENA FINI;ALBERTO LEARDINI;ALESSANDRA LONGHI;EMANUELA PALMERINI;ALBERTO RIGHI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;GIUSEPPE BIANCHI;GIOVANNI BARBANTI BR√íDANO;GIANLUCA GIAVARESI;KATIA SCOTLANDI;SAVERIO AFFATATO;GIULIO MARIA MARCHEGGIANI MUCCIOLI;MARCO VICECONTI;ALESSANDRO DI MARTINO;ANNA PAIOLI","42;31;22;22;18;17;16;15;14;14;13;10;10;9;9;9;8;8;8;8","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;GEOLOGY;BUSINESS;HISTORY;ART;GEOGRAPHY","325;98;47;47;44;40;39;26;18;14;11;11;7;6;5;2;1;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;ANATOMY;BIOCHEMISTRY;RADIOLOGY;PHYSICAL THERAPY;GENETICS;BIOMEDICAL ENGINEERING;COMPOSITE MATERIAL;ORTHODONTICS;CANCER RESEARCH;ONCOLOGY;PHYSICAL MEDICINE AND REHABILITATION;CELL BIOLOGY;ENVIRONMENTAL HEALTH;PALEONTOLOGY;IMMUNOLOGY;NANOTECHNOLOGY;ENDOCRINOLOGY","188;149;132;52;43;43;35;34;33;33;31;30;27;26;25;25;21;17;17;15","ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;GENE;DISEASE;SARCOMA;CANCER;RETROSPECTIVE COHORT STUDY;IMPLANT;POPULATION;CHEMOTHERAPY;ARTHROPLASTY;OSTEOPOROSIS;IN VITRO;ANTERIOR CRUCIATE LIGAMENT;COHORT;ANKLE;MAGNETIC RESONANCE IMAGING;MESENCHYMAL STEM CELL;RADIOGRAPHY;PROSTHESIS;SOFT TISSUE","55;40;38;37;33;32;31;25;24;22;20;19;18;17;17;16;16;14;14;13;13","OSTEOARTHRITIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);METASTASIS;SOFT TISSUE SARCOMA;2019-20 CORONAVIRUS OUTBREAK;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BREAST CANCER;COLORECTAL CANCER;ARTHRODESIS;GAIT ANALYSIS;MUTATION;ACHILLES TENDON;ACL INJURY;DEPOSITION (GEOLOGY);FIXATION (POPULATION GENETICS);GENE SILENCING;SUBLUXATION;SURVIVORSHIP CURVE;BONE MINERAL;CHONDROCYTE;ETOPOSIDE;EWING'S SARCOMA;HAZARD RATIO;HIP FRACTURE;INJURY PREVENTION;MICRORNA;MYXOFIBROSARCOMA;PHENOTYPE;PROGRESSIVE DISEASE;TRANSCRIPTION FACTOR;VIABILITY ASSAY","41;17;12;10;9;7;7;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);ARTICULAR CARTILAGE;IFOSFAMIDE;TRABECTEDIN;IRINOTECAN;METASTASECTOMY;UNICOMPARTMENTAL KNEE ARTHROPLASTY;WOMAC;NUCLEAR PROTEIN;SYNOVIAL FLUID;ANTHRACYCLINE;BONE METASTASIS;CCL2;CTL*;CXCL10;EXOME SEQUENCING;IDH1;LMNA;MYXOID LIPOSARCOMA;QUANTITATIVE COMPUTED TOMOGRAPHY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS","17;5;5;5;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;BONE NEOPLASMS;AGED;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ADOLESCENT;KNEE JOINT;YOUNG ADULT;ITALY;SOFT TISSUE NEOPLASMS;CHILD;SARCOMA;NEOPLASM RECURRENCE, LOCAL;OSTEOARTHRITIS, KNEE;OSTEOSARCOMA","215;140;72;72;51;47;45;40;36;28;24;23;22;20;20;19;19;18;18;18","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TISSUE ENGINEERING AND BIOMATERIALS;BIOMECHANICS OF RUNNING-RELATED INJURIES;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;MANAGEMENT OF SPINAL METASTATIC TUMORS;3D BIOPRINTING TECHNOLOGY;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;GENETIC DISORDERS CAUSING TISSUE MINERALIZATION ABNORMALITIES;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS","34;20;19;17;15;14;13;11;7;7;7;6;5;5;5;4;4;4;4;4","KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;SOFT TISSUE SARCOMA;TOTAL HIP REPLACEMENT;EWING'S SARCOMA;PANDEMIC;FOOT (PROSODY);HIP ARTHROPLASTY;BIOMECHANICS;FOOT STRIKE PATTERNS;2019-20 CORONAVIRUS OUTBREAK;CHONDROSARCOMA;KNEE OSTEOARTHRITIS;LIMB RECONSTRUCTION;BIOCOMPATIBILITY;MESENCHYMAL CHONDROSARCOMA;PROXIMAL HUMERUS FRACTURES;REVISION SURGERY;SHOULDER PATHOLOGY;SPINAL FUSION","28;22;20;18;13;13;10;10;9;9;8;8;8;8;6;6;6;6;6;6","KNEE ARTHROPLASTY;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;EWING SARCOMA;TOTAL KNEE;LIGAMENT RECONSTRUCTION;SOFT TISSUE;BONE MARROW;COVID- PANDEMIC;MESENCHYMAL STROMAL;TOTAL HIP;ITALIAN SARCOMA;RETROSPECTIVE STUDY;STROMAL CELLS;ACHILLES TENDON;CLINICAL TRIAL;GIANT CELL;HIP ARTHROPLASTY;LUNG METASTASES;MID-TERM FOLLOW-UP;OSTEOCHONDRITIS DISSECANS;PILOT STUDY;SPINE SURGERY;ACETABULAR CUPS;CHONDROCYTE TRANSPLANTATION;COMPUTED TOMOGRAPHY;FACTORS AFFECTING;FATTY ACIDS;FEMORAL HEADS;FUNCTIONAL EVALUATION","11;9;9;9;9;8;8;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","ISI GOOGLE;PATIENTS UNDERGOING;COVID PERIOD;COMPUTATIONAL BIOMEDICINE;ACHILLES TENDON;PATIENTS AFFECTED;SIGNIFICANT DIFFERENCES;BLOOD FLOW;GENE EXPRESSION;MUSCLE MASS;NO-COVID PERIOD;OS CELLS;CROSSREF PUBMED;INTERFACE FOCUS;LINK ISI;PUBMED ISI;AUTOIMMUNE SYSTEMIC;BONE DISEASES;DOIRSFS LINK;FOCUS DOIRSFS;MASS INDEX;MM PATIENTS;ADVERSE EVENTS;BODY MASS;CELL DEATH;CLINICAL PRACTICE;COVID- PANDEMIC;EXTRACELLULAR MATRIX;ISTITUTO ORTOPEDICO;KNEE ARTHROPLASTY","27;22;18;15;14;14;13;12;12;12;12;12;11;11;11;11;10;10;10;10;10;10;9;9;9;9;9;9;9;9",365,4,0.01,1.125,3,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,3,0,0,0,0,0,0,3,3,3,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,2,2,2,0,0,0,0,0,0,15,15,15,15,15,15
"IRCCS_RIZZOLI",2021,381,11.3989501312336,3.86089238845144,0.259007477906186,0.47244094488189,0.467191601049869,0.506561679790026,0.677165354330709,5,134,95,20,33,0.35,0.25,0.05,0.09,15,0.972717765748049,0.388451443569554,0.876640419947507,5.41693244418673,0.537730504892407,0.481984478935699,0.450892348369156,0.472777129389369,"STEFANO ZAFFAGNINI;ALBERTO GRASSI;EMANUELA PALMERINI;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO RIGHI;GIUSEPPE FILARDO;ALESSANDRA LONGHI;STEFANO DI PAOLO;FRANCESCO URSINI;GIAN ANDREA LUCIDI;CESARE FALDINI;GIOVANNI TRISOLINO;ALESSANDRO GASBARRINI;ALBERTO LEARDINI;RICCARDO MELIC√íNI;PAOLO SPINNATO;GIOVANNI GRIGNANI;PIERO PICCI;GIACOMO DAL FABBRO","49;36;27;25;21;19;19;17;16;16;15;15;15;14;13;13;13;13;13;12","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;DAVIDE MAR√çA DONATI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;MILENA FINI;STEFANO DI PAOLO;GIAN ANDREA LUCIDI;MARCO VICECONTI;CESARE FALDINI;GIACOMO DAL FABBRO;ALBERTO LEARDINI;LUCA MACCHIAROLA;EMANUELA PALMERINI;BRUNELLA GRIGOLO;ALESSANDRO GASBARRINI;ALBERTO RIGHI;ALBERTO BAZZOCCHI;FRANCESCO URSINI","7.04;5.3;3.25;3.03;2.48;2.36;2.28;2.22;2.18;2.05;2.02;1.97;1.88;1.87;1.73;1.63;1.61;1.6;1.58;1.58","STEFANO ZAFFAGNINI;ALBERTO GRASSI;EMANUELA PALMERINI;DAVIDE MAR√çA DONATI;MILENA FINI;ALBERTO RIGHI;GIUSEPPE FILARDO;ALESSANDRA LONGHI;STEFANO DI PAOLO;FRANCESCO URSINI;GIAN ANDREA LUCIDI;CESARE FALDINI;GIOVANNI TRISOLINO;ALESSANDRO GASBARRINI;ALBERTO LEARDINI;RICCARDO MELIC√íNI;PAOLO SPINNATO;PIERO PICCI;GIACOMO DAL FABBRO;STEFANO STALLONE","49;36;27;25;21;19;19;17;16;16;15;15;15;14;13;13;13;13;12;12","STEFANO ZAFFAGNINI;ALBERTO GRASSI;PAOLO SPINNATO;DAVIDE MAR√çA DONATI;MARIA GRAZIA BENEDETTI;GIUSEPPE FILARDO;MILENA FINI;STEFANO DI PAOLO;GIAN ANDREA LUCIDI;MARCO VICECONTI;CESARE FALDINI;GIACOMO DAL FABBRO;ALBERTO LEARDINI;LUCA MACCHIAROLA;EMANUELA PALMERINI;BRUNELLA GRIGOLO;ALESSANDRO GASBARRINI;ALBERTO RIGHI;ALBERTO BAZZOCCHI;FRANCESCO URSINI","7.04;5.3;3.25;3.03;2.48;2.36;2.28;2.22;2.18;2.05;2.02;1.97;1.88;1.87;1.73;1.63;1.61;1.6;1.58;1.58","EMANUELA PALMERINI;SANDRA J. STRAUSS;VIRGINIA FERRARESI;ANGELO PAOLO DEI TOS;GIOVANNI GRIGNANI;JAVIER MART√çN‚ÄêBROTO;JEAN‚ÄêYVES BLAY;PAOLO G. CASALI;SILVIA STACCHIOTTI;KIRSTEN SUNDBY HALL;CARLO MOROSI;ALESSANDRO GRONCHI;KJETIL BOYE;MICHIEL A. J. VAN DE SANDE;PETER REICHARDT;HANS GELDERBLOM;JUDITH V.M.G. BOV√âE;MARTA SBARAGLIA;SEBASTIAN BAUER;MIKAEL ERIKSSON","1439;1236;1216;1209;1208;1205;1198;1196;1187;1185;1180;1173;1162;1157;1153;1148;1143;1141;1134;1128","EMANUELA PALMERINI;STEFANO ZAFFAGNINI;ALBERTO GRASSI;NICOLA BALDINI;DAVIDE MAR√çA DONATI;ALBERTO BAZZOCCHI;FRANCESCO URSINI;GIUSEPPE FILARDO;RICCARDO MELIC√íNI;ALESSANDRA LONGHI;BRUNELLA GRIGOLO;MILENA FINI;GINA LISIGNOLI;ALBERTO RIGHI;MAURO PETRETTA;CESARE FALDINI;SOFIA AVNET;NICOLETTA ZINI;CHIARA GASPERINI;CAROLA CAVALLO","1439;509;482;446;309;291;291;287;266;261;255;239;227;209;206;199;197;191;178;173","STEFANO ZAFFAGNINI;ALBERTO GRASSI;EMANUELA PALMERINI;DAVIDE MAR√çA DONATI;MILENA FINI;GIUSEPPE FILARDO;ALBERTO RIGHI;ALESSANDRA LONGHI;CESARE FALDINI;GIAN ANDREA LUCIDI;GIOVANNI TRISOLINO;FRANCESCO URSINI;ALBERTO LEARDINI;ALESSANDRO GASBARRINI;PAOLO SPINNATO;RICCARDO MELIC√íNI;COSTANTINO ERRANI;LUCA MACCHIAROLA;PAOLA ZARANTONELLO;STEFANO STALLONE","44;36;27;25;21;19;18;17;15;15;15;14;13;13;13;13;12;12;12;12","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;ECONOMICS;SOCIOLOGY;GEOLOGY;BUSINESS;HISTORY;ART;GEOGRAPHY","334;104;55;54;47;44;43;27;17;16;15;13;8;7;6;4;3;3","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;PHYSICAL THERAPY;RADIOLOGY;GENETICS;BIOCHEMISTRY;CANCER RESEARCH;CELL BIOLOGY;BIOMEDICAL ENGINEERING;PHYSICAL MEDICINE AND REHABILITATION;COMPOSITE MATERIAL;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ORTHODONTICS;ONCOLOGY;OPTICS;CLASSICAL MECHANICS;ARTIFICIAL INTELLIGENCE;BIOTECHNOLOGY","193;143;138;58;57;54;42;38;37;34;33;31;30;28;25;25;21;19;17;15;15","ALTERNATIVE MEDICINE;CANCER;GENE;SARCOMA;ORTHOPEDIC SURGERY;DISEASE;POPULATION;ANTERIOR CRUCIATE LIGAMENT;RADIOGRAPHY;IMPLANT;ARTHROPLASTY;MAGNETIC RESONANCE IMAGING;CHEMOTHERAPY;INCIDENCE (GEOMETRY);MESENCHYMAL STEM CELL;OSTEOSARCOMA;RETROSPECTIVE COHORT STUDY;IN VIVO;KINEMATICS;CARTILAGE;COHORT;OSTEOPOROSIS;SOFT TISSUE","56;39;35;33;32;30;28;23;23;22;21;20;18;17;17;17;17;16;16;13;13;13;13","OSTEOARTHRITIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MENISCUS;SOFT TISSUE SARCOMA;METASTASIS;ACL INJURY;BREAST CANCER;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;FIXATION (POPULATION GENETICS);2019-20 CORONAVIRUS OUTBREAK;BONE SARCOMA;GENE EXPRESSION;HARRIS HIP SCORE;PROINFLAMMATORY CYTOKINE;CLINICAL ENDPOINT;HIP FRACTURE;PHENOTYPE;SUBLUXATION;TUMOR MICROENVIRONMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES;AVASCULAR NECROSIS;CHONDROCYTE;CHONDROGENESIS;CISPLATIN;DNA DAMAGE;DOWNREGULATION AND UPREGULATION;MICRORNA;NEURORADIOLOGY;OSSEOINTEGRATION;PERIPROSTHETIC;PROGRESSIVE DISEASE;SYNOVIAL SARCOMA","42;16;14;12;11;10;10;8;8;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);ARTICULAR CARTILAGE;IFOSFAMIDE;WOMAC;GENOME INSTABILITY;INTRA ARTICULAR;METASTASECTOMY;BONE METASTASIS;MEDIAL MENISCUS;NEOADJUVANT THERAPY;ANTHRACYCLINE;CD163;DBM;FLI1;IŒöB KINASE;KNEE PAIN;LENVATINIB;MICROVESICLES;POSTURAL INSTABILITY;PRIMARY TUMOR;RANKL;STERILIZATION (ECONOMICS);TRABECTEDIN;TRANSCRIPTOME;TRANSLATION (BIOLOGY)","16;8;6;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;BONE NEOPLASMS;FEMALE;MALE;RETROSPECTIVE STUDIES;SARCOMA;ADULT;MIDDLE AGED;OSTEOSARCOMA;AGED;KNEE JOINT;TREATMENT OUTCOME;ADOLESCENT;ITALY;COVID-19;OSTEOARTHRITIS;FOLLOW-UP STUDIES;ANTERIOR CRUCIATE LIGAMENT INJURIES;CHILD","203;166;65;57;55;42;36;34;34;33;28;26;25;24;24;23;22;20;19;19","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;BONE TISSUE ENGINEERING AND BIOMATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BIOMECHANICS OF RUNNING-RELATED INJURIES;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;TREATMENT AND OUTCOMES OF HAND INJURIES;MANAGEMENT OF SPINAL METASTATIC TUMORS;EPIDEMIOLOGY OF SPORTS-RELATED MUSCULOSKELETAL INJURIES;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;3D BIOPRINTING TECHNOLOGY;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS","36;32;22;19;16;10;8;8;8;7;7;7;6;5;5;5;4;4;4;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;SOFT TISSUE SARCOMA;TOTAL KNEE REPLACEMENT;ANTERIOR CRUCIATE LIGAMENT;MENISCUS;BIOMECHANICS;ACL INJURY;HIP ARTHROPLASTY;EWING'S SARCOMA;INJURY RISK;MENISCUS INJURIES;ATHLETIC REHABILITATION;KNEE OSTEOARTHRITIS;OSTEOARTHRITIS TREATMENT;PANDEMIC;HIP ARTHROSCOPY;HIP FRACTURE;BIOMECHANICAL ANALYSIS;FOOT (PROSODY)","38;22;16;16;14;14;13;11;11;10;10;10;9;9;9;9;8;8;7;7","ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;HIP ARTHROPLASTY;SOFT TISSUE;TOTAL HIP;KNEE OSTEOARTHRITIS;BONE MARROW;MESENCHYMAL STROMAL;STEM CELLS;GIANT CELL;STROMAL CELLS;CELL TUMOR;LIGAMENT INJURY;LOWER LIMB;CUTTING GUIDE;EWING SARCOMA;HIP FRACTURE;HYALURONIC ACID;MESENCHYMAL STEM;TISSUE SARCOMA;TOTAL KNEE;AUTOIMMUNE SYSTEMIC;CLINICAL PRACTICE;COVID- PANDEMIC;ITALIAN SARCOMA;LIGAMENT RECONSTRUCTION;MUSCULOSKELETAL SYSTEM;PATIENTS TREATED;RANDOMIZED CONTROLLED;RETROSPECTIVE STUDY","15;14;11;11;11;10;8;8;8;7;7;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","PUBMED SCOPUS;BONE ALLOGRAFT;MASSIVE BONE;PATIENTS TREATED;SOFT TISSUE;EWING SARCOMA;ACL INJURY;CELL LINES;ANTERIOR CRUCIATE;CROSSREF PUBMED;CRUCIATE LIGAMENT;GIANT CELL;ONCOL -ABSTRACT;FREE FIBULA;INTERVENTIONAL PROCEDURES;KNEE OA;LOWER LIMB;OSTEOARTHRITIS OA;VASCULARIZED FREE;LIGAMENT ACL;ACL RECONSTRUCTION;ASD PATIENTS;BONE BRUISE;LOCAL RECURRENCE;PATIENTS UNDERGOING;RISK FACTORS;TOTAL HIP;CLINICAL OUTCOMES;CLINICAL PRACTICE;MINIMALLY INVASIVE","40;30;29;23;20;19;18;18;17;17;17;17;17;15;15;15;15;15;15;14;13;13;13;13;13;13;13;12;12;12",381,1,0,2.75,5,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,6,6,0,0,0,0,0,0,5,5,5,0,0,0,0,0,0,1,1,1,0,0,0,3,3,3,1,1,1,0,0,0,0,0,0,31,31,31,31,31,31
"IRCCS_RIZZOLI",2022,339,10.9026548672566,4.15634218289086,0.240596167494677,0.507374631268437,0.492625368731563,0.442477876106195,0.769911504424779,1,114,81,10,20,0.34,0.24,0.03,0.06,6.48,0.725665407899942,0.336283185840708,0.911504424778761,4.95876887340299,0.504474909999858,0.46236638625645,0.436779324055666,0.435015744489429,"STEFANO ZAFFAGNINI;ALBERTO GRASSI;CESARE FALDINI;MILENA FINI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;TONI IBRAHIM;FRANCESCA BARILE;ALBERTO RIGHI;BARBARA BORDINI;MARCO MANZETTI;EMANUELA PALMERINI;FRANCESCO URSINI;ALESSANDRO GASBARRINI;BRUNELLA GRIGOLO;ALBERTO LEARDINI;NICOLA BALDINI;GIAN ANDREA LUCIDI;GIOVANNI BARBANTI BR√íDANO","40;20;20;19;19;17;16;14;14;13;13;13;13;12;12;11;11;11;11;11","STEFANO ZAFFAGNINI;ALBERTO GRASSI;GIUSEPPE FILARDO;CESARE FALDINI;MILENA FINI;BARBARA BORDINI;ANGELO BOFFA;FRANCESCA BARILE;GIANCARLO FACCHINI;NICOLA BALDINI;SOFIA AVNET;GIAN ANDREA LUCIDI;DAVIDE MAR√çA DONATI;MARCO MANZETTI;STEFANO DI PAOLO;ALBERTO LEARDINI;MARIA GRAZIA BENEDETTI;MARCO VICECONTI;ALBERTO BAZZOCCHI;FRANCESCO TRAINA","5.24;2.72;2.64;2.51;2.4;1.79;1.75;1.64;1.59;1.59;1.58;1.57;1.55;1.5;1.49;1.49;1.48;1.4;1.39;1.3","STEFANO ZAFFAGNINI;ALBERTO GRASSI;CESARE FALDINI;MILENA FINI;GIUSEPPE FILARDO;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;TONI IBRAHIM;FRANCESCA BARILE;ALBERTO RIGHI;BARBARA BORDINI;MARCO MANZETTI;EMANUELA PALMERINI;FRANCESCO URSINI;ALESSANDRO GASBARRINI;BRUNELLA GRIGOLO;ALBERTO LEARDINI;NICOLA BALDINI;GIAN ANDREA LUCIDI;GIOVANNI BARBANTI BR√íDANO","40;20;20;19;19;17;16;14;14;13;13;13;13;12;12;11;11;11;11;11","STEFANO ZAFFAGNINI;ALBERTO GRASSI;GIUSEPPE FILARDO;CESARE FALDINI;MILENA FINI;BARBARA BORDINI;ANGELO BOFFA;FRANCESCA BARILE;GIANCARLO FACCHINI;NICOLA BALDINI;SOFIA AVNET;GIAN ANDREA LUCIDI;DAVIDE MAR√çA DONATI;MARCO MANZETTI;STEFANO DI PAOLO;ALBERTO LEARDINI;MARIA GRAZIA BENEDETTI;MARCO VICECONTI;ALBERTO BAZZOCCHI;FRANCESCO TRAINA","5.24;2.72;2.64;2.51;2.4;1.79;1.75;1.64;1.59;1.59;1.58;1.57;1.55;1.5;1.49;1.49;1.48;1.4;1.39;1.3","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ANGELO BOFFA;ALBERTO GRASSI;ALESSANDRO DI MARTINO;MILENA FINI;LUCA ANDRIOLO;BRUNELLA GRIGOLO;ANNARITA CENACCHI;DAVIDE MAR√çA DONATI;IACOPO ROMANDINI;TONI IBRAHIM;KATIA SCOTLANDI;FRANCESCO URSINI;NICOLA BALDINI;ELIZAVETA KON;STEFANO DI PAOLO;PIERO RUSCITTI;ROBERTO GIACOMELLI;SANTE ALESSANDRO ALTAMURA","344;249;188;163;159;149;138;115;114;109;98;94;90;88;83;82;77;75;75;75","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ANGELO BOFFA;ALBERTO GRASSI;ALESSANDRO DI MARTINO;MILENA FINI;LUCA ANDRIOLO;BRUNELLA GRIGOLO;DAVIDE MAR√çA DONATI;IACOPO ROMANDINI;KATIA SCOTLANDI;NICOLA BALDINI;TONI IBRAHIM;FRANCESCO URSINI;SANTE ALESSANDRO ALTAMURA;CESARE FALDINI;EMANUELA PALMERINI;MARCO VICECONTI;SPARTACO SANTI;ALBERTO RIGHI","329;249;188;163;159;149;138;115;109;98;90;83;82;81;75;74;74;74;69;67","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;GIUSEPPE FILARDO;MILENA FINI;DAVIDE MAR√çA DONATI;KATIA SCOTLANDI;BARBARA BORDINI;FRANCESCA BARILE;EMANUELA PALMERINI;ALBERTO RIGHI;TONI IBRAHIM;MARCO MANZETTI;ALESSANDRO GASBARRINI;ALBERTO RUFFILLI;GIOVANNI BARBANTI BR√íDANO;ALBERTO LEARDINI;FRANCESCO URSINI;ANGELO BOFFA;GIAN ANDREA LUCIDI","38;22;20;19;19;17;16;13;13;13;13;13;12;12;12;11;11;11;11;11","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;PSYCHOLOGY;BUSINESS;POLITICAL SCIENCE;GEOLOGY;SOCIOLOGY;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","293;103;48;44;41;40;31;21;17;15;7;7;4;4;3;1;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;RADIOLOGY;BIOCHEMISTRY;GENETICS;PHYSICAL THERAPY;CANCER RESEARCH;BIOMEDICAL ENGINEERING;ENVIRONMENTAL HEALTH;CELL BIOLOGY;ORTHODONTICS;ONCOLOGY;COMPOSITE MATERIAL;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;OPTICS;ARTIFICIAL INTELLIGENCE;GEOMETRY;PALEONTOLOGY","181;126;108;56;51;46;42;40;39;35;32;31;27;25;24;24;20;18;16;14;14","ALTERNATIVE MEDICINE;GENE;ORTHOPEDIC SURGERY;RETROSPECTIVE COHORT STUDY;POPULATION;CANCER;CHEMOTHERAPY;DISEASE;MAGNETIC RESONANCE IMAGING;OSTEOPOROSIS;ARTHROPLASTY;CARTILAGE;RADIOGRAPHY;IMPLANT;OSTEOSARCOMA;SARCOMA;ANTERIOR CRUCIATE LIGAMENT;CLINICAL TRIAL;MESENCHYMAL STEM CELL;RANDOMIZED CONTROLLED TRIAL","57;39;37;34;32;29;19;19;19;19;18;17;17;16;16;16;14;14;14;14","OSTEOARTHRITIS;FIXATION (POPULATION GENETICS);METASTASIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BONE MINERAL;PLATELET-RICH PLASMA;CISPLATIN;CLINICAL ENDPOINT;EPIGENETICS;MICRORNA;MENISCUS;CHONDROGENESIS;GENOTYPE;GIANT-CELL TUMOR OF BONE;HAZARD RATIO;IMPLANT FAILURE;METHYLATION;STAPHYLOCOCCUS AUREUS;SURVIVORSHIP CURVE;SYNOVITIS;TRANSCRIPTION FACTOR;TUMOR MICROENVIRONMENT;VIABILITY ASSAY","45;11;11;8;8;7;7;7;6;6;6;6;5;4;4;4;4;4;4;4;4;4;4;4;4","ARTICULAR CARTILAGE;CORONAVIRUS DISEASE 2019 (COVID-19);BONE METASTASIS;IFOSFAMIDE;KNEE PAIN;DNA METHYLATION;HIGH TIBIAL OSTEOTOMY;INTRA ARTICULAR;MEDIAL MENISCUS;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SINGLE-NUCLEOTIDE POLYMORPHISM;THORACIC VERTEBRAE;TRABECTEDIN;ANKLE ARTHRODESIS;CD99;CONNECTIVE TISSUE DISEASE;COPY-NUMBER VARIATION;DEBULKING;EPITHELIAL‚ÄìMESENCHYMAL TRANSITION;GENOTYPING;INDUCED PLURIPOTENT STEM CELL;LMNA;MICROVESICLES;NUCLEAR PROTEIN;SPASTIC CEREBRAL PALSY;STAPHYLOCOCCUS EPIDERMIDIS;VANCOMYCIN","10;8;6;6;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;BONE NEOPLASMS;RETROSPECTIVE STUDIES;OSTEOARTHRITIS, KNEE;TREATMENT OUTCOME;FEMALE;KNEE JOINT;MALE;MAGNETIC RESONANCE IMAGING;ADULT;ANTERIOR CRUCIATE LIGAMENT INJURIES;OSTEOSARCOMA;NEOPLASM RECURRENCE, LOCAL;PAIN;CHILD;SARCOMA, EWING;ARTHROPLASTY, REPLACEMENT, HIP;FEMUR;PROSPECTIVE STUDIES","168;158;53;43;26;26;25;25;23;22;21;21;19;18;18;16;16;15;14;14","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;MANAGEMENT OF SPINAL METASTATIC TUMORS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BONE TISSUE ENGINEERING AND BIOMATERIALS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;ELBOW INJURIES AND TREATMENTS IN ATHLETES AND ADULTS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;APPLICATION OF 3D PRINTING IN MEDICAL ANATOMY EDUCATION;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS","23;22;15;14;11;10;10;9;7;6;6;6;5;5;5;4;4;4;4;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;HIP ARTHROPLASTY;KNEE OSTEOARTHRITIS;SOFT TISSUE SARCOMA;SPINAL FUSION;BONE METASTASES;CLINICAL ENDPOINT;DISTAL RADIUS FRACTURES;EWING'S SARCOMA;FOOT (PROSODY);MENISCUS INJURIES;OSTEOARTHRITIS TREATMENT;REPEATABILITY;TREATMENT;3D PRINTED;ATHLETIC REHABILITATION;GIANT CELL TUMOR;HIP ARTHROSCOPY","24;22;15;10;9;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6","KNEE ARTHROPLASTY;BONE MARROW;GIANT CELL;TOTAL KNEE;ANTERIOR CRUCIATE;CONTROLLED TRIAL;CRUCIATE LIGAMENT;EWING SARCOMA;RANDOMIZED CONTROLLED;HIP ARTHROPLASTY;PLATELET-RICH PLASMA;SOFT TISSUE;CLINICAL OUTCOMES;COHORT STUDY;KNEE OSTEOARTHRITIS;LIGAMENT RECONSTRUCTION;MESENCHYMAL STROMAL;RISK FACTORS;STROMAL CELLS;BONE METASTASES;CEREBRAL PALSY;COMPARATIVE STUDY;RETROSPECTIVE COHORT;RETROSPECTIVE STUDY;SURGICAL SITE;TOTAL HIP;ASPIRATE CONCENTRATE;CELL TUMOR;MAGNETIC RESONANCE;MARROW ASPIRATE","11;10;9;9;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4","BONE MARROW;STATISTICALLY SIGNIFICANT;BONE METASTASES;MAGNETIC RESONANCE;PATIENTS TREATED;CELL LINES;CLINICAL OUTCOMES;ACL RECONSTRUCTION;CLINICAL FAILURE;PATIENTS UNDERGOING;RISK FACTORS;SURVIVAL RATE;ADVERSE EVENTS;CEREBRAL PALSY;MIGRATION PERCENTAGE;INCLUDED PATIENTS;KNEE OA;PRESSURE ULCERS;AML CELLS;BONE METASTASIS;GENE EXPRESSION;GOLD STANDARD;MONTHS NA;OSTEOARTHRITIS OA;PROTEIN INTAKE;SOFT TISSUE;SSC PATIENTS;STROMAL CELLS;BLOC RESECTION;CONSECUTIVE PATIENTS","23;21;16;16;16;15;15;14;14;14;14;14;13;13;13;12;12;12;11;11;11;11;11;11;11;11;11;11;10;10",339,1,0,1.75,4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,4,4,0,0,0,0,0,0,4,4,4,0,0,0,0,0,0,1,1,1,0,0,0,2,2,2,1,1,1,0,0,0,0,0,0,6,6,6,6,6,6
"IRCCS_RIZZOLI",2023,338,10.9467455621302,4.22189349112426,0.236860546601261,0.464497041420118,0.464497041420118,0.402366863905325,0.781065088757396,0,119,59,21,23,0.35,0.17,0.06,0.07,3.6,0.820798478519907,0.369822485207101,0.931952662721893,4.63951899426074,0.525905090428362,0.49368626513703,0.431234854853865,0.446950013110534,"STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;BARBARA BORDINI;FRANCESCO TRAINA;TONI IBRAHIM;JACOPO CIAFFI;MILENA FINI;FRANCESCO URSINI;ALBERTO DI MARTINO;ALBERTO RIGHI;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;PAOLO SPINNATO;EMANUELA PALMERINI;GIUSEPPE FILARDO;GIACOMO DAL FABBRO;KATIA SCOTLANDI;ALBERTO LEARDINI","32;32;24;23;18;18;17;17;16;16;16;15;15;14;14;14;14;13;13;12","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO DI MARTINO;DAVIDE MAR√çA DONATI;ANTONIO MAZZOTTI;PAOLO SPINNATO;GIACOMO DAL FABBRO;ALBERTO LEARDINI;GIANLUCA GIAVARESI;FRANCESCO CASTAGNINI;GIUSEPPE FILARDO;MILENA FINI;MARIA GRAZIA BENEDETTI;JACOPO CIAFFI;MARCO INNOCENTI;ELENA ARTIOLI;MATTEO BRUNELLO","4.48;4.09;3.21;2.65;2.42;2.11;2.02;2;1.93;1.88;1.85;1.85;1.8;1.76;1.71;1.68;1.67;1.58;1.58;1.47","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;BARBARA BORDINI;FRANCESCO TRAINA;TONI IBRAHIM;JACOPO CIAFFI;MILENA FINI;FRANCESCO URSINI;ALBERTO DI MARTINO;ALBERTO RIGHI;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;PAOLO SPINNATO;EMANUELA PALMERINI;GIUSEPPE FILARDO;GIACOMO DAL FABBRO;KATIA SCOTLANDI;ALBERTO LEARDINI","32;32;24;23;18;18;17;17;16;16;16;15;15;14;14;14;14;13;13;12","STEFANO ZAFFAGNINI;CESARE FALDINI;ALBERTO GRASSI;FRANCESCO TRAINA;BARBARA BORDINI;ALBERTO DI MARTINO;DAVIDE MAR√çA DONATI;ANTONIO MAZZOTTI;PAOLO SPINNATO;GIACOMO DAL FABBRO;ALBERTO LEARDINI;GIANLUCA GIAVARESI;FRANCESCO CASTAGNINI;GIUSEPPE FILARDO;MILENA FINI;MARIA GRAZIA BENEDETTI;JACOPO CIAFFI;MARCO INNOCENTI;ELENA ARTIOLI;MATTEO BRUNELLO","4.48;4.09;3.21;2.65;2.42;2.11;2.02;2;1.93;1.88;1.85;1.85;1.8;1.76;1.71;1.68;1.67;1.58;1.58;1.47","STEFANO ZAFFAGNINI;CESARE FALDINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;GIOVANNI GRIGNANI;SILVIA STACCHIOTTI;BRUNO VINCENZI;PALMA DILEO;RAVIN RATAN;PETER REICHARDT;HANS GELDERBLOM;ALLISON LIM;BERND KASPER;BREELYN A. WILKY;BRIAN A. VAN TINE;CHARLOTTE BENSON;ELIZABETH T. LOGGERS;F MAZZEO;GABRIEL TINOCO;GINA Z. D‚ÄôAMATO","146;135;134;121;118;115;113;109;109;100;98;97;97;97;97;97;97;97;97;97","STEFANO ZAFFAGNINI;EMANUELA PALMERINI;CESARE FALDINI;GIUSEPPE FILARDO;ANGELO BOFFA;LUCA ANDRIOLO;BARBARA BORDINI;DAVIDE MAR√çA DONATI;MILENA FINI;TONI IBRAHIM;ALBERTO DI MARTINO;GIANLUCA GIAVARESI;MATTEO BRUNELLO;ALBERTO GRASSI;PAOLO SASSU;PAOLO SPINNATO;KATIA SCOTLANDI;ALBERTO LEARDINI;ELETTRA PIGNOTTI;MARCO FRANCESCHINI","144;134;123;121;73;73;70;64;64;63;62;55;54;49;48;47;45;44;44;44","CESARE FALDINI;STEFANO ZAFFAGNINI;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;BARBARA BORDINI;TONI IBRAHIM;JACOPO CIAFFI;MILENA FINI;ALBERTO RIGHI;ALBERTO DI MARTINO;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;FRANCESCO URSINI;EMANUELA PALMERINI;GIUSEPPE FILARDO;PAOLO SPINNATO;KATIA SCOTLANDI;GIACOMO DAL FABBRO;FRANCESCO CASTAGNINI;FRANCESCO TRAINA","34;31;23;21;17;17;17;16;15;15;15;14;14;14;14;14;13;13;12;12","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;MATERIALS SCIENCE;ENGINEERING;MATHEMATICS;PHILOSOPHY;ECONOMICS;GEOLOGY;SOCIOLOGY;PSYCHOLOGY;POLITICAL SCIENCE;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","302;96;47;42;39;38;31;21;13;9;8;8;7;6;2;2;1","SURGERY;INTERNAL MEDICINE;PATHOLOGY;ANATOMY;BIOCHEMISTRY;PHYSICAL THERAPY;GENETICS;BIOMEDICAL ENGINEERING;CANCER RESEARCH;PHYSICAL MEDICINE AND REHABILITATION;RADIOLOGY;CELL BIOLOGY;IMMUNOLOGY;ONCOLOGY;ORTHODONTICS;COMPOSITE MATERIAL;NURSING;ENVIRONMENTAL HEALTH;NUCLEAR MEDICINE;OPTICS","177;123;113;43;43;43;39;33;32;32;32;30;27;25;25;19;18;17;17;17","ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;GENE;CANCER;RETROSPECTIVE COHORT STUDY;ARTHROPLASTY;IMPLANT;SARCOMA;DISEASE;RADIOGRAPHY;COHORT;IN VITRO;POPULATION;CHEMOTHERAPY;ANTERIOR CRUCIATE LIGAMENT;MESENCHYMAL STEM CELL;RANDOMIZED CONTROLLED TRIAL;VALGUS;COMPLICATION;CONFIDENCE INTERVAL;PROSTHESIS;SOFT TISSUE","51;41;33;31;30;29;27;21;20;20;18;17;15;14;13;13;13;13;12;12;12;12","OSTEOARTHRITIS;SOFT TISSUE SARCOMA;METASTASIS;GENE EXPRESSION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BREAST CANCER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MENISCUS;PERIPROSTHETIC;VIABILITY ASSAY;BONE MINERAL;OSSEOINTEGRATION;OSTEOBLAST;PHENOTYPE;UNIVARIATE ANALYSIS;3D BIOPRINTING;ALKALINE PHOSPHATASE;ANEURYSMAL BONE CYST;ARTHRODESIS;BONE SARCOMA;CD8;CLINICAL ENDPOINT;DECELLULARIZATION;FIXATION (POPULATION GENETICS);FOREFOOT;HAZARD RATIO;LIPOSARCOMA;ROTATOR CUFF INJURY;SURVIVORSHIP CURVE","43;9;8;7;6;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);HIGH TIBIAL OSTEOTOMY;IFOSFAMIDE;ARTICULAR CARTILAGE;CD3;MEDIAL MENISCUS;SYNOVIAL FLUID;TRANSCRIPTOME;WOMAC;ANTHRACYCLINE;ANTIRETROVIRAL THERAPY;BONE METASTASIS;CD163;CHROMATIN REMODELING;GIANT CELL ARTERITIS;KNEE PAIN;LACHMAN TEST;LENVATINIB;LMNA;METHYLENETETRAHYDROFOLATE REDUCTASE;MICROVESICLES;MYXOID LIPOSARCOMA;OSTEOCYTE;OSTEOPENIA;OSWESTRY DISABILITY INDEX;STAPHYLOCOCCUS EPIDERMIDIS;SUPERPARAMAGNETISM;TRABECTEDIN","6;6;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;RETROSPECTIVE STUDIES;BONE NEOPLASMS;TREATMENT OUTCOME;ADULT;FEMALE;MALE;ARTHROPLASTY, REPLACEMENT, HIP;KNEE JOINT;SARCOMA;AGED;MIDDLE AGED;ANTERIOR CRUCIATE LIGAMENT INJURIES;OSTEOARTHRITIS, KNEE;QUALITY OF LIFE;OSTEOARTHRITIS;OSTEOSARCOMA;PAIN;OSTEOTOMY","163;160;47;41;34;33;31;30;26;26;26;22;21;20;20;18;17;17;17;15","SARCOMA RESEARCH AND TREATMENT;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;BONE TISSUE ENGINEERING AND BIOMATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;3D BIOPRINTING TECHNOLOGY;MANAGEMENT OF SPINAL METASTATIC TUMORS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;RHEUMATOID ARTHRITIS;TREATMENT AND OUTCOMES OF HAND INJURIES;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING","27;24;20;14;14;10;10;9;9;8;8;7;7;5;4;4;4;4;4;3","TOTAL HIP REPLACEMENT;KNEE BIOMECHANICS;TOTAL KNEE REPLACEMENT;SOFT TISSUE SARCOMA;HIP ARTHROPLASTY;SPINAL FUSION;BONE REGENERATION;FOOT (PROSODY);LIMB RECONSTRUCTION;OSTEOSARCOMA;SYSTEMIC SCLEROSIS;BONE METASTASES;HIP ARTHROSCOPY;REVISION SURGERY;ATHLETIC REHABILITATION;HIGH TIBIAL OSTEOTOMY;MENISCUS;OSTEOBLAST ADHESION;SHOULDER PATHOLOGY;UNIVARIATE ANALYSIS","26;25;18;16;15;9;8;8;8;8;8;7;7;7;6;6;6;6;6;6","HIP ARTHROPLASTY;TOTAL HIP;SYSTEMIC SCLEROSIS;CRUCIATE LIGAMENT;RETROSPECTIVE STUDY;ANTERIOR CRUCIATE;TIBIAL OSTEOTOMY;COMPARATIVE STUDY;KNEE ARTHROPLASTY;LIGAMENT RECONSTRUCTION;PHASE II;SOFT TISSUE;ANEURYSMAL BONE;BONE LOSS;BONE MARROW;COHORT STUDY;DIRECT ANTERIOR;EWING SARCOMA;KNEE OSTEOARTHRITIS;LOWER LIMB;MINIMALLY INVASIVE;RETROSPECTIVE ANALYSIS;ROTATOR CUFF;STILLS DISEASE;SURGICAL TECHNIQUE;ACL RECONSTRUCTION;ADULT-ONSET STILLS;ANKLE ARTHROPLASTY;ANTERIOR APPROACH;BONE CYST","16;14;10;8;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3","RISK FACTORS;SSC PATIENTS;SYSTEMIC SCLEROSIS;CLINICAL PRACTICE;PATIENTS TREATED;HIP ARTHROPLASTY;HR CI;PATIENTS AFFECTED;TOTAL HIP;OBESE PATIENTS;ROTATOR CUFF;SIGNIFICANT DIFFERENCES;PATIENTS UNDERGOING;REVISION SURGERY;ACL RECONSTRUCTION;ASSESSMENT QUESTIONNAIRE-DISABILITY;GENE EXPRESSION;HEALTH ASSESSMENT;QUESTIONNAIRE-DISABILITY INDEX;RETROSPECTIVE STUDY;SURGICAL TECHNIQUE;IRCCS ISTITUTO;ISTITUTO ORTOPEDICO;LOCAL RECURRENCE;LOWER LIMB;ORTOPEDICO RIZZOLI;SOFT TISSUE;SURVIVAL RATES;BOLOGNA ITALYSEARCH;CLINICAL OUTCOMES","25;25;23;19;19;18;18;18;18;17;17;16;15;15;14;14;14;14;14;14;14;13;13;13;13;13;13;13;12;12",338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
"IRCCS_RIZZOLI",2024,370,10.8351351351351,4.32972972972973,0.230961298377029,0.521621621621622,0.508108108108108,0.318918918918919,0.702702702702703,4,139,62,13,25,0.38,0.17,0.04,0.07,0.77,0.808799109848019,0.372972972972973,0.937837837837838,4.00838635049162,0.540195010106457,0.447021226058604,0.441283918847506,0.381873252562908,"STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO GRASSI;GIANLUCA GIAVARESI;ROBERTO TEDESCHI;CESARE FALDINI;ANTONIO MAZZOTTI;FRANCESCO TRAINA;MILENA FINI;FABIO VITA;ELENA ARTIOLI;CESARE FALDINI;DANILO DONATI;EMANUELA PALMERINI;PAOLO SPINNATO;NICOLA BALDINI;DAVIDE MAR√çA DONATI;SIMONE OTTAVIO ZIELLI;KATIA SCOTLANDI;TONI IBRAHIM","49;30;25;23;22;20;19;19;17;17;16;16;16;16;15;15;15;14;13;13","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ROBERTO TEDESCHI;ALBERTO GRASSI;GABRIELA GRAZIANI;ANTONIO MAZZOTTI;PAOLO SPINNATO;FRANCESCO TRAINA;GIANLUCA GIAVARESI;CESARE FALDINI;DANILO DONATI;NICOLA BALDINI;DANIELA PLATANO;CLAUDIO BELVEDERE;ELENA ARTIOLI;FABIO VITA;CESARE FALDINI;KATIA SCOTLANDI;SIMONE OTTAVIO ZIELLI;MILENA FINI","6.37;4.01;3.53;3.14;3.13;2.56;2.55;2.5;2.49;2.36;2.28;2.15;2.12;2.06;2.03;2.01;1.87;1.85;1.77;1.65","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ALBERTO GRASSI;GIANLUCA GIAVARESI;ROBERTO TEDESCHI;CESARE FALDINI;ANTONIO MAZZOTTI;FRANCESCO TRAINA;MILENA FINI;FABIO VITA;ELENA ARTIOLI;CESARE FALDINI;DANILO DONATI;EMANUELA PALMERINI;PAOLO SPINNATO;NICOLA BALDINI;DAVIDE MAR√çA DONATI;SIMONE OTTAVIO ZIELLI;KATIA SCOTLANDI;TONI IBRAHIM","49;30;25;23;22;20;19;19;17;17;16;16;16;16;15;15;15;14;13;13","STEFANO ZAFFAGNINI;GIUSEPPE FILARDO;ROBERTO TEDESCHI;ALBERTO GRASSI;GABRIELA GRAZIANI;ANTONIO MAZZOTTI;PAOLO SPINNATO;FRANCESCO TRAINA;GIANLUCA GIAVARESI;CESARE FALDINI;DANILO DONATI;NICOLA BALDINI;DANIELA PLATANO;CLAUDIO BELVEDERE;ELENA ARTIOLI;FABIO VITA;CESARE FALDINI;KATIA SCOTLANDI;SIMONE OTTAVIO ZIELLI;MILENA FINI","6.37;4.01;3.53;3.14;3.13;2.56;2.55;2.5;2.49;2.36;2.28;2.15;2.12;2.06;2.03;2.01;1.87;1.85;1.77;1.65","ROBERTO TEDESCHI;DANILO DONATI;GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;CESARE FALDINI;THOMAS TISCHER;DANIELA PLATANO;ALBERTO GRASSI;BARI≈û KOCAOƒûLU;DAVIDE MAR√çA DONATI;ELIZAVETA KON;J√âR√âMY MAGALON;LAURA DE GIROLAMO;LIOR LAVER;MARKO OSTOJIƒÜ;MIKEL S√ÅNCHEZ;PHILIPPE BEAUFILS;RAM√ìN CUGAT;RICARDO BASTOS;RODICA MARINESCU","46;41;40;32;30;30;28;27;22;22;22;22;22;22;22;22;22;22;22;22","GIUSEPPE FILARDO;STEFANO ZAFFAGNINI;CESARE FALDINI;DANIELA PLATANO;ALBERTO GRASSI;DAVIDE MAR√çA DONATI;MILENA FINI;EMANUELA PALMERINI;COSTANTINO ERRANI;L√öCIA MARTINI;MATILDE TSCHON;GINA LISIGNOLI;PAOLO SPINNATO;CHIARA DELBALDO;CRISTINA MANFERDINI;DIEGO TRUCCO;ELENA GABUSI;ENRICO LENZI;FABIO VITA;GIORGIA CODISPOTI","40;31;28;28;27;22;21;19;17;17;16;15;15;14;14;14;14;14;14;14","STEFANO ZAFFAGNINI;CESARE FALDINI;GIUSEPPE FILARDO;ALBERTO GRASSI;GIANLUCA GIAVARESI;ANTONIO MAZZOTTI;FRANCESCO TRAINA;MILENA FINI;ELENA ARTIOLI;EMANUELA PALMERINI;FABIO VITA;NICOLA BALDINI;PAOLO SPINNATO;SIMONE OTTAVIO ZIELLI;LUCA ANDRIOLO;MARCO MICELI;KATIA SCOTLANDI;TONI IBRAHIM;DAVIDE MAR√çA DONATI;ANGELO BOFFA","48;42;27;25;23;19;18;17;16;16;16;15;15;14;13;13;13;13;13;12","MEDICINE;BIOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;PHYSICS;ENGINEERING;CHEMISTRY;MATHEMATICS;PSYCHOLOGY;POLITICAL SCIENCE;PHILOSOPHY;ECONOMICS;GEOLOGY;SOCIOLOGY;ART;BUSINESS;HISTORY;GEOGRAPHY","328;91;60;56;43;42;41;23;18;15;12;7;7;7;3;3;3;1","SURGERY;PATHOLOGY;INTERNAL MEDICINE;PHYSICAL THERAPY;ANATOMY;PHYSICAL MEDICINE AND REHABILITATION;BIOMEDICAL ENGINEERING;RADIOLOGY;GENETICS;COMPOSITE MATERIAL;BIOCHEMISTRY;ORTHODONTICS;CELL BIOLOGY;CANCER RESEARCH;ARTIFICIAL INTELLIGENCE;PALEONTOLOGY;IMMUNOLOGY;NANOTECHNOLOGY;LAW;OPTICS","189;125;105;69;53;44;42;39;38;36;33;31;30;27;22;19;18;16;15;15","ALTERNATIVE MEDICINE;ORTHOPEDIC SURGERY;ARTHROPLASTY;CANCER;IMPLANT;GENE;COHORT;RETROSPECTIVE COHORT STUDY;SARCOMA;ANKLE;RANGE OF MOTION;CLINICAL TRIAL;RADIOGRAPHY;ANTERIOR CRUCIATE LIGAMENT;CHEMOTHERAPY;OSTEOSARCOMA;RANDOMIZED CONTROLLED TRIAL;SOFT TISSUE;TIBIA;VALGUS","67;45;31;26;26;25;23;21;16;15;15;14;14;13;13;13;13;13;13;13","OSTEOARTHRITIS;OSSEOINTEGRATION;LOW BACK PAIN;PERIPROSTHETIC;CLINICAL ENDPOINT;MENISCUS;FIBULA;IDIOPATHIC SCOLIOSIS;PLATELET-RICH PLASMA;SURVIVORSHIP CURVE;CAPSULITIS;CELL CYCLE;IMMUNOTHERAPY;STAPHYLOCOCCUS AUREUS;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BIOFILM;HIP ARTHROPLASTY;OSTEOCLAST;ACL INJURY;ARTHRODESIS;BREAST CANCER;CHONDROGENESIS;COBB ANGLE;COLLAGEN VI;DENOSUMAB;ETOPOSIDE;EWING'S SARCOMA;FIRST METATARSAL;FIXATION (POPULATION GENETICS);FOREFOOT;IN SILICO;LIPOSARCOMA;METASTASIS;OSTEOBLAST;PLACEBO;SOFT TISSUE SARCOMA;SPONDYLOLISTHESIS;TUMOR MICROENVIRONMENT;UNIVARIATE ANALYSIS;VIABILITY ASSAY","52;11;8;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ARTICULAR CARTILAGE;HIGH TIBIAL OSTEOTOMY;MEDIAL MENISCUS;OSWESTRY DISABILITY INDEX;UNICOMPARTMENTAL KNEE ARTHROPLASTY;IFOSFAMIDE;BONE METASTASIS;CANCER IMMUNOTHERAPY;CD99;CHIMERIC ANTIGEN RECEPTOR;FLI1;KNEE PAIN;NEOADJUVANT THERAPY;NIVOLUMAB;QUANTITATIVE COMPUTED TOMOGRAPHY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;WOMAC;ANTIRETROVIRAL THERAPY;BALLET DANCER;C2C12;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CELL COUNTING;CERVICAL CARCINOMA;CHROMATIN REMODELING;CORONAVIRUS DISEASE 2019 (COVID-19);CUT;CYCLIN;CYCLIN-DEPENDENT KINASE 1;DBM;DESMIN;DNA METHYLATION;ELECTROCHEMOTHERAPY;ENDOSCOPIC CARPAL TUNNEL RELEASE;ENTEROCOCCUS FAECALIS;FACET (PSYCHOLOGY);FLUORESCENCE IN SITU HYBRIDIZATION;GATA3;GENETIC ARCHITECTURE;GERMLINE MUTATION;HAMSTRING INJURY;HAPLOTYPE;HEME OXYGENASE;INTERMEDIATE FILAMENT;INTRA ARTICULAR;IRINOTECAN;JOINT INFECTIONS;KNEE ARTHRITIS;LACHMAN TEST;LACTOBACILLUS PLANTARUM;LENVATINIB;LMNA;LOW LEVEL LASER THERAPY;LOW-INTENSITY PULSED ULTRASOUND;MATRIX GLA PROTEIN;METHACRYLATE;MICROFILAMENT;MICROVESICLES;MONOCLONAL;MULTIFIDUS MUSCLE;MYXOID LIPOSARCOMA;ONCOGENE;OSTEOCALCIN;OSTEONECROSIS OF THE JAW;OSTEOPENIA;OXFORD KNEE SCORE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PERICYTE;PIVOT-SHIFT TEST;RPOB;SYNOVIAL FLUID;TELEHEALTH;TRABECTEDIN;TURNOUT;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;VANCOMYCIN;VENETOCLAX","6;5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;BONE NEOPLASMS;YOUNG ADULT;ADOLESCENT;ANIMALS;FOLLOW-UP STUDIES;PROSPECTIVE STUDIES;KNEE JOINT;CHILD;ITALY;OSTEOARTHRITIS, KNEE;OSTEOSARCOMA","240;124;61;58;39;38;32;26;21;16;15;14;13;12;12;11;10;10;10;8","SARCOMA RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;BONE TISSUE ENGINEERING AND BIOMATERIALS;OSTEOARTHRITIS AND CARTILAGE REPAIR;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;IMPACT OF SPINAL DEFORMITY ON HEALTH AND FUNCTION;TREATMENT AND OUTCOMES OF HAND INJURIES;BIOMECHANICS OF RUNNING-RELATED INJURIES;EPIDEMIOLOGY OF SPORTS-RELATED MUSCULOSKELETAL INJURIES;3D BIOPRINTING TECHNOLOGY;DIAGNOSIS AND TREATMENT OF SYNOVIAL DISORDERS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE","32;24;19;17;14;13;12;10;9;8;7;7;7;7;6;6;5;5;5;4","KNEE BIOMECHANICS;TOTAL HIP REPLACEMENT;TOTAL KNEE REPLACEMENT;BIOMECHANICS;HIP ARTHROPLASTY;BONE REGENERATION;SPINAL FUSION;SOFT TISSUE SARCOMA;ANTERIOR CRUCIATE LIGAMENT;EWING'S SARCOMA;KNEE OSTEOARTHRITIS;MICROSURGICAL RECONSTRUCTION;OSTEOARTHRITIS;CLINICAL ENDPOINT;MENISCUS;OSTEOBLAST ADHESION;REHABILITATION;BIOCOMPATIBILITY;BONE TISSUE;IDIOPATHIC SCOLIOSIS","30;20;17;14;14;12;12;11;9;9;9;9;8;7;7;7;7;6;6;6","ANTERIOR CRUCIATE;KNEE OSTEOARTHRITIS;CRUCIATE LIGAMENT;HIP ARTHROPLASTY;KNEE ARTHROPLASTY;RETROSPECTIVE STUDY;TOTAL HIP;RANDOMIZED CONTROLLED;TOTAL ANKLE;ANKLE ARTHROPLASTY;CLINICAL OUTCOMES;CONTROLLED TRIAL;GIANT CELL;IDIOPATHIC SCOLIOSIS;MINIMALLY INVASIVE;PILOT STUDY;REGISTRY STUDY;TOTAL KNEE;ADHESIVE CAPSULITIS;ADOLESCENT IDIOPATHIC;BONE TISSUE;CLINICAL STUDY;COHORT STUDY;CROSS-SECTIONAL STUDY;EWING SARCOMA;SOFT TISSUE;TENOSYNOVIAL GIANT;ALLOGRAFT TRANSPLANTATION;BONE TUMORS;CELL TUMOR","11;11;10;9;9;9;9;8;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4","KNEE OA;OSTEOARTHRITIS OA;ABSTRACT PURPOSE;PATIENTS LOST;STATISTICALLY SIGNIFICANT;CLINICAL OUTCOMES;SIGNIFICANT DIFFERENCES;SOFT TISSUE;TOTAL HIP;ADVERSE EVENTS;CLINICAL SCORES;HIP ARTHROPLASTY;POSTAMPUTATION PAIN;RANDOMIZED CONTROLLED;COLLAGEN VI;KNEE OSTEOARTHRITIS;CLINICAL PRACTICE;MINIMALLY INVASIVE;ANTERIOR CRUCIATE;CLINICAL RESULTS;CONTROLLED TRIAL;CRUCIATE LIGAMENT;HR CI;KNEE ARTHROPLASTY;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;RISK FACTORS;STUDY DESIGN;ANALOG SCALE;FUNCTIONAL OUTCOMES;IKDC SUBJECTIVE","23;17;16;16;16;15;15;15;15;14;14;14;14;14;13;13;12;12;11;11;11;11;11;11;11;11;11;10;10;10",370,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
